syndrome	score	normalized_score
DRAVET SYNDROME	2.66982904	100.0
CHILDHOOD ABSENCE EPILEPSY	1.5207408500000001	56.96023330392721
MYOCLONIC-ASTASTIC EPILEPSY	1.223545494	45.828608336659634
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.193694	44.71050326128747
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.1564266	43.314631112110455
HEMIDYSTONIA-HEMIATROPHY SYNDROME	1.000541419	37.4758609637417
PAROXYSMAL KINESIGENIC DYSKINESIA	1.0	37.45558180009908
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0	37.45558180009908
MYOCLONIC EPILEPSY OF LAFORA	0.93444076	35.00002232352675
LAFORA DISEASE	0.7715289599999999	28.898066072425365
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706171	28.863911825605133
CRANIOSYNOSTOSIS 4; CRS4	0.75406504	28.243944788314984
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.748578964	28.038460619935424
EARLY MYOCLONIC ENCEPHALOPATHY	0.708728914	26.545853812422386
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.688410474	25.78481482095198
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.59705175	22.362920661017306
ROLANDIC EPILEPSY	0.5906213	22.12206441503086
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.5555556	20.808658220303126
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.5333330000000001	19.976297808192243
MENINGIOMA	0.5277778	19.76822456017633
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.527027	19.740102909360818
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.516847064	19.358807483793044
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.5135696	19.23604816284416
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	18.99156247098129
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.500545554	18.74822494252291
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.500545554	18.74822494252291
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	18.72779090004954
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.5	18.72779090004954
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.5	18.72779090004954
CREST SYNDROME	0.5	18.72779090004954
PAROXYSMAL HEMICRANIA	0.5	18.72779090004954
TRICHODENTOOSSEOUS SYNDROME	0.5	18.72779090004954
INHALATIONAL ANTHRAX	0.5	18.72779090004954
TRICHO-DENTO-OSSEOUS SYNDROME	0.5	18.72779090004954
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.42505119	15.920539616274457
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.415131304	15.548984514753798
SPINOCEREBELLAR ATAXIA TYPE 10	0.4088913	15.315261534498854
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.38836981000000004	14.546617187143937
PERIORAL MYOCLONIA WITH ABSENCES	0.36455991	13.654803530041756
EPILEPSY, JUVENILE ABSENCE	0.35751765999999996	13.391031959110009
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	13.391031959110009
CENTRALOPATHIC EPILEPSY	0.35470090000000004	13.285528574518764
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.34968319400000003	13.097587476986916
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.348573844	13.056036127316975
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.3448273	12.915707142057306
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.34259226	12.83199241851081
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34037525	12.748953019104176
COG4-CDG	0.333878554	12.505615490645797
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	0.333333	12.485181448172424
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.333333	12.485181448172424
OROFACIODIGITAL SYNDROME TYPE 3	0.333333	12.485181448172424
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.31997624999999996	11.984896605963952
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.30128141399999997	11.284670646926514
DOORS SYNDROME	0.290935564	10.897160815959959
DYSTONIA 6, TORSION	0.2635135	9.870051454680409
PALLISTER-HALL SYNDROME	0.261290384	9.786783351491298
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.259940294	9.736214945058803
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.25327035400000003	9.486388461787051
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.252506059	9.457761347895143
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.252176874	9.445431532200278
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25196464	9.437482184252517
NIJMEGEN BREAKAGE SYNDROME	0.25	9.36389545002477
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	9.36389545002477
HYPEROSTOSIS CRANIALIS INTERNA; HCIN	0.25	9.36389545002477
HYPERPARATHYROIDISM 2	0.25	9.36389545002477
HYPEREKPLEXIA 1; HKPX1	0.25	9.36389545002477
OTOFACIOCERVICAL SYNDROME 2	0.25	9.36389545002477
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE	0.25	9.36389545002477
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.24304515400000004	9.103397646764678
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.23908618000000004	8.955111972263213
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.234614804	8.787633982736212
LENNOX-GASTAUT SYNDROME	0.23257130999999998	8.7110937260612
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915	8.462307758851855
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.216847064	8.12213294376332
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.21135259	7.916334223407803
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.20840336	7.805869097895496
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.20518830000000002	7.685447155073271
6P22 MICRODELETION SYNDROME	0.20163132	7.552218399721953
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.2	7.491116360019816
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.2	7.491116360019816
JUVENILE HYALINE FIBROMATOSIS	0.2	7.491116360019816
BETA-THALASSEMIA	0.2	7.491116360019816
INFANTILE MYOFIBROMATOSIS	0.2	7.491116360019816
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.18939175000000003	7.093778184388916
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.18559615399999999	6.951611927930785
MYOCLONIC EPILEPSY OF INFANCY	0.18559615399999999	6.951611927930785
JUVENILE MYOCLONIC EPILEPSY	0.18297529999999998	6.853446316547668
AURICULOOSTEODYSPLASIA	0.17473152	6.544670740415648
AURICULOOSTEODYSPLASIA	0.17473152	6.544670740415648
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.171434473	6.421177926808378
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.17042955399999998	6.3835381010014025
MICROTRIPLICATION 11Q24.1	0.1693918	6.344668421166023
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.16926173400000002	6.3397967234636114
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.168466454	6.310009048369627
UNILATERAL POLYMICROGYRIA	0.1680017	6.292601416905705
BRANCHIOSKELETOGENITAL SYNDROME	0.167208419	6.26288861551974
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.1595057	5.974378793932064
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.1595057	5.974378793932064
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.15945895	5.972627745482908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.15489685399999997	5.801751785575003
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.15266181399999998	5.718037062028509
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.15266181399999998	5.718037062028509
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.1515915	5.677947828449719
NEUROGENIC ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.15155264999999998	5.676492679096785
LÉRI-WEILL DYSCHONDROSTEOSIS	0.14959561999999998	5.603190981846537
DISTAL MONOSOMY 7Q36	0.14612321899999997	5.4731301821482905
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.14520145	5.438604787967996
PIEBALDISM	0.14482163999999997	5.424378783444499
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.143402554	5.371226091690125
PACMAN DYSPLASIA	0.14285699999999998	5.3507920492167536
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.14285699999999998	5.3507920492167536
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	0.14285699999999998	5.3507920492167536
MACROSOMIA-MICROPHTHALMIA-CLEFT PALATE SYNDROME	0.14285699999999998	5.3507920492167536
COMBINED SAPOSIN DEFICIENCY	0.14285699999999998	5.3507920492167536
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.13756670399999998	5.152640934642017
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.13678895400000002	5.123509855896991
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.1324787	4.962066784620786
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.12522615399999998	4.690418454658803
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.12406020000000001	4.646746969236652
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.12231927000000001	4.581539423213405
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.11815324999999999	4.4254987203225555
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.11309530000000001	4.236050260356746
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.11157119400000001	4.178963983401724
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.11106920400000002	4.1601616558938925
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.10689451999999999	4.003796437842326
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.10576764	3.961588491823431
BILATERAL POLYMICROGYRIA	0.104660764	3.9201298072628648
AICARDI SYNDROME; AIC	0.1036867	3.883645673432333
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.10044303400000001	3.7621522762371336
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.098953104	3.7063460812457114
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.09839385400000002	3.6853990471240063
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185	3.6752109790520517
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185	3.6752109790520517
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185	3.6752109790520517
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185	3.6752109790520517
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185	3.6752109790520517
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.097203194	3.6408021840979
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.09636237	3.609308631986413
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.08992909	3.3683463867034718
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.08122672	3.042394055313744
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.07904281	2.9605944356646896
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.077789744	2.9136601196007663
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.07746865400000001	2.901633506840573
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.07746865400000001	2.901633506840573
TURNPENNY-FRY SYNDROME; TPFS	0.077216954	2.8922059369014876
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.07692310000000001	2.8811994643672016
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.0763091	2.8582017371419406
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.07628449400000001	2.8572801050961676
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.07573894	2.8368460626227963
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.07485825	2.8038593062872668
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.07300403999999999	2.7344087919577045
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.07197415400000001	2.6958338126399286
TUBEROUS SCLEROSIS COMPLEX	0.0715302	2.679205257277447
SCHINZEL-GIEDION SYNDROME	0.07142860000000001	2.6753997701665573
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.071273159	2.669577637075968
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.07077939999999999	2.6510836064619325
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.07073174	2.64929847343334
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.06871588	2.573793264305792
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.06871588	2.573793264305792
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.067212254	2.5174740776660367
ATELOSTEOGENESIS TYPE II	0.06683839999999999	2.5034711585877423
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.0666667	2.497040035192665
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.0666667	2.497040035192665
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.0666667	2.497040035192665
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0666667	2.497040035192665
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.0666667	2.497040035192665
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	2.497040035192665
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.0666667	2.497040035192665
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.0666667	2.497040035192665
AUTOIMMUNE HYPOPARATHYROIDISM	0.0666667	2.497040035192665
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.0666667	2.497040035192665
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.06609343300000001	2.475567986180868
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.06590177300000001	2.468389249373061
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.0648148	2.427676043257062
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.0648148	2.427676043257062
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.064030564	2.398302027608479
HOLMES-GANG SYNDROME	0.06350412400000001	2.3785839111256353
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.06259785000000001	2.3446388911853324
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.061868669	2.3173269925927538
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.061868669	2.3173269925927538
611961 STEVENSON-CAREY SYNDROME	0.061783093	2.3141216937246285
PENILE AGENESIS	0.06132725	2.2970478289501264
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.060411494	2.262747655183195
49,XXXYY SYNDROME	0.0602926	2.2582944112406538
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.05874582	2.200358866423896
WHITE-SUTTON SYNDROME; WHSUS	0.058150334	2.1780545918400827
15Q13.3 MICRODELETION SYNDROME	0.058074693	2.175221414177141
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.05777791	2.1641052342437623
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.057314533	2.1467491791159783
AUTOSOMAL RECESSIVE ATAXIA, BEAUCE TYPE	0.05694194	2.132793491526334
2P15P16.1 MICRODELETION SYNDROME	0.056773114	2.12647001547335
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.056773114	2.12647001547335
2Q23.1 MICRODUPLICATION SYNDROME	0.055901954	2.0938402108323757
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.055555600000000004	2.0808673202535846
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	2.0808673202535846
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.055555600000000004	2.0808673202535846
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	2.0808673202535846
GITELMAN SYNDROME	0.055555600000000004	2.0808673202535846
CONGENITAL ISOLATED ACTH DEFICIENCY	0.055555600000000004	2.0808673202535846
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.055555600000000004	2.0808673202535846
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.055555600000000004	2.0808673202535846
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.055555600000000004	2.0808673202535846
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.055555600000000004	2.0808673202535846
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	2.0808673202535846
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	2.0808673202535846
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	2.0808673202535846
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.055555600000000004	2.0808673202535846
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	2.0808673202535846
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.055222199	2.0683795918258494
MOWAT-WILSON SYNDROME; MOWS	0.055137659000000006	2.0652130969404694
BAKER-GORDON SYNDROME; BAGOS	0.054808473999999996	2.0528832812456033
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.054804339	2.0527284024148598
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.05426292	2.0324492387722324
POTOCKI-LUPSKI SYNDROME	0.053718573	2.0120604051860935
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.053177154	1.991781241543466
KEPPEN-LUBINSKY SYNDROME	0.053173019	1.9916263627127224
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.053173019	1.9916263627127224
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.05286995	1.980274736992148
THREE M SYNDROME 2; 3M2	0.0526316	1.9713471990700944
MOEBIUS SYNDROME-AXONAL NEUROPATHY-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.0526316	1.9713471990700944
ARTHROGRYPOSIS-OCULOMOTOR LIMITATION-ELECTRORETINAL ANOMALIES SYNDROME	0.0526316	1.9713471990700944
%601356 LETHAL SHORT-LIMB SKELETAL DYSPLASIA, AL GAZALI TYPE	0.0526316	1.9713471990700944
HUMEROFEMORAL HYPOPLASIA WITH RADIOTIBIAL RAY DEFICIENCY; HHRRD	0.0526316	1.9713471990700944
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.0526316	1.9713471990700944
CHROMOSOME 1P36 DELETION SYNDROME	0.05187993299999999	1.9431930742651593
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.051281214	1.920767705785386
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.051181119000000004	1.9170185893251053
AICARDI SYNDROME	0.05084892	1.9045758825066939
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.049076854	1.8382021194885196
ADNP SYNDROME	0.048677239000000004	1.823234307167473
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.0475633	1.7815110738326527
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.045921983999999985	1.7200346281348404
DISTAL MONOSOMY 12Q	0.04493705399999999	1.683143501952469
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.6827111147161689
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.044297953999999994	1.659205639624026
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.043986594	1.6475434696747473
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.04326676399999999	1.6205818182275817
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.043248754	1.6199072431993624
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.042756550000000004	1.6014714560150263
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.042756550000000004	1.6014714560150263
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.0427032	1.5994732007259909
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.042599213999999996	1.5955783445969256
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.04236914	1.5869607890698498
PITT-HOPKINS-LIKE SYNDROME	0.042317719000000004	1.585034785598107
WITTEVEEN-KOLK SYNDROME	0.042292453	1.5840884328683456
COG2-CDG	0.04221225399999999	1.581084532663559
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.041904993999999994	1.5695759305996606
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.04134734	1.5486886755865088
CANAVAN DISEASE	0.04134734	1.5486886755865088
CHRISTIANSON SYNDROME	0.04134734	1.5486886755865088
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.041271154	1.5458350846314861
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.04126499	1.5456042084252706
AARSKOG-SCOTT SYNDROME	0.04016549399999999	1.5044219460583883
ALPERS-HUTTENLOCHER SYNDROME	0.039675944000000005	1.4860855659881504
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.03961993999999999	1.4839879035850172
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.03930035	1.4720174741975238
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.039272100000000004	1.4709593540116712
TRICHOTHIODYSTROPHY	0.039213873999999996	1.4687784653057783
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.038925143999999995	1.4579639151726356
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.03857885999999999	1.44499364648457
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	1.4428377031961563
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.038470234	1.4409249964559527
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.03837959	1.4375298726992645
HELSMOORTEL-VAN DER AA SYNDROME	0.038366653	1.4370453098375167
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	1.4189395437844212
LISSENCEPHALY 2; LIS2	0.037582554	1.4076764256036407
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.037582554	1.4076764256036407
16P13.11 MICRODELETION SYNDROME	0.037582554	1.4076764256036407
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.037037	1.3872423831302696
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.037037	1.3872423831302696
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.037037	1.3872423831302696
MCLEOD SYNDROME; MCLDS	0.037037	1.3872423831302696
MYOCLONUS AND ATAXIA	0.037037	1.3872423831302696
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.037037	1.3872423831302696
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.036868693999999994	1.380938383979822
MENTAL RETARDATION, X-LINKED 98; MRX98	0.036765932999999994	1.3770894109384617
WEST SYNDROME	0.03656844	1.3696921957220152
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.036484994	1.366566677243124
LUSCAN-LUMISH SYNDROME; LLS	0.036402013	1.36345857560977
THUMBS, CONGENITAL CLASPED	0.0361093	1.3524948398943175
WOLF-HIRSCHHORN SYNDROME	0.03593293299999999	1.3458889112989794
15Q24 MICRODELETION SYNDROME	0.03593293299999999	1.3458889112989794
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.035842320000000004	1.3424949486653273
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.03566625	1.3359001443777836
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.03566625	1.3359001443777836
JUVENILE ABSENCE EPILEPSY	0.03566625	1.3359001443777836
TEMPLE-BARAITSER SYNDROME	0.035387379	1.3254548688256083
RAMOS-ARROYO SYNDROME	0.03531504	1.3227453694937708
15Q26 OVERGROWTH SYNDROME	0.03526382	1.3208268945939698
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.034820050000000005	1.3042052310585401
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.034820050000000005	1.3042052310585401
TRISOMY 17P	0.034520353999999996	1.2929799430153772
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.034520353999999996	1.2929799430153772
PEHO SYNDROME	0.03443497399999999	1.2897819854412846
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.034069249999999995	1.2760835802430255
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.033889419999999996	1.2693479429679135
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.033844733999999994	1.2676742028395944
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.033760194	1.2645077079542142
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.033426873999999995	1.252023013428605
MÜLLERIAN APLASIA AND HYPERANDROGENISM	0.03329918	1.247240160366223
NOONAN SYNDROME 4; NS4	0.03288132	1.2315889709552337
OROFACIAL CLEFT 15	0.03288132	1.2315889709552337
3P25.3 MICRODELETION SYNDROME	0.032858229999999995	1.2307241215714693
SLC35A2-CDG	0.032803653999999995	1.228679945739147
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.032799519	1.228525066908404
TUBEROUS SCLEROSIS 2; TSC2	0.032799519	1.228525066908404
TUBEROUS SCLEROSIS-1	0.032799519	1.228525066908404
PIERPONT SYNDROME	0.032336973	1.2112001373690953
WIEACKER-WOLFF SYNDROME	0.032336973	1.2112001373690953
ALG13-CDG	0.0322581	1.208245903265776
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.0322581	1.208245903265776
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.03208814	1.2018799525830313
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.031795554	1.1909209737264674
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.031795554	1.1909209737264674
XP22.13P22.2 DUPLICATION SYNDROME	0.031791419	1.1907660948957242
BLEPHAROCHEILODONTIC SYNDROME 1; BCDS1	0.03125	1.1704869312530963
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.03125	1.1704869312530963
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.03125	1.1704869312530963
EPILEPSY, IDIOPATHIC GENERALIZED	0.031226909999999997	1.169622081869332
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.029710972999999998	1.1128417795620351
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.02907618	1.0890652384244048
CHROMOSOME 17Q12 DELETION SYNDROME	0.028658319999999998	1.0734140490134154
FEBRILE CONVULSIONS, FAMILIAL, 9	0.028623999999999997	1.072128573446036
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	1.072128573446036
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.028341363999999997	1.0615422776283832
EPILEPSY, PYRIDOXINE-DEPENDENT	0.028341363999999997	1.0615422776283832
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.028323354000000002	1.0608677026001636
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.028323354000000002	1.0608677026001636
8Q24.3 MICRODELETION SYNDROME	0.028232943	1.0574813059940347
GANGLIOCYTOMA	0.027777800000000002	1.0404336601267923
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.027777800000000002	1.0404336601267923
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.027777800000000002	1.0404336601267923
PERIVENTRICULAR NODULAR HETEROTOPIA	0.027777800000000002	1.0404336601267923
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.027572554	1.032746051784649
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.027568419	1.0325911729539057
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.027535599	1.0313618807592264
AYMÉ-GRIPP SYNDROME	0.027495253999999997	1.0298507353115014
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.027442294	1.027867087699368
APNEA, OBSTRUCTIVE SLEEP	0.027027	1.0123120093112776
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.027027	1.0123120093112776
BENIGN OCCIPITAL EPILEPSY	0.027027	1.0123120093112776
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.027027	1.0123120093112776
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	1.0123120093112776
CONGENITAL TRACHEAL STENOSIS	0.02593705	0.9714872979282597
DISTAL MONOSOMY 10Q	0.025924793	0.9710282048621361
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.025664603999999997	0.9612826744891498
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.025609454	0.9592169991528745
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.024730213999999997	0.9262845534109552
19P13.3 MICRODUPLICATION SYNDROME	0.023939994	0.896686403560881
PENTASOMY X	0.023825814	0.8924097252309459
HAREL-YOON SYNDROME; HAYOS	0.023535473999999997	0.881534871611105
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.023392444	0.8761775997462368
SALT-AND-PEPPER SYNDROME	0.023392444	0.8761775997462368
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.022989919999999997	0.8611008291377337
AMISH INFANTILE EPILEPSY SYNDROME	0.022846889999999998	0.8557435572728654
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.022601589999999998	0.8465557030573011
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.022513204	0.8432451540043178
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.022513204	0.8432451540043178
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.022513204	0.8432451540043178
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.022513204	0.8432451540043178
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.022402593000000002	0.8391021546458272
LETHAL CONGENITAL CONTRACTURE SYNDROME 10; LCCS10	0.022209149999999997	0.8318566345356703
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.02196765	0.8228111115309464
SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA	0.02157802	0.8082172931941739
ZUNICH NEUROECTODERMAL SYNDROME	0.021453519	0.8035540358044798
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.021286404	0.7972946462519561
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.021164049999999997	0.7927118059963868
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.021101304	0.790361618060758
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.021096879000000002	0.7901958771112926
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.021045054	0.7882547415845024
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.020910783000000002	0.7832255431606212
BEEMER LETHAL MALFORMATION SYNDROME	0.02083254	0.780294906073836
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.020740849999999998	0.7768606037785849
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.7768606037785849
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.7768606037785849
X SMALL RINGS	0.020639573999999997	0.7730672522761981
GAUCHER DISEASE	0.02061185	0.7720288337263722
MEGAEPIPHYSEAL DWARFISM	0.02049922	0.7678102115482269
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.020443213999999998	0.7657124742339306
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.020369364	0.7629463795179934
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.020150623	0.7547533080994578
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.020088733999999997	0.7524352195974314
FG SYNDROME TYPE 1	0.020016633000000002	0.7497346346940627
BAND HETEROTOPIA; BH	0.019954873	0.7474213779620885
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.019954873	0.7474213779620885
CORNELIA DE LANGE SYNDROME	0.019734099	0.7391521593457535
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.019704194	0.7380320501720214
16P13.2 MICRODELETION SYNDROME	0.019677793000000002	0.7370431853569172
COPPER DEFICIENCY, FAMILIAL BENIGN	0.019409319	0.7269873354887173
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.019409319	0.7269873354887173
HHHH SYNDROME	0.019409319	0.7269873354887173
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.01929058	0.7225398971613554
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.019275884	0.7219894499312209
OKAMOTO SYNDROME	0.019270363999999998	0.7217826951196844
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.01920604	0.7193734022759749
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.019082104	0.7147313072899978
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.018933593999999998	0.709168778836865
NON-DISTAL MONOSOMY 20Q	0.018932909	0.709143121763332
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.018910813	0.708315503227877
TOE, MISSHAPEN	0.0188679	0.7067081718460894
TRACHEOBRONCHOMEGALY	0.0188679	0.7067081718460894
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.0188679	0.7067081718460894
MONOPHALANGY OF GREAT TOE	0.0188679	0.7067081718460894
MICROPHTHALMIA, SYNDROMIC 4	0.0188679	0.7067081718460894
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0188679	0.7067081718460894
THROMBOCYTHEMIA, ESSENTIAL	0.0188679	0.7067081718460894
RAYNAUD DISEASE	0.0188679	0.7067081718460894
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0188679	0.7067081718460894
THROMBOCYTOPENIA 3	0.0188679	0.7067081718460894
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0188679	0.7067081718460894
CARPAL DISPLACEMENT	0.0188679	0.7067081718460894
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0188679	0.7067081718460894
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0188679	0.7067081718460894
THALIDOMIDE SUSCEPTIBILITY	0.0188679	0.7067081718460894
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.0188679	0.7067081718460894
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0188679	0.7067081718460894
KNUCKLE PADS	0.0188679	0.7067081718460894
248100 MACROSOMIA ADIPOSA CONGENITA	0.0188679	0.7067081718460894
DERMOCHONDROCORNEAL DYSTROPHY	0.0188679	0.7067081718460894
TRACHEOPATHIA OSTEOPLASTICA	0.0188679	0.7067081718460894
CIRCUMVALLATE PLACENTA SYNDROME	0.0188679	0.7067081718460894
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0188679	0.7067081718460894
LETTERER-SIWE DISEASE	0.0188679	0.7067081718460894
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0188679	0.7067081718460894
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0188679	0.7067081718460894
SPINAL ARACHNOIDITIS	0.0188679	0.7067081718460894
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0188679	0.7067081718460894
PACHYDERMODACTYLY, FAMILIAL	0.0188679	0.7067081718460894
VAN DEN BOSCH SYNDROME	0.0188679	0.7067081718460894
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0188679	0.7067081718460894
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0188679	0.7067081718460894
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0188679	0.7067081718460894
VESICOURETERAL REFLUX 1	0.0188679	0.7067081718460894
DOUBLE NAIL FOR FIFTH TOE	0.0188679	0.7067081718460894
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0188679	0.7067081718460894
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0188679	0.7067081718460894
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.0188679	0.7067081718460894
NEPHROSIALIDOSIS	0.0188679	0.7067081718460894
PUBIC BONE DYSPLASIA	0.0188679	0.7067081718460894
PRIMARY HYPEROXALURIA TYPE 1	0.0188679	0.7067081718460894
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.01859082	0.696329979240918
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.6942972648166265
AL KAISSI SYNDROME; ALKAS	0.018196433	0.6815579847015223
EMANUEL SYNDROME	0.018185983	0.6811665738717112
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.018008939999999998	0.6745353253030762
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.017981514	0.6735080685166267
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.017954909999999998	0.6725116002184168
6Q25 MICRODELETION SYNDROME	0.017934033000000002	0.6717296400371764
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.017644563999999998	0.6608874102290833
PEDIATRIC-ONSET GRAVES DISEASE	0.017644563999999998	0.6608874102290833
RUBINSTEIN-TAYBI SYNDROME	0.017521433000000003	0.6562754669864554
1P36 DELETION SYNDROME	0.017521433	0.6562754669864553
SAETHRE-CHOTZEN SYNDROME	0.017473019000000003	0.6544620924491855
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.017365939	0.6504513487500309
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.017309632999999998	0.6483423747611943
CRANIOFRONTONASAL DYSPLASIA	0.01726492	0.6466676233321665
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.6457866680482283
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.6457866680482283
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.6457866680482283
ERYTHERMALGIA, PRIMARY	0.0172414	0.6457866680482283
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.6457866680482283
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.6457866680482283
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.6457866680482283
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.6457866680482283
CARDIAC ARRHYTHMIA	0.0172414	0.6457866680482283
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	0.6457866680482283
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.6457866680482283
MOSAIC TRISOMY 15	0.0172414	0.6457866680482283
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.6457866680482283
CERVICAL RIB	0.0172414	0.6457866680482283
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.6457866680482283
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.6457866680482283
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.6457866680482283
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.6457866680482283
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.6457866680482283
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.6457866680482283
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.6457866680482283
TRANSSEXUALITY	0.0172414	0.6457866680482283
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.6457866680482283
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.6457866680482283
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.6457866680482283
SICKLE CELL ANEMIA	0.0172414	0.6457866680482283
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.6457866680482283
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.6457866680482283
PALMOMENTAL REFLEX	0.0172414	0.6457866680482283
ALCOHOL DEPENDENCE	0.0172414	0.6457866680482283
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.6457866680482283
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.6457866680482283
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.6457866680482283
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.6457866680482283
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	0.6457866680482283
DIASTEMATOMYELIA	0.0172414	0.6457866680482283
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.6457866680482283
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.6457866680482283
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.6457866680482283
MOTION SICKNESS	0.0172414	0.6457866680482283
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.6457866680482283
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.6457866680482283
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.6457866680482283
RHEUMATOID ARTHRITIS	0.0172414	0.6457866680482283
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.6457866680482283
JUMPING FRENCHMAN OF MAINE	0.0172414	0.6457866680482283
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.6457866680482283
269800 SENILE PLAQUE FORMATION	0.0172414	0.6457866680482283
MYOPATHY, CONGENITAL	0.0172414	0.6457866680482283
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.6457866680482283
DESMOSTEROLOSIS	0.01719066	0.6438861718276913
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.017102273999999997	0.6405756227747076
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.017099009999999998	0.640453367755712
CONGENITAL ANALBUMINEMIA	0.017099009999999998	0.640453367755712
INDOMETHACIN EMBRYOFETOPATHY	0.017099009999999998	0.640453367755712
RENAL TUBULAR DYSGENESIS	0.017099009999999998	0.640453367755712
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.0169316	0.6341829288065576
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.0169316	0.6341829288065576
SUMMITT SYNDROME	0.016931599999999998	0.6341829288065575
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.016898069	0.6329270056932185
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.016891613	0.632685192457117
PERMANENT NEONATAL DIABETES MELLITUS	0.016847064	0.6310165837435042
TRANSIENT NEONATAL DIABETES MELLITUS	0.016847064	0.6310165837435042
RING CHROMOSOME 7 SYNDROME	0.01684706	0.6310164339211771
CUTIS LAXA	0.016768214	0.6280632111185666
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.016764078999999998	0.6279083322878231
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.016716994	0.6261447362187654
236410 HUMERORADIAL SYNOSTOSIS WITH CRANIOFACIAL ANOMALIES	0.016555979999999998	0.6201138631708043
CORNELIA DE LANGE SYNDROME 3	0.016387252999999997	0.613794095220419
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.016350194	0.612406028814489
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.016350194	0.612406028814489
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.016350194	0.612406028814489
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.016350194	0.612406028814489
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.016301509999999998	0.610582541270133
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.016301509999999998	0.610582541270133
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.016301509999999998	0.610582541270133
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.016301509999999998	0.610582541270133
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.016301509999999998	0.610582541270133
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.016293334	0.6102763044333355
NEUROFACIODIGITORENAL SYNDROME	0.01622266	0.6076291686451952
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.016125574	0.6039927560305509
3MC SYNDROME 2	0.016023693999999998	0.6001767813567568
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.015969393	0.5981429058094295
AICARDI-GOUTIÈRES SYNDROME	0.015923612999999996	0.5964281892746209
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.015845833999999996	0.593514931577791
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.015845833999999996	0.593514931577791
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.01580464	0.5919719863411178
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.01580464	0.5919719863411178
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.01580464	0.5919719863411178
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.01580464	0.5919719863411178
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.0157379	0.5894722008117793
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.015678313	0.5872403350590567
6Q TERMINAL DELETION SYNDROME	0.015678313	0.5872403350590567
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.01566324	0.5866757670745838
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.01566324	0.5866757670745838
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.015635813999999998	0.5856485102881342
PERLMAN SYNDROME	0.015635813999999998	0.5856485102881342
DUANE RETRACTION SYNDROME	0.015627092999999998	0.5853218601592557
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.015557829	0.5827275367414536
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.015470953999999999	0.57947358307257
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.015470953999999999	0.57947358307257
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.015470953999999999	0.57947358307257
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.015470953999999999	0.57947358307257
MENTAL RETARDATION, X-LINKED 41	0.015470953999999999	0.57947358307257
MUCOPOLYSACCHARIDOSIS TYPE 2	0.015426473000000001	0.5778075213385199
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.015423839	0.5777088633360583
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.015378058999999998	0.5759941468012497
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.015293772999999998	0.5728371656336466
SILVER-RUSSELL SYNDROME	0.0151932	0.5690701454052653
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.015181173	0.5686196671229554
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.015181173	0.5686196671229554
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.015178729	0.5685281256810361
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.015136893999999998	0.5669611714164289
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.015135473	0.5669079470346909
MALAN OVERGROWTH SYNDROME	0.015132758999999997	0.5668062925856855
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.01510677	0.5658328594702827
TETRASOMY X	0.015015374000000001	0.5624095691160809
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.014925399999999998	0.5590395405991987
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.014925399999999998	0.5590395405991987
NIEMANN-PICK DISEASE TYPE B	0.014925399999999998	0.5590395405991987
MYOCLONIC-ATONIC EPILEPSY	0.014925399999999998	0.5590395405991987
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.01480866	0.5546669759798551
PFEIFFER SYNDROME	0.014803140000000001	0.5544602211683186
COFFIN-SIRIS SYNDROME 6; CSS6	0.014752353999999999	0.5525580019910188
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.01472412	0.5515004810944748
VELO-FACIAL-SKELETAL SYNDROME	0.01472412	0.5515004810944748
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.014667814	0.5493915071056384
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.014656573	0.5489704689106235
SPINOCEREBELLAR ATAXIA TYPE 13	0.014600473	0.546869210771638
FAMILIAL LAMBDOID SYNOSTOSIS	0.014591339999999998	0.5465271289430575
SPASTIC PARAPLEGIA-INTELLECTUAL DISABILITY-NYSTAGMUS-OBESITY SYNDROME	0.014591339999999998	0.5465271289430575
300064 MENTAL RETARDATION, X-LINKED, WITH CRANIOFACIAL DYSMORPHISM;;MENTAL RETARDATION, X-LINKED, HYDE-FORSTER TYPE	0.014591339999999998	0.5465271289430575
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.014591339999999998	0.5465271289430575
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.014591339999999998	0.5465271289430575
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.01439201	0.5390611078228439
HAMAMY SYNDROME; HMMS	0.014339500000000002	0.5370943152225207
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.014244153999999998	0.5335230753202084
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.014244153999999998	0.5335230753202084
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.014244153999999998	0.5335230753202084
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.014244153999999998	0.5335230753202084
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.014244153999999998	0.5335230753202084
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.014244153999999998	0.5335230753202084
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.014240018999999998	0.533368196489465
TRISOMY 20P	0.014206799999999999	0.5321239595176475
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.014059054	0.5265900471290101
ZEBRA BODY MYOPATHY	0.014059054	0.5265900471290101
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.014059054	0.5265900471290101
OGDEN SYNDROME	0.014059054	0.5265900471290101
CITRULLINEMIA TYPE I	0.014054918999999999	0.5264351682982666
KUFOR-RAKEB SYNDROME	0.014054918999999999	0.5264351682982666
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.014054918999999999	0.5264351682982666
RAPID-ONSET DYSTONIA-PARKINSONISM	0.014054918999999999	0.5264351682982666
QAZI-MARKOUIZOS SYNDROME	0.014054918999999999	0.5264351682982666
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.014004494	0.5245464705859967
ROBERTS SYNDROME	0.013722894000000001	0.5139989787510889
ROIFMAN SYNDROME; RFMN	0.013722894000000001	0.5139989787510889
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.013698599999999998	0.5130890328468372
EPILEPSY, HOT WATER, 1	0.013698599999999998	0.5130890328468372
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.013698599999999998	0.5130890328468372
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.013698599999999998	0.5130890328468372
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.013698599999999998	0.5130890328468372
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.013698599999999998	0.5130890328468372
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.5130890328468372
MENTAL RETARDATION, X-LINKED 77	0.013698599999999998	0.5130890328468372
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.013698599999999998	0.5130890328468372
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.013671174	0.5120617760603877
RING CHROMOSOME 14 SYNDROME	0.013671174	0.5120617760603877
WRINKLY SKIN SYNDROME	0.013671174	0.5120617760603877
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.013671174	0.5120617760603877
PEHO-LIKE SYNDROME; PEHOL	0.013671174	0.5120617760603877
MUENKE SYNDROME	0.013662452999999998	0.5117351259315089
FANCONI ANEMIA	0.013597324	0.5092956813444504
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.013577912999999999	0.5085686310461286
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.013577912999999999	0.5085686310461286
CARNOSINASE DEFICIENCY	0.013569600000000001	0.5082572627946245
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.013555372999999999	0.5077243822323544
SPASMUS NUTANS	0.0135135	0.5061560046556388
DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE; DYT2	0.0135135	0.5061560046556388
BETHLEM MYOPATHY	0.0135135	0.5061560046556388
PRIMARY DYSTONIA, DYT17 TYPE	0.0135135	0.5061560046556388
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.0135135	0.5061560046556388
DYSTONIA 26, MYOCLONIC; DYT26	0.0135135	0.5061560046556388
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.0135135	0.5061560046556388
BENIGN PAROXYSMAL TORTICOLLIS OF INFANCY	0.0135135	0.5061560046556388
OROMANDIBULAR DYSTONIA	0.0135135	0.5061560046556388
DYSTONIA 11, MYOCLONIC	0.0135135	0.5061560046556388
LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY	0.0135135	0.5061560046556388
SPINOCEREBELLAR ATAXIA TYPE 35	0.0135135	0.5061560046556388
DYSTONIA 21; DYT21	0.0135135	0.5061560046556388
PAROXYSMAL NON-KINESIGENIC DYSKINESIA	0.0135135	0.5061560046556388
MYOCLONUS-DYSTONIA SYNDROME	0.0135135	0.5061560046556388
CONTRACTURES, CONGENITAL, TORTICOLLIS, AND MALIGNANT HYPERTHERMIA	0.0135135	0.5061560046556388
ACERULOPLASMINEMIA	0.0135135	0.5061560046556388
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.0135135	0.5061560046556388
FAMILIAL PAROXYSMAL ATAXIA	0.0135135	0.5061560046556388
SPRENGEL DEFORMITY	0.0135135	0.5061560046556388
OPHTHALMOPLEGIA, EXTERNAL, WITH RIB AND VERTEBRAL ANOMALIES; EORVA	0.0135135	0.5061560046556388
CRANIO-CERVICAL DYSTONIA WITH LARYNGEAL AND UPPER-LIMB INVOLVEMENT	0.0135135	0.5061560046556388
SANDIFER SYNDROME	0.0135135	0.5061560046556388
DYSTONIA 16	0.0135135	0.5061560046556388
DYSTONIA 7, TORSION	0.0135135	0.5061560046556388
BETHLEM MYOPATHY 1	0.0135135	0.5061560046556388
PRIMARY DYSTONIA, DYT21 TYPE	0.0135135	0.5061560046556388
TORTICOLLIS, KELOIDS, CRYPTORCHIDISM, AND RENAL DYSPLASIA; TKCR	0.0135135	0.5061560046556388
AUTOSOMAL DOMINANT FOCAL DYSTONIA, DYT25 TYPE	0.0135135	0.5061560046556388
ADULT-ONSET CERVICAL DYSTONIA, DYT23 TYPE	0.0135135	0.5061560046556388
PRIMARY DYSTONIA, DYT4 TYPE	0.0135135	0.5061560046556388
DYSTONIA 13, TORSION	0.0135135	0.5061560046556388
TORTICOLLIS	0.0135135	0.5061560046556388
PRIMARY DYSTONIA, DYT2 TYPE	0.0135135	0.5061560046556388
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.0135135	0.5061560046556388
DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT; DYT4	0.0135135	0.5061560046556388
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.0135135	0.5061560046556388
DYSTONIA, DOPA-RESPONSIVE; DRD	0.0135135	0.5061560046556388
PRIMARY DYSTONIA, DYT6 TYPE	0.0135135	0.5061560046556388
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.0135135	0.5061560046556388
DYSTONIA 12; DYT12	0.0135135	0.5061560046556388
DYSTONIA 23; DYT23	0.0135135	0.5061560046556388
MESOAXIAL HEXADACTYLY AND CARDIAC MALFORMATION	0.0135135	0.5061560046556388
PRIMARY DYSTONIA, DYT13 TYPE	0.0135135	0.5061560046556388
DYSTONIA 25	0.0135135	0.5061560046556388
SPINOCEREBELLAR ATAXIA TYPE 17	0.0135135	0.5061560046556388
DYSTONIA 17, TORSION, AUTOSOMAL RECESSIVE; DYT17	0.0135135	0.5061560046556388
ACERULOPLASMINEMIA	0.0135135	0.5061560046556388
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.0135135	0.5061560046556388
TRISOMY X	0.013507613	0.5059355036455817
48,XXYY SYNDROME	0.013507613	0.5059355036455817
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.013507613	0.5059355036455817
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.013461833000000001	0.5042207871107732
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.013384054	0.5013075294139432
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.013379919	0.5011526505831998
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.013305034	0.4983477893400995
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.013302108999999998	0.49823823176333404
MIETENS SYNDROME	0.013299514000000002	0.49814103452856295
PELIZAEUS-MERZBACHER DISEASE	0.013255119000000001	0.49647819397454757
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.013244592999999999	0.4960839365205196
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.013244592999999999	0.4960839365205196
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.013244592999999999	0.4960839365205196
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.013244592999999999	0.4960839365205196
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.013216533	0.49503293289520883
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.013177340000000001	0.4935649362777176
RAINE SYNDROME	0.013121033999999998	0.49145596228888117
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.013121033999999998	0.49145596228888117
JACOBSEN SYNDROME	0.013086293	0.49015471792156395
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.013032358999999999	0.4881345885727573
ACROCALLOSAL SYNDROME; ACLS	0.012976399	0.48603857421522384
MUCOPOLYSACCHARIDOSIS TYPE 3	0.012916279000000001	0.48378674463740196
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.012837164	0.4808234462832871
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.012760689999999998	0.4779590681207062
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.012703174	0.4758047728778918
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.012670979	0.4745988904218376
HYPERPROLINEMIA, TYPE I	0.012581272999999999	0.47123890000087787
FIBROCHONDROGENESIS	0.012575479999999998	0.4710219198155099
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.012575479999999998	0.4710219198155099
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.012540739	0.46972067544819274
ZELLWEGER SYNDROME	0.012540739	0.46972067544819274
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.012490939999999999	0.46785542493012955
FACIOCARDIORENAL SYNDROME	0.012490939999999999	0.46785542493012955
FACIOCARDIORENAL SYNDROME	0.012490939999999999	0.46785542493012955
TEMPLE SYNDROME	0.012468400000000001	0.46701117611635534
X-LINKED DOMINANT CHONDRODYSPLASIA PUNCTATA	0.01242064	0.4652222975295826
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.012215133000000001	0.45752491328058975
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.01215762	0.45537073040452053
FRANK-TER HAAR SYNDROME; FTHS	0.012129560000000001	0.4543197267792098
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.01207834	0.45240125187940866
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.012039854	0.45095973635825004
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.012039854	0.45095973635825004
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.012039854	0.45095973635825004
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.012039854	0.45095973635825004
BETA-UREIDOPROPIONASE DEFICIENCY	0.012039854	0.45095973635825004
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.012039854	0.45095973635825004
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.012039854	0.45095973635825004
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.012039854	0.45095973635825004
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.012039854	0.45095973635825004
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.012039854	0.45095973635825004
FUMARASE DEFICIENCY; FMRD	0.012039854	0.45095973635825004
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.012039854	0.45095973635825004
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.012039854	0.45095973635825004
PYRIDOXINE-DEPENDENT EPILEPSY	0.012039854	0.45095973635825004
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.012039854	0.45095973635825004
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.012039854	0.45095973635825004
CLASSICAL EHLERS-DANLOS SYNDROME	0.01199932	0.4494415118055649
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.011876293000000001	0.44483346394344414
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.011876293	0.44483346394344403
ROIFMAN-CHITAYAT SYNDROME	0.011769454	0.4408317470395033
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.011652843999999999	0.43646405164579366
PELGER-HUET ANOMALY; PHA	0.011652843999999999	0.43646405164579366
W SYNDROME	0.011652843999999999	0.43646405164579366
KLEEFSTRA SYNDROME 2; KLEFS2	0.011613272999999999	0.43498189681838195
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.011613272999999999	0.43498189681838195
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.011613272999999999	0.43498189681838195
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.011613272999999999	0.43498189681838195
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.011613272999999999	0.43498189681838195
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.011613272999999999	0.43498189681838195
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.011613272999999999	0.43498189681838195
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.011511533000000001	0.43117116592604
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.011494299999999999	0.4305256938848788
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.011494299999999999	0.4305256938848788
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.011494299999999999	0.4305256938848788
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.011494299999999999	0.4305256938848788
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.011494299999999999	0.4305256938848788
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.011494299999999999	0.4305256938848788
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.011494299999999999	0.4305256938848788
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.011472772999999999	0.429719387575468
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.011472772999999999	0.429719387575468
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.011454973	0.4290526782194264
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.011420449999999999	0.4277595991689415
MULTINUCLEATED NEURONS, ANHYDRAMNIOS, RENAL DYSPLASIA, CEREBELLAR HYPOPLASIA, AND HYDRANENCEPHALY; MARCH	0.011420449999999999	0.4277595991689415
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.011413943	0.42751587569816824
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.011413943	0.42751587569816824
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.011413943	0.42751587569816824
MELAS	0.01135259	0.4252178633879867
ARTERIAL TORTUOSITY SYNDROME	0.011334874000000002	0.4245543003008163
2Q23.1 MICRODELETION SYNDROME	0.011330739000000001	0.42439942147007287
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.011290383999999999	0.4228879014665298
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.011286248999999998	0.4227330226357863
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.0112239	0.42039770456613207
COG5-CDG	0.011201708999999999	0.419566527750406
TEMPLE SYNDROME	0.011128160000000002	0.4168117071645906
INFANTILE SIALIC ACID STORAGE DISEASE	0.011121653	0.41656798369381737
ISOLATED PLAGIOCEPHALY	0.011071853999999999	0.4147027331757542
CRANIOSYNOSTOSIS 6; CRS6	0.011071853999999999	0.4147027331757542
BRESEK SYNDROME	0.011071853999999999	0.4147027331757542
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.011071853999999999	0.4147027331757542
LINEAR NEVUS SEBACEUS SYNDROME	0.011067718999999998	0.41454785434501074
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.011067718999999998	0.41454785434501074
9Q33.3Q34.11 MICRODELETION SYNDROME	0.011067718999999998	0.41454785434501074
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.011067718999999998	0.41454785434501074
CINCA SYNDROME	0.010998094	0.41194000946217885
ADAMS-OLIVER SYNDROME	0.010993959	0.41178513063143546
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.010970114	0.4108920022834121
PALLISTER-KILLIAN SYNDROME	0.010927218999999998	0.40928534510209674
XQ12-Q13.3 DUPLICATION SYNDROME	0.01089058	0.40791301004052305
TRISOMY 18	0.010872524	0.40723671205554046
DIAPHANOSPONDYLODYSOSTOSIS	0.010872524	0.40723671205554046
20Q13.33 MICRODELETION SYNDROME	0.010868389	0.407081833224797
HYPERTELORISM, TEEBI TYPE	0.01080366	0.4046573708704584
RADIO-ULNAR SYNOSTOSIS-AMEGAKARYOCYTIC THROMBOCYTOPENIA SYNDROME	0.010789320000000002	0.4041202578274451
SECKEL SYNDROME	0.010789320000000002	0.4041202578274451
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.010782813	0.40387653435667176
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.010782813	0.40387653435667176
KOOLEN-DE VRIES SYNDROME; KDVS	0.010782813	0.40387653435667176
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.010782813	0.40387653435667176
CRANIOSYNOSTOSIS, HERRMANN-OPITZ TYPE	0.010744829999999999	0.40245385899315855
CAMPOMELIA, CUMMING TYPE	0.010744829999999999	0.40245385899315855
DOWN SYNDROME	0.01071564	0.40136053056041365
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.01066029	0.3992873641077782
FREEMAN-SHELDON SYNDROME	0.01066029	0.3992873641077782
MECKEL SYNDROME 12; MKS12	0.01066029	0.3992873641077782
MARINESCO-SJÖGREN SYNDROME	0.010659254	0.3992485601250333
OCCIPITAL HORN SYNDROME	0.010659254	0.3992485601250333
THANATOPHORIC DYSPLASIA	0.010655119	0.39909368129428985
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.010655119	0.39909368129428985
WILLIAMS SYNDROME	0.010631100000000001	0.3981940356750333
COSTELLO SYNDROME; CSTLO	0.010580234	0.3962888200511895
CARDIOFACIOCUTANEOUS SYNDROME	0.010580234	0.3962888200511895
VASCULAR EHLERS-DANLOS SYNDROME	0.010580234	0.3962888200511895
HEREDITARY OROTIC ACIDURIA	0.010574714	0.39608206523965295
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.010574714	0.39608206523965295
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.010526299999999999	0.39426869070238285
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.010526299999999999	0.39426869070238285
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.010526299999999999	0.39426869070238285
ROBINOW-SORAUF SYNDROME	0.010526299999999999	0.39426869070238285
CRANIOFRONTONASAL DYSPLASIA-POLAND ANOMALY SYNDROME	0.010526299999999999	0.39426869070238285
ATELOSTEOGENESIS, TYPE I; AO1	0.01045254	0.3915059669888076
CORNEODERMATOOSSEOUS SYNDROME	0.01045254	0.3915059669888076
KNIEST-LIKE DYSPLASIA, LETHAL	0.01045254	0.3915059669888076
CORNEODERMATOOSSEOUS SYNDROME	0.01045254	0.3915059669888076
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.01045254	0.3915059669888076
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.010368	0.3883394721034273
RENAL AGENESIS, BILATERAL	0.01032697	0.38680266958216913
ACRORENAL-MANDIBULAR SYNDROME	0.01032697	0.38680266958216913
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.01032697	0.38680266958216913
EPIPHYSEAL DYSPLASIA, MULTIPLE, 4	0.0101137	0.3788145176516621
MULTIPLE EPIPHYSEAL DYSPLASIA	0.0101137	0.3788145176516621
GMS SYNDROME	0.01003468	0.3758547775778182
ACITRETIN/ETRETINATE EMBRYOPATHY	0.01003468	0.3758547775778182
DIAMOND-BLACKFAN ANEMIA 1	0.01003468	0.3758547775778182
PETERS-PLUS SYNDROME; PTRPLS	0.009925993	0.37178384275871085
FILIPPI SYNDROME	0.009841453	0.3686173478733305
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.009804814	0.36724501281175664
KRABBE DISEASE	0.009804814	0.36724501281175664
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.009804814	0.36724501281175664
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.009804814	0.36724501281175664
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.009804814	0.36724501281175664
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.009804814	0.36724501281175664
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.009804814	0.36724501281175664
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.009804814	0.36724501281175664
BIOTINIDASE DEFICIENCY	0.009804814	0.36724501281175664
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.009804814	0.36724501281175664
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.009804814	0.36724501281175664
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.009804814	0.36724501281175664
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.009804814	0.36724501281175664
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.009800679	0.3670901339810132
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.009800679	0.3670901339810132
17Q12 MICRODELETION SYNDROME	0.009782622999999999	0.3664138359960306
ADAMS-OLIVER SYNDROME 2; AOS2	0.009782622999999999	0.3664138359960306
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.009782622999999999	0.3664138359960306
OLIVER SYNDROME	0.00976705	0.3658305402206577
METAPHYSEAL ACROSCYPHODYSPLASIA	0.009710179999999999	0.363700441283686
METAPHYSEAL ACROSCYPHODYSPLASIA	0.009710179999999999	0.363700441283686
CRANIOFACIOFRONTODIGITAL SYNDROME	0.009710179999999999	0.363700441283686
ARTHROCHALASIA EHLERS-DANLOS SYNDROME	0.00969584	0.36316332824067266
MOSAIC MONOSOMY X	0.00969584	0.36316332824067266
DERMATOSPARAXIS EHLERS-DANLOS SYNDROME	0.00969584	0.36316332824067266
TURNER SYNDROME	0.00969584	0.36316332824067266
MONOSOMY X	0.00969584	0.36316332824067266
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.00969584	0.36316332824067266
OROFACIODIGITAL SYNDROME TYPE 2	0.009552444	0.35779234763286566
CONGENITAL TOXOPLASMOSIS	0.009490333	0.3554659439916797
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.009490333	0.3554659439916797
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.009490333	0.3554659439916797
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.009490333	0.3554659439916797
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.009490333	0.3554659439916797
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.009490333	0.3554659439916797
GALLOWAY-MOWAT SYNDROME	0.009490333	0.3554659439916797
KAGAMI-OGATA SYNDROME	0.009490333	0.3554659439916797
KAGAMI-OGATA SYNDROME	0.009490333	0.3554659439916797
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.009462353	0.3544179368129129
PETERS PLUS SYNDROME	0.009384574	0.351504679116083
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.009300034	0.3483381842307026
8P INVERTED DUPLICATION/DELETION SYNDROME	0.009295899	0.34818330539995923
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.009295899	0.34818330539995923
GAUCHER DISEASE TYPE 3	0.00925926	0.34681097033838537
MICROHYDRANENCEPHALY; MHAC	0.00925926	0.34681097033838537
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00925926	0.34681097033838537
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.34681097033838537
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00925926	0.34681097033838537
HYDROXYLYSINURIA	0.00925926	0.34681097033838537
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.00925926	0.34681097033838537
GLYCINE ENCEPHALOPATHY	0.00925926	0.34681097033838537
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.00925926	0.34681097033838537
CARNOSINEMIA	0.00925926	0.34681097033838537
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.00925926	0.34681097033838537
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.00925926	0.34681097033838537
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.00925926	0.34681097033838537
MERRF	0.00925926	0.34681097033838537
PAINE SYNDROME	0.00925926	0.34681097033838537
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.00925926	0.34681097033838537
GAUCHER DISEASE TYPE 2	0.00925926	0.34681097033838537
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.34681097033838537
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.00925926	0.34681097033838537
OROFACIODIGITAL SYNDROME TYPE 4	0.009241204	0.34613467235340273
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.009241204	0.34613467235340273
MOSAIC TRISOMY 9	0.009241204	0.34613467235340273
EVEN-PLUS SYNDROME	0.009241204	0.34613467235340273
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.009241204	0.34613467235340273
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.009237068999999999	0.34597979352265934
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.009237068999999999	0.34597979352265934
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.009237068999999999	0.34597979352265934
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.009237068999999999	0.34597979352265934
HADDAD SYNDROME	0.009237068999999999	0.34597979352265934
1Q44 MICRODELETION SYNDROME	0.009219124	0.34530765310725664
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.009151493	0.34277449465453413
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.009151493	0.34277449465453413
1Q21.1 MICRODUPLICATION SYNDROME	0.009151493	0.34277449465453413
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.009151493	0.34277449465453413
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.009151493	0.34277449465453413
PRADER-WILLI SYNDROME; PWS	0.009151493	0.34277449465453413
TYSHCHENKO SYNDROME	0.008948914	0.33518678034905186
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.008948914	0.33518678034905186
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.008948914	0.33518678034905186
MICROFORM HOLOPROSENCEPHALY	0.008944779	0.3350319015183084
GAUCHER DISEASE, PERINATAL LETHAL	0.008944779	0.3350319015183084
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.008944779	0.3350319015183084
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.008916799	0.3339838943395416
DYSOSTEOSCLEROSIS	0.008916799	0.3339838943395416
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.008916799	0.3339838943395416
OROFACIODIGITAL SYNDROME TYPE 1	0.008911358999999999	0.3337801359745491
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.008832513	0.3308269131719385
SIALURIA	0.008747973	0.3276604182865581
SERKAL SYNDROME	0.00869565	0.3257006298800315
STÜVE-WIEDEMANN SYNDROME	0.00869565	0.3257006298800315
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.00869565	0.3257006298800315
TRANSALDOLASE DEFICIENCY	0.00869565	0.3257006298800315
MECKEL SYNDROME, TYPE 1; MKS1	0.00869565	0.3257006298800315
COLE-CARPENTER SYNDROME 2; CLCRP2	0.00869565	0.3257006298800315
HOLZGREVE SYNDROME	0.00869565	0.3257006298800315
RENAL-HEPATIC-PANCREATIC DYSPLASIA 2; RHPD2	0.00869565	0.3257006298800315
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.00869565	0.3257006298800315
TERMINAL TRANSVERSE LIMB DEFECT	0.00869565	0.3257006298800315
POSTERIOR URETHRAL VALVE	0.00869565	0.3257006298800315
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.00869565	0.3257006298800315
APHALANGY-HEMIVERTEBRAE-UROGENITAL-INTESTINAL DYSGENESIS SYNDROME	0.00869565	0.3257006298800315
RENAL AGENESIS	0.00869565	0.3257006298800315
THOMAS SYNDROME	0.00869565	0.3257006298800315
46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS; SERKAL	0.00869565	0.3257006298800315
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.00869565	0.3257006298800315
MECKEL SYNDROME	0.00869565	0.3257006298800315
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.00869565	0.3257006298800315
ABSENT RADIUS-ANOGENITAL ANOMALIES SYNDROME	0.00869565	0.3257006298800315
SPONDYLOCOSTAL DYSOSTOSIS WITH ANAL ATRESIA AND UROGENITAL ANOMALIES	0.00869565	0.3257006298800315
NPHP3-RELATED MECKEL-LIKE SYNDROME	0.00869565	0.3257006298800315
ULBRIGHT-HODES SYNDROME	0.00869565	0.3257006298800315
HEMOCHROMATOSIS, NEONATAL	0.00869565	0.3257006298800315
HB BART'S HYDROPS FETALIS	0.00869565	0.3257006298800315
POLYCYSTIC KIDNEY DISEASE 4 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD4	0.00869565	0.3257006298800315
FONTAINE PROGEROID SYNDROME; FPS	0.00869565	0.3257006298800315
FRONTONASAL DYSPLASIA-ALOPECIA-GENITAL ANOMALIES SYNDROME	0.00869565	0.3257006298800315
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.00869565	0.3257006298800315
SPONDYLOCOSTAL DYSOSTOSIS-ANAL ATRESIA-GENITOURINARY MALFORMATION SYNDROME	0.00869565	0.3257006298800315
LETHAL HEMOLYTIC ANEMIA-GENITAL ANOMALIES SYNDROME	0.00869565	0.3257006298800315
ACRO-RENAL-MANDIBULAR SYNDROME	0.00869565	0.3257006298800315
PRUNE BELLY SYNDROME	0.00869565	0.3257006298800315
46,XX DISORDER OF SEX DEVELOPMENT-ANORECTAL ANOMALIES SYNDROME	0.00869565	0.3257006298800315
ALPHA-MANNOSIDOSIS	0.008610074	0.3224953310119063
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.008610074	0.3224953310119063
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.008610074	0.3224953310119063
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.008610074	0.3224953310119063
AU-KLINE SYNDROME; AUKS	0.008610074	0.3224953310119063
PRADER-WILLI SYNDROME	0.008605939	0.32234045218116286
16Q24.3 MICRODELETION SYNDROME	0.008605939	0.32234045218116286
SECKEL SYNDROME 7; SCKL7	0.008605939	0.32234045218116286
9Q21.13 MICRODELETION SYNDROME	0.008605939	0.32234045218116286
CONGENITAL PULMONARY AIRWAY MALFORMATION	0.00840336	0.3147527378756806
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.00840336	0.3147527378756806
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.00840336	0.3147527378756806
HYDROLETHALUS	0.00840336	0.3147527378756806
SEVERE CONGENITAL NEMALINE MYOPATHY	0.00840336	0.3147527378756806
BECKWITH-WIEDEMANN SYNDROME	0.00840336	0.3147527378756806
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.00840336	0.3147527378756806
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.00840336	0.3147527378756806
OMPHALOCELE	0.00840336	0.3147527378756806
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.00840336	0.3147527378756806
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.00840336	0.3147527378756806
SCHISIS ASSOCIATION	0.00840336	0.3147527378756806
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.00840336	0.3147527378756806
FATCO SYNDROME	0.00840336	0.3147527378756806
HEC SYNDROME	0.00840336	0.3147527378756806
CONGENITAL ENTEROVIRUS INFECTION	0.00840336	0.3147527378756806
RETINOPATHY OF PREMATURITY	0.00840336	0.3147527378756806
INTERMEDIATE NEMALINE MYOPATHY	0.00840336	0.3147527378756806
PEMPHIGOID GESTATIONIS	0.00840336	0.3147527378756806
ICHTHYOSIS-PREMATURITY SYNDROME	0.00840336	0.3147527378756806
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.00840336	0.3147527378756806
PTOSIS-VOCAL CORD PARALYSIS SYNDROME	0.00840336	0.3147527378756806
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.00840336	0.3147527378756806
VACTERL/VATER ASSOCIATION	0.00840336	0.3147527378756806
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.00840336	0.3147527378756806
DIETHYLSTILBESTROL SYNDROME	0.00840336	0.3147527378756806
YUNIS-VARON SYNDROME	0.00840336	0.3147527378756806
NEMALINE MYOPATHY 10	0.00840336	0.3147527378756806
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00840336	0.3147527378756806
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00840336	0.3147527378756806
RESTRICTIVE DERMOPATHY, LETHAL	0.00840336	0.3147527378756806
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.00840336	0.3147527378756806
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.00840336	0.3147527378756806
DISTAL MONOSOMY 17Q	0.00840336	0.3147527378756806
PULMONARY ATRESIA-INTACT VENTRICULAR SEPTUM SYNDROME	0.00840336	0.3147527378756806
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.00840336	0.3147527378756806
FIBULAR APLASIA-ECTRODACTYLY SYNDROME	0.00840336	0.3147527378756806
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.00840336	0.3147527378756806
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.00840336	0.3147527378756806
BRONCHOPULMONARY DYSPLASIA	0.00840336	0.3147527378756806
EBSTEIN MALFORMATION	0.00840336	0.3147527378756806
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.00840336	0.3147527378756806
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00840336	0.3147527378756806
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.00840336	0.3147527378756806
MONOSOMY 13Q14	0.00836994	0.31350097233192126
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.00836994	0.31350097233192126
NON-DISTAL MONOSOMY 10Q	0.00836994	0.31350097233192126
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.008291093999999999	0.31054774952931063
OGDEN SYNDROME; OGDNS	0.008206554	0.3073812546439303
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.008206554	0.3073812546439303
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.008206554	0.3073812546439303
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.008206554	0.3073812546439303
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.008206554	0.3073812546439303
OPITZ G/BBB SYNDROME	0.008206554	0.3073812546439303
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.008202418999999999	0.30722637581318685
SHORT SYNDROME	0.00807886	0.30259840158154844
ANGEL-SHAPED PHALANGO-EPIPHYSEAL DYSPLASIA	0.00806452	0.30206128853853503
CRANIOECTODERMAL DYSPLASIA 4	0.00806452	0.30206128853853503
FAMILIAL CLUBFOOT DUE TO 17Q23.1Q23.2 MICRODUPLICATION	0.00806452	0.30206128853853503
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.00806452	0.30206128853853503
HIP DYSPLASIA, BEUKES TYPE	0.00806452	0.30206128853853503
FEMORAL-FACIAL SYNDROME	0.00806452	0.30206128853853503
13Q12.3 MICRODELETION SYNDROME	0.00806452	0.30206128853853503
CLASSIC MULTIMINICORE MYOPATHY	0.00806452	0.30206128853853503
CAT-EYE SYNDROME	0.00806452	0.30206128853853503
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 1	0.00806452	0.30206128853853503
TIBIAL HEMIMELIA	0.00806452	0.30206128853853503
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.00806452	0.30206128853853503
COXOPODOPATELLAR SYNDROME	0.00806452	0.30206128853853503
DEVELOPMENTAL DYSPLASIA OF THE HIP 2; DDH2	0.00806452	0.30206128853853503
SCHWARTZ-JAMPEL SYNDROME	0.00806452	0.30206128853853503
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 5	0.00806452	0.30206128853853503
DIASTROPHIC DWARFISM	0.00806452	0.30206128853853503
MULTIPLE EPIPHYSEAL DYSPLASIA DUE TO COLLAGEN 9 ANOMALY	0.00806452	0.30206128853853503
SPONASTRIME DYSPLASIA	0.00806452	0.30206128853853503
MEIER-GORLIN SYNDROME 6; MGORS6	0.00806452	0.30206128853853503
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 3; CMTX3	0.00806452	0.30206128853853503
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.00806452	0.30206128853853503
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.00806452	0.30206128853853503
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.00806452	0.30206128853853503
BRITTLE CORNEA SYNDROME	0.00806452	0.30206128853853503
BICD2-RELATED AUTOSOMAL DOMINANT CHILDHOOD-ONSET PROXIMAL SPINAL MUSCULAR ATROPHY	0.00806452	0.30206128853853503
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.00806452	0.30206128853853503
ARTERIOSCLEROSIS, SEVERE JUVENILE	0.00806452	0.30206128853853503
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.00806452	0.30206128853853503
HIP DYSPLASIA, BEUKES TYPE	0.00806452	0.30206128853853503
ATYPICAL WERNER SYNDROME	0.00806452	0.30206128853853503
SPONDYLOMETAPHYSEAL DYSPLASIA	0.00806452	0.30206128853853503
SMITH-MAGENIS SYNDROME	0.007825593	0.29311213874578274
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.007825593	0.29311213874578274
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.007660999999999999	0.286947212170559
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.007660999999999999	0.286947212170559
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.007660999999999999	0.286947212170559
CARTILAGE-HAIR HYPOPLASIA	0.007660999999999999	0.286947212170559
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.007587804	0.28420561340511896
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.007587804	0.28420561340511896
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.007587804	0.28420561340511896
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.007587804	0.28420561340511896
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.007587804	0.28420561340511896
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.007587804	0.28420561340511896
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.007587804	0.28420561340511896
SARCOSINEMIA	0.007587804	0.28420561340511896
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.0075836689999999995	0.2840507345743756
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.2840507345743756
ATYPICAL RETT SYNDROME	0.007576559	0.2837844253877769
RETT SYNDROME	0.007576559	0.2837844253877769
2Q31.1 MICRODELETION SYNDROME	0.007492272999999999	0.28062744422017366
11Q22.2Q22.3 MICRODELETION SYNDROME	0.007492272999999999	0.28062744422017366
TETRASOMY 5P	0.007407733	0.2774609493347933
MONOSOMY 22Q13.3	0.007407733	0.2774609493347933
MAN1B1-CDG	0.007407733	0.2774609493347933
PHELAN-MCDERMID SYNDROME	0.007407733	0.2774609493347933
SIMPSON-GOLABI-BEHMEL SYNDROME	0.007407733	0.2774609493347933
WIEDEMANN-STEINER SYNDROME; WDSTS	0.007407733	0.2774609493347933
20Q11.2 MICRODUPLICATION SYNDROME	0.007407733	0.2774609493347933
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.007407733	0.2774609493347933
1Q21.1 MICRODELETION SYNDROME	0.007407733	0.2774609493347933
ZTTK SYNDROME; ZTTKS	0.007361953000000001	0.27574623279998484
LARSEN-LIKE SYNDROME	0.007335394	0.274751450002956
CRANIOFRONTONASAL SYNDROME; CFNS	0.007284174000000001	0.2728329751031549
FLOATING-HARBOR SYNDROME	0.007284174000000001	0.2728329751031549
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.007201193	0.2697248734698009
GRACILE BONE DYSPLASIA; GCLEB	0.007201193	0.2697248734698009
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.007116653	0.2665583785844205
BOHRING-OPITZ SYNDROME	0.007116653	0.2665583785844205
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.007116653	0.2665583785844205
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.007116653	0.2665583785844205
HEART AND BRAIN MALFORMATION SYNDROME	0.007116653	0.2665583785844205
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.007116653	0.2665583785844205
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.00704225	0.26377157093174775
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.00704225	0.26377157093174775
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00704225	0.26377157093174775
HALLERMANN-STREIFF SYNDROME; HSS	0.00704225	0.26377157093174775
MYOCLONIC EPILEPSY, JUVENILE, 2	0.00704225	0.26377157093174775
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00704225	0.26377157093174775
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.00704225	0.26377157093174775
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.00704225	0.26377157093174775
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00704225	0.26377157093174775
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.00704225	0.26377157093174775
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.00704225	0.26377157093174775
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.00704225	0.26377157093174775
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.00704225	0.26377157093174775
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.00704225	0.26377157093174775
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.00704225	0.26377157093174775
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.00704225	0.26377157093174775
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.26377157093174775
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.26377157093174775
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.00704225	0.26377157093174775
AMISH LETHAL MICROCEPHALY	0.00704225	0.26377157093174775
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.00704225	0.26377157093174775
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.00704225	0.26377157093174775
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.00704225	0.26377157093174775
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.00704225	0.26377157093174775
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.26377157093174775
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00704225	0.26377157093174775
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.007028633	0.26326153827437576
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.007028632999999999	0.26326153827437576
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.007028632999999999	0.26326153827437576
RING CHROMOSOME 22 SYNDROME	0.007028632999999999	0.26326153827437576
CHARGE SYNDROME	0.006950853999999999	0.26034828057754583
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.006946718999999999	0.26019340174680244
DUBOWITZ SYNDROME	0.006946718999999999	0.26019340174680244
DUPLICATION/INVERSION 15Q11	0.006946718999999999	0.26019340174680244
OCULODENTODIGITAL DYSPLASIA	0.006946718999999999	0.26019340174680244
TRISOMY 12P	0.006866314	0.2571817856921655
LIG4 SYNDROME	0.006866314	0.2571817856921655
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.006862179	0.2570269068614221
RENPENNING SYNDROME 1; RENS1	0.0068621789999999995	0.25702690686142204
WIEDEMANN-STEINER SYNDROME	0.0068621789999999995	0.25702690686142204
OHDO SYNDROME	0.0068621789999999995	0.25702690686142204
NEONATAL ADRENOLEUKODYSTROPHY	0.006816399000000001	0.25531219032661356
MICROPHTHALMIA WITH LIMB ANOMALIES	0.00678984	0.2543174075295847
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.00678984	0.2543174075295847
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.006783333	0.2540736840588115
DISTAL MONOSOMY 1Q	0.006783333	0.2540736840588115
PMM2-CDG	0.006783333	0.2540736840588115
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.006783333	0.2540736840588115
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.006783333	0.2540736840588115
19P13.13 MICRODELETION SYNDROME	0.006783333	0.2540736840588115
FRANK-TER HAAR SYNDROME	0.006738620000000001	0.2523989326297837
MATERNAL PHENYLKETONURIA	0.006732113	0.2521552091590104
SMITH-LEMLI-OPITZ SYNDROME	0.006732113	0.2521552091590104
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.006732113	0.2521552091590104
COFFIN-SIRIS SYNDROME 7; CSS7	0.006659773999999999	0.249445709827173
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.006659773999999999	0.249445709827173
20P13 MICRODELETION SYNDROME	0.006655639	0.24929083099642962
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.006575234	0.24627921494179264
STEEL SYNDROME; STLS	0.006575234	0.24627921494179264
SYNDROMIC DIARRHEA	0.006575234	0.24627921494179264
ZECHI-CEIDE SYNDROME	0.006575234	0.24627921494179264
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.006571099	0.24612433611104928
14Q12 MICRODELETION SYNDROME	0.006483078999999999	0.2428274958010045
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.006405299999999999	0.2399142381041746
JACOBSEN SYNDROME	0.006405299999999999	0.2399142381041746
URBAN-ROGERS-MEYER SYNDROME	0.006405299999999999	0.2399142381041746
CRANIOECTODERMAL DYSPLASIA	0.006405299999999999	0.2399142381041746
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.006405299999999999	0.2399142381041746
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.006405299999999999	0.2399142381041746
MOEBIUS SYNDROME	0.006405299999999999	0.2399142381041746
9P13 MICRODELETION SYNDROME	0.00632076	0.23674774321879424
CRANIOFACIAL DYSSYNOSTOSIS	0.00632076	0.23674774321879424
DUBOWITZ SYNDROME	0.00632076	0.23674774321879424
DE BARSY SYNDROME	0.0062419139999999994	0.2337945204161836
NOONAN SYNDROME 5; NS5	0.0062419139999999994	0.2337945204161836
FETAL TRIMETHADIONE SYNDROME	0.0062419139999999994	0.2337945204161836
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.0062419139999999994	0.2337945204161836
JOUBERT SYNDROME 1	0.0062419139999999994	0.2337945204161836
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.0062419139999999994	0.2337945204161836
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.006237779	0.23363964158544023
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.006237779	0.23363964158544023
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.006237779	0.23363964158544023
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.006237779	0.23363964158544023
DISTAL MONOSOMY 9P	0.006190694	0.23187604551638255
MONOSOMY 18P	0.006190694	0.23187604551638255
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.006190694	0.23187604551638255
HALL-RIGGS SYNDROME	0.0061865589999999995	0.23172116668563913
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.0061865589999999995	0.23172116668563913
OROFACIODIGITAL SYNDROME I; OFD1	0.0061865589999999995	0.23172116668563913
POTOCKI-SHAFFER SYNDROME	0.0061865589999999995	0.23172116668563913
SPONDYLOEPIPHYSEAL DYSPLASIA, KONDO-FU TYPE; SEDKF	0.00611422	0.2290116673538018
ODONTOCHONDRODYSPLASIA; ODCD	0.00611422	0.2290116673538018
ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE	0.00611422	0.2290116673538018
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.00611422	0.2290116673538018
LARSEN SYNDROME	0.00611422	0.2290116673538018
KEIPERT SYNDROME; KPTS	0.00611422	0.2290116673538018
HYPERTELORISM, TEEBI TYPE; TBHS	0.00602968	0.2258451724684214
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.00602968	0.2258451724684214
SHORT SYNDROME	0.00602968	0.2258451724684214
HUMERORADIAL SYNOSTOSISHUMERORADIAL/MULTIPLE SYNOSTOSIS SYNDROME	0.00602968	0.2258451724684214
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00602968	0.2258451724684214
KOSAKI OVERGROWTH SYNDROME; KOGS	0.00602968	0.2258451724684214
ZECHI-CEIDE SYNDROME	0.00602968	0.2258451724684214
TEEBI-SHALTOUT SYNDROME; TBSH	0.00602968	0.2258451724684214
AXENFELD-RIEGER SYNDROME	0.00602968	0.2258451724684214
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.005860953	0.2195254045180361
RUVALCABA SYNDROME	0.005860953	0.2195254045180361
2Q37 MICRODELETION SYNDROME	0.005860953	0.2195254045180361
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.005776413000000001	0.21635890963265575
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.005696359999999999	0.21336047794281235
NASODIGITOACOUSTIC SYNDROME	0.005696359999999999	0.21336047794281235
CEREBROOCULONASAL SYNDROME	0.005696359999999999	0.21336047794281235
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.005696359999999999	0.21336047794281235
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.005696359999999999	0.21336047794281235
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.005696359999999999	0.21336047794281235
CEREBROOCULONASAL SYNDROME	0.005696359999999999	0.21336047794281235
CRANIOECTODERMAL DYSPLASIA 1	0.00564514	0.2114420030430113
FRONTONASAL DYSPLASIA 1; FND1	0.00564514	0.2114420030430113
ACRODYSOSTOSIS	0.00564514	0.2114420030430113
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.00564514	0.2114420030430113
GORLIN SYNDROME	0.00564514	0.2114420030430113
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.00564514	0.2114420030430113
15Q11Q13 MICRODUPLICATION SYNDROME	0.005443093	0.2038742151070467
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.0054430929999999995	0.20387421510704665
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.0054430929999999995	0.20387421510704665
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.0054430929999999995	0.20387421510704665
48,XXXY SYNDROME	0.0054430929999999995	0.20387421510704665
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.0054430929999999995	0.20387421510704665
49,XXXXY SYNDROME	0.0054430929999999995	0.20387421510704665
19P13.12 MICRODELETION SYNDROME	0.0054430929999999995	0.20387421510704665
TETRASOMY 9P	0.0054430929999999995	0.20387421510704665
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.005397313000000001	0.2021594985722382
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.005397313000000001	0.2021594985722382
CHÉDIAK-HIGASHI SYNDROME	0.005397313000000001	0.2021594985722382
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.005397313000000001	0.2021594985722382
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.005397313000000001	0.2021594985722382
AICARDI-GOUTIERES SYNDROME 7	0.005397313000000001	0.2021594985722382
OPTIC PATHWAY GLIOMA	0.005397313000000001	0.2021594985722382
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.005397313000000001	0.2021594985722382
KLEEFSTRA SYNDROME	0.005397313000000001	0.2021594985722382
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.005397313000000001	0.2021594985722382
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.005397313000000001	0.2021594985722382
CANAVAN DISEASE	0.005397313000000001	0.2021594985722382
MULTIPLE SULFATASE DEFICIENCY	0.005397313000000001	0.2021594985722382
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.005397313000000001	0.2021594985722382
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.005397313000000001	0.2021594985722382
SCHINDLER DISEASE, TYPE I	0.005397313000000001	0.2021594985722382
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.005397313000000001	0.2021594985722382
HSD10 DISEASE	0.005397313000000001	0.2021594985722382
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.005397313000000001	0.2021594985722382
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.005397313000000001	0.2021594985722382
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.005397313000000001	0.2021594985722382
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.005397313000000001	0.2021594985722382
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.005397313000000001	0.2021594985722382
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.005397313000000001	0.2021594985722382
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.005397313000000001	0.2021594985722382
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.005397313000000001	0.2021594985722382
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.005397313000000001	0.2021594985722382
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.005397313000000001	0.2021594985722382
NIEMANN-PICK DISEASE TYPE C	0.005397313000000001	0.2021594985722382
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.005397313000000001	0.2021594985722382
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.005397313000000001	0.2021594985722382
TAY-SACHS DISEASE	0.005397313000000001	0.2021594985722382
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.005397313000000001	0.2021594985722382
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.005397313000000001	0.2021594985722382
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.005397313000000001	0.2021594985722382
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.005397313000000001	0.2021594985722382
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.005397313000000001	0.2021594985722382
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.005397313000000001	0.2021594985722382
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.005397313000000001	0.2021594985722382
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.005397313000000001	0.2021594985722382
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.005397313000000001	0.2021594985722382
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.005397313000000001	0.2021594985722382
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.005397313000000001	0.2021594985722382
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.005397313000000001	0.2021594985722382
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.005397313000000001	0.2021594985722382
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.005397313000000001	0.2021594985722382
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.005397313000000001	0.2021594985722382
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.005397313000000001	0.2021594985722382
%300712 CRANIOFACIOSKELETAL SYNDROME	0.005319534000000001	0.19924624087540826
TEMTAMY SYNDROME	0.005319534000000001	0.19924624087540826
TRISOMY 9P	0.005319534000000001	0.19924624087540826
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.005319534000000001	0.19924624087540826
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.005319534000000001	0.19924624087540826
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.005319534	0.19924624087540826
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.005315399	0.19909136204466485
TRISOMY 8P	0.005315399	0.19909136204466485
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.005315399	0.19909136204466485
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.005234994000000001	0.19607974599002792
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.005230859000000001	0.1959248671592845
INTELLECTUAL DISABILITY, WOLFF TYPE	0.005230859000000001	0.1959248671592845
15Q OVERGROWTH SYNDROME	0.005230859000000001	0.1959248671592845
FRYNS SYNDROME	0.005230859000000001	0.1959248671592845
HENNEKAM-BEEMER SYNDROME	0.005230859000000001	0.1959248671592845
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.005152013	0.19297164435667385
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.0051520129999999996	0.19297164435667383
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.0051520129999999996	0.19297164435667383
FUCOSIDOSIS	0.0051520129999999996	0.19297164435667383
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.0051520129999999996	0.19297164435667383
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.0051520129999999996	0.19297164435667383
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.0051520129999999996	0.19297164435667383
WEBB-DATTANI SYNDROME; WEDAS	0.0051520129999999996	0.19297164435667383
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.0051520129999999996	0.19297164435667383
DESANTO-SHINAWI SYNDROME	0.0051520129999999996	0.19297164435667383
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.0051520129999999996	0.19297164435667383
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.0051520129999999996	0.19297164435667383
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.0051520129999999996	0.19297164435667383
SOTOS SYNDROME	0.0051520129999999996	0.19297164435667383
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.0051520129999999996	0.19297164435667383
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.0051520129999999996	0.19297164435667383
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.0051520129999999996	0.19297164435667383
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.0051520129999999996	0.19297164435667383
PETTIGREW SYNDROME	0.0051520129999999996	0.19297164435667383
SMITH-MAGENIS SYNDROME; SMS	0.005100792999999999	0.19105316945687276
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.004901674	0.18359505146441885
DISTAL MONOSOMY 6P	0.004901674	0.18359505146441885
14Q22Q23 MICRODELETION SYNDROME	0.004901674	0.18359505146441885
17Q21.31 MICRODUPLICATION SYNDROME	0.004901674	0.18359505146441885
6Q16 MICRODELETION SYNDROME	0.004901674	0.18359505146441885
MILLER-DIEKER SYNDROME	0.004897539	0.18344017263367546
C SYNDROME	0.004897538999999999	0.1834401726336754
RENPENNING SYNDROME	0.004897538999999999	0.1834401726336754
DISTAL MONOSOMY 3P	0.004897538999999999	0.1834401726336754
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.004897538999999999	0.1834401726336754
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.004855894	0.1818803349296103
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.004855894	0.1818803349296103
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.004855894	0.1818803349296103
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.004855894	0.1818803349296103
HYPERMANGANESEMIA WITH DYSTONIA 2	0.004855894	0.1818803349296103
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.004855894	0.1818803349296103
AICARDI-GOUTIERES SYNDROME 6	0.004855894	0.1818803349296103
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.004855894	0.1818803349296103
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.004855894	0.1818803349296103
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.004855894	0.1818803349296103
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.004855894	0.1818803349296103
NEURONAL CEROID LIPOFUSCINOSIS	0.004851759000000001	0.18172545609886692
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.004851759000000001	0.18172545609886692
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.004851759000000001	0.18172545609886692
FLYNN-AIRD SYNDROME	0.004851759000000001	0.18172545609886692
NASU-HAKOLA DISEASE	0.004851759000000001	0.18172545609886692
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.004851759000000001	0.18172545609886692
ALEXANDER DISEASE	0.004851759000000001	0.18172545609886692
CHILDHOOD DISINTEGRATIVE DISORDER	0.004851759000000001	0.18172545609886692
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.004851759000000001	0.18172545609886692
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.004851759000000001	0.18172545609886692
CADASIL	0.004851759000000001	0.18172545609886692
SNEDDON SYNDROME	0.004851759000000001	0.18172545609886692
CHOREOACANTHOCYTOSIS	0.004851759000000001	0.18172545609886692
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.004851759000000001	0.18172545609886692
BEHÇET DISEASE	0.004851759000000001	0.18172545609886692
NORRIE DISEASE	0.004851759000000001	0.18172545609886692
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.004851759000000001	0.18172545609886692
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.004851759000000001	0.18172545609886692
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.004851759000000001	0.18172545609886692
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.004851759000000001	0.18172545609886692
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.004851759000000001	0.18172545609886692
LYNCH SYNDROME	0.004851759000000001	0.18172545609886692
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.004851759000000001	0.18172545609886692
MENKES DISEASE	0.004851759000000001	0.18172545609886692
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.004851759000000001	0.18172545609886692
DILATED CARDIOMYOPATHY WITH ATAXIA	0.004851759000000001	0.18172545609886692
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.004851759000000001	0.18172545609886692
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.004851759000000001	0.18172545609886692
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.004851759000000001	0.18172545609886692
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.004851759000000001	0.18172545609886692
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.004851759000000001	0.18172545609886692
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.004851759000000001	0.18172545609886692
METACHROMATIC LEUKODYSTROPHY	0.004851759000000001	0.18172545609886692
ETHYLMALONIC ENCEPHALOPATHY	0.004851759000000001	0.18172545609886692
ADIPOSIS DOLOROSA	0.004851759000000001	0.18172545609886692
TRIPLE A SYNDROME	0.004851759000000001	0.18172545609886692
RETT SYNDROME, CONGENITAL VARIANT	0.004851759000000001	0.18172545609886692
FAMILIAL COLORECTAL CANCER TYPE X	0.004851759000000001	0.18172545609886692
ASPARTYLGLUCOSAMINURIA; AGU	0.004851759000000001	0.18172545609886692
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.004851759000000001	0.18172545609886692
KRABBE DISEASE	0.004851759000000001	0.18172545609886692
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.004851759000000001	0.18172545609886692
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.004851759000000001	0.18172545609886692
ALEXANDER DISEASE	0.004851759000000001	0.18172545609886692
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.004851759000000001	0.18172545609886692
COG8-CDG	0.004851759000000001	0.18172545609886692
GM2 GANGLIOSIDOSIS, AB VARIANT	0.004851759000000001	0.18172545609886692
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.004851759000000001	0.18172545609886692
WOLFRAM SYNDROME	0.004851759000000001	0.18172545609886692
INFANTILE NEUROAXONAL DYSTROPHY	0.004851759000000001	0.18172545609886692
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.004851759000000001	0.18172545609886692
RETT SYNDROME; RTT	0.004851759000000001	0.18172545609886692
CEREBROTENDINOUS XANTHOMATOSIS	0.004851759000000001	0.18172545609886692
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.004851759000000001	0.18172545609886692
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.004851759000000001	0.18172545609886692
XERODERMA PIGMENTOSUM	0.004851759000000001	0.18172545609886692
WHIPPLE DISEASE	0.004851759000000001	0.18172545609886692
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.004851759000000001	0.18172545609886692
FABRY DISEASE	0.004851759000000001	0.18172545609886692
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.004773980000000001	0.17881219840203702
AUTOSOMAL RECESSIVE FACIODIGITOGENITAL SYNDROME	0.004773980000000001	0.17881219840203702
WEYERS ACROFACIAL DYSOSTOSIS	0.004773980000000001	0.17881219840203702
PROXIMAL SYMPHALANGISM	0.004773980000000001	0.17881219840203702
604381 PATENT DUCTUS ARTERIOSUS AND BICUSPID AORTIC VALVE WITH HAND ANOMALIES	0.004773980000000001	0.17881219840203702
BANKI SYNDROME	0.004773980000000001	0.17881219840203702
ROIFMAN SYNDROME	0.004773980000000001	0.17881219840203702
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.004773980000000001	0.17881219840203702
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.004773980000000001	0.17881219840203702
NOONAN SYNDROME	0.004773980000000001	0.17881219840203702
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.004773980000000001	0.17881219840203702
PERIPHERAL DYSOSTOSIS	0.004773980000000001	0.17881219840203702
269870 SHORT STATURE-OBESITY SYNDROME; SSOS	0.004773980000000001	0.17881219840203702
FEINGOLD SYNDROME	0.004773980000000001	0.17881219840203702
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.004773980000000001	0.17881219840203702
CLEIDOCRANIAL DYSPLASIA	0.004773980000000001	0.17881219840203702
HAND-FOOT-GENITAL SYNDROME; HFG	0.004773980000000001	0.17881219840203702
BRACHYDACTYLY-ELBOW WRIST DYSPLASIA SYNDROME	0.004773980000000001	0.17881219840203702
MESOMELIA-SYNOSTOSES SYNDROME	0.004773980000000001	0.17881219840203702
TETRALOGY OF FALLOT	0.004773980000000001	0.17881219840203702
HOLOPROSENCEPHALY	0.0047674729999999995	0.17856847493126374
OROFACIODIGITAL SYNDROME TYPE 6	0.0047674729999999995	0.17856847493126374
DISTAL MONOSOMY 10P	0.0046894400000000004	0.17564570351665665
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE SYNDROME	0.0046894400000000004	0.17564570351665665
MENTAL RETARDATION, BUENOS AIRES TYPE	0.0046894400000000004	0.17564570351665665
FRONTONASAL DYSPLASIA-BIFID NOSE-UPPER LIMB ANOMALIES SYNDROME	0.0046894400000000004	0.17564570351665665
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.0046894400000000004	0.17564570351665665
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.0046894400000000004	0.17564570351665665
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.0046894400000000004	0.17564570351665665
FRONTONASAL DYSPLASIA	0.0046894400000000004	0.17564570351665665
RING CHROMOSOME 1 SYNDROME	0.0046894400000000004	0.17564570351665665
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME; NPLCS	0.0046894400000000004	0.17564570351665665
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.004682933	0.1754019800458834
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.004682933	0.1754019800458834
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.004682933	0.1754019800458834
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.004682933	0.1754019800458834
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.004682933	0.1754019800458834
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.004682933	0.1754019800458834
BARAITSER-WINTER SYNDROME 1; BRWS1	0.004682933	0.1754019800458834
KOOLEN-DE VRIES SYNDROME	0.004682933	0.1754019800458834
CHROMOSOME 10Q26 DELETION SYNDROME	0.004682933	0.1754019800458834
C SYNDROME	0.004682933	0.1754019800458834
8P23.1 MICRODELETION SYNDROME	0.004682933	0.1754019800458834
22Q11.2 DELETION SYNDROME	0.004682933	0.1754019800458834
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.004682933	0.1754019800458834
COFFIN-SIRIS SYNDROME	0.004682933	0.1754019800458834
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.004682933	0.1754019800458834
PYRUVATE DEHYDROGENASE DEFICIENCY	0.004682933	0.1754019800458834
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.004682933	0.1754019800458834
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.004682933	0.1754019800458834
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.004682933	0.1754019800458834
20P12.3 MICRODELETION SYNDROME	0.004682933	0.1754019800458834
OCULOECTODERMAL SYNDROME; OES	0.004682933	0.1754019800458834
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.004682933	0.1754019800458834
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.004610594	0.172692480714046
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.004610594	0.172692480714046
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.004610594	0.172692480714046
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.004610594	0.172692480714046
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.004610594	0.172692480714046
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.004610594	0.172692480714046
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.004610594	0.172692480714046
SAUL-WILSON SYNDROME; SWILS	0.004610594	0.172692480714046
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.004610594	0.172692480714046
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.004610594	0.172692480714046
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.004610594	0.172692480714046
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.004610594	0.172692480714046
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.004610594	0.172692480714046
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.004610594	0.172692480714046
MENTAL RETARDATION, X-LINKED 99	0.004610594	0.172692480714046
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.004610594	0.172692480714046
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.004610594	0.172692480714046
ATKIN-FLAITZ SYNDROME	0.004606459	0.1725376018833026
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.004606459	0.1725376018833026
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.004606459	0.1725376018833026
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.004606459	0.1725376018833026
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.004606459	0.1725376018833026
AICA-RIBOSIDURIA	0.004606459	0.1725376018833026
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.004606459	0.1725376018833026
NOONAN SYNDROME 7; NS7	0.004606459	0.1725376018833026
CLARK-BARAITSER SYNDROME	0.004606459	0.1725376018833026
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.004606459	0.1725376018833026
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.004606459	0.1725376018833026
TONNE-KALSCHEUER SYNDROME; TOKAS	0.004559374	0.17077400581424493
TRISOMY 8Q	0.004559374	0.17077400581424493
ELSAHY-WATERS SYNDROME; ESWS	0.004559374	0.17077400581424493
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.004559374	0.17077400581424493
3C SYNDROME	0.004559374	0.17077400581424493
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.004555238999999999	0.17061912698350148
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.004555238999999999	0.17061912698350148
AYME-GRIPP SYNDROME; AYGRP	0.004555238999999999	0.17061912698350148
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.00435612	0.1631610089910476
KEIPERT SYNDROME	0.00435612	0.1631610089910476
CONDUCTIVE DEAFNESS-PTOSIS-SKELETAL ANOMALIES SYNDROME	0.00435612	0.1631610089910476
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.00435612	0.1631610089910476
17Q23.1Q23.2 MICRODELETION SYNDROME	0.00435612	0.1631610089910476
FRAXE INTELLECTUAL DISABILITY	0.00435612	0.1631610089910476
WHITE FORELOCK WITH MALFORMATIONS	0.00435612	0.1631610089910476
WILLIAMS-BEUREN SYNDROME; WBS	0.00435612	0.1631610089910476
MONOSOMY 22	0.00435612	0.1631610089910476
PENOSCROTAL TRANSPOSITION	0.00435612	0.1631610089910476
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.00435612	0.1631610089910476
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	0.00431034	0.16144629245623907
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.00431034	0.16144629245623907
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.00431034	0.16144629245623907
NEUROFERRITINOPATHY	0.00431034	0.16144629245623907
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.00431034	0.16144629245623907
DUCHENNE AND BECKER MUSCULAR DYSTROPHY	0.00431034	0.16144629245623907
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.00431034	0.16144629245623907
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.00431034	0.16144629245623907
BIRK-LANDAU-PEREZ SYNDROME; BILAPES	0.00431034	0.16144629245623907
DYSOSTEOSCLEROSIS	0.00431034	0.16144629245623907
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.00431034	0.16144629245623907
TRISOMY 5P	0.00431034	0.16144629245623907
HUNTINGTON DISEASE	0.00431034	0.16144629245623907
REFSUM DISEASE	0.00431034	0.16144629245623907
SPASTIC TETRAPLEGIA-RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY SYNDROME	0.00431034	0.16144629245623907
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00431034	0.16144629245623907
MUCOPOLYSACCHARIDOSIS TYPE 1	0.00431034	0.16144629245623907
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.00431034	0.16144629245623907
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	0.00431034	0.16144629245623907
ATAXIA WITH VITAMIN E DEFICIENCY	0.00431034	0.16144629245623907
PANDAS	0.00431034	0.16144629245623907
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00431034	0.16144629245623907
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.004226054	0.1582893112886359
PHENOBARBITAL EMBRYOPATHY	0.004226054	0.1582893112886359
OROFACIODIGITAL SYNDROME VI	0.004226054	0.1582893112886359
PSEUDOAMINOPTERIN SYNDROME	0.004226054	0.1582893112886359
BARATELA-SCOTT SYNDROME	0.004226054	0.1582893112886359
CODAS SYNDROME	0.004226054	0.1582893112886359
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.004226054	0.1582893112886359
WOLCOTT-RALLISON SYNDROME	0.004221918999999999	0.15813443245789247
COFFIN-LOWRY SYNDROME	0.004221918999999999	0.15813443245789247
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.004221918999999999	0.15813443245789247
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.004221918999999999	0.15813443245789247
FOUNTAIN SYNDROME	0.004221918999999999	0.15813443245789247
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.004221918999999999	0.15813443245789247
OCULOSKELETODENTAL SYNDROME; OCSKD	0.004141514	0.15512281640325554
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.004141514	0.15512281640325554
JOUBERT SYNDROME 10	0.004141514	0.15512281640325554
8Q12 MICRODUPLICATION SYNDROME	0.004141514	0.15512281640325554
CHROMOSOME 16Q22 DELETION SYNDROME	0.004141514	0.15512281640325554
CHROMOSOME 9P DELETION SYNDROME	0.004141514	0.15512281640325554
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.004141514	0.15512281640325554
COHEN-GIBSON SYNDROME; COGIS	0.004141514	0.15512281640325554
NOONAN SYNDROME 6; NS6	0.004141514	0.15512281640325554
LAMB-SHAFFER SYNDROME	0.004141514	0.15512281640325554
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.004141514	0.15512281640325554
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.004141514	0.15512281640325554
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.004141514	0.15512281640325554
CEREBROFACIOARTICULAR SYNDROME	0.004141514	0.15512281640325554
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.004137379	0.15496793757251212
HENNEKAM SYNDROME	0.004137379	0.15496793757251212
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.004137379	0.15496793757251212
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.004137379	0.15496793757251212
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.004137379	0.15496793757251212
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.004137379	0.15496793757251212
LATHOSTEROLOSIS	0.004137379	0.15496793757251212
MOWAT-WILSON SYNDROME	0.004137379	0.15496793757251212
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00406504	0.15225843824067475
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.00406504	0.15225843824067475
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00406504	0.15225843824067475
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.00406504	0.15225843824067475
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.00406504	0.15225843824067475
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.00406504	0.15225843824067475
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.00406504	0.15225843824067475
MENTAL RETARDATION, X-LINKED 93	0.00406504	0.15225843824067475
CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-POLYDACTYLY SYNDROME	0.00406504	0.15225843824067475
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.00406504	0.15225843824067475
TRICHOHEPATOENTERIC SYNDROME 1	0.00406504	0.15225843824067475
MELANOCYTIC NEVUS SYNDROME, CONGENITAL; CMNS	0.00406504	0.15225843824067475
TRICHOHEPATOENTERIC SYNDROME 2	0.00406504	0.15225843824067475
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.00406504	0.15225843824067475
138920 GRANDDAD SYNDROME;;GROWTH RETARDATION, AGED FACIES, NORMAL DEVELOPMENT, DECREASED SUBCUTANEOUSFAT, AUTOSOMAL DOMINANT INHERITANCE	0.00406504	0.15225843824067475
AUTOSOMAL DOMINANT HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.00406504	0.15225843824067475
MARSHALL-SMITH SYNDROME	0.00406504	0.15225843824067475
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.00406504	0.15225843824067475
FG SYNDROME 2; FGS2	0.00406504	0.15225843824067475
PLATYSPONDYLIC DYSPLASIA, TORRANCE TYPE	0.00406504	0.15225843824067475
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00406504	0.15225843824067475
TETRASOMY 12P	0.00406504	0.15225843824067475
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00406504	0.15225843824067475
GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID	0.00406504	0.15225843824067475
HYPER-IGE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.00406504	0.15225843824067475
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.00406504	0.15225843824067475
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.00406504	0.15225843824067475
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00406504	0.15225843824067475
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00406504	0.15225843824067475
OSTEOGENESIS IMPERFECTA, TYPE X	0.00406504	0.15225843824067475
MENTAL RETARDATION, X-LINKED 19	0.00406504	0.15225843824067475
268650 RUDIGER SYNDROME	0.00406504	0.15225843824067475
CRANIOMETADIAPHYSEAL DYSPLASIA, WORMIAN BONE TYPE	0.00406504	0.15225843824067475
MARSHALL-SMITH SYNDROME; MRSHSS	0.00406504	0.15225843824067475
CATARACT-GROWTH HORMONE DEFICIENCY-SENSORY NEUROPATHY-SENSORINEURAL HEARING LOSS-SKELETAL DYSPLASIA SYNDROME	0.00406504	0.15225843824067475
DAHLBERG-BORER-NEWCOMER SYNDROME	0.0040138199999999995	0.15033996334087366
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.0040138199999999995	0.15033996334087366
CHARLIE M SYNDROME	0.0040138199999999995	0.15033996334087366
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.0040138199999999995	0.15033996334087366
HYPOGLOSSIA-HYPODACTYLY SYNDROME	0.0040138199999999995	0.15033996334087366
BASAL CELL NEVUS SYNDROME	0.0040138199999999995	0.15033996334087366
608028 THAI SYMPHALANGISM SYNDROME	0.0040138199999999995	0.15033996334087366
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.0040138199999999995	0.15033996334087366
ACROOSTEOLYSIS DOMINANT TYPE	0.0040138199999999995	0.15033996334087366
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.0040138199999999995	0.15033996334087366
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.0040138199999999995	0.15033996334087366
GENITOPALATOCARDIAC SYNDROME	0.0040138199999999995	0.15033996334087366
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.0040138199999999995	0.15033996334087366
BRACHYDACTYLY-PREAXIAL HALLUX VARUS SYNDROME	0.0040138199999999995	0.15033996334087366
14Q24.1Q24.3 MICRODELETION SYNDROME	0.0040138199999999995	0.15033996334087366
OCULOMAXILLOFACIAL DYSOSTOSIS	0.0040138199999999995	0.15033996334087366
OROFACIODIGITAL SYNDROME XVIII; OFD18	0.0040138199999999995	0.15033996334087366
ROBERTS SYNDROME; RBS	0.0040138199999999995	0.15033996334087366
CARPENTER-WAZIRI SYNDROME	0.0040138199999999995	0.15033996334087366
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.0040138199999999995	0.15033996334087366
MULTIPLE METAPHYSEAL DYSPLASIA	0.0040138199999999995	0.15033996334087366
SHORT STATURE-WORMIAN BONES-DEXTROCARDIA SYNDROME	0.0040138199999999995	0.15033996334087366
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.0040138199999999995	0.15033996334087366
SPONDYLOEPIPHYSEAL DYSPLASIA, CANTU TYPE	0.0040138199999999995	0.15033996334087366
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.0040138199999999995	0.15033996334087366
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.0040138199999999995	0.15033996334087366
CATEL-MANZKE SYNDROME; CATMANS	0.003811773	0.14277217540490905
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.003811773	0.14277217540490905
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.003811773	0.14277217540490905
COHEN SYNDROME	0.003811773	0.14277217540490905
RECOMBINANT CHROMOSOME 8 SYNDROME	0.003811773	0.14277217540490905
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.003811773	0.14277217540490905
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.003811773	0.14277217540490905
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.003811773	0.14277217540490905
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.003811773	0.14277217540490905
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.003811773	0.14277217540490905
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.003811773	0.14277217540490905
RECOMBINANT 8 SYNDROME	0.003811773	0.14277217540490905
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.003811773	0.14277217540490905
CHROMOSOME 16P13.2 DELETION SYNDROME	0.003811773	0.14277217540490905
DPAGT1-CDG	0.003811773	0.14277217540490905
CHROMOSOME 16P13.3 DELETION SYNDROME	0.003811773	0.14277217540490905
ACROCEPHALOPOLYDACTYLY	0.0036804999999999997	0.13785526881526466
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.0036804999999999997	0.13785526881526466
TERMINAL OSSEOUS DYSPLASIA; TOD	0.0036804999999999997	0.13785526881526466
16P12.1P12.3 TRIPLICATION SYNDROME	0.0036804999999999997	0.13785526881526466
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.0036804999999999997	0.13785526881526466
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.0036804999999999997	0.13785526881526466
MOEBIUS SYNDROME; MBS	0.0036804999999999997	0.13785526881526466
FRONTORHINY	0.0036804999999999997	0.13785526881526466
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.0036804999999999997	0.13785526881526466
CAREY-FINEMAN-ZITER SYNDROME	0.0036804999999999997	0.13785526881526466
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.0036804999999999997	0.13785526881526466
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.0036804999999999997	0.13785526881526466
TORIELLO-LACASSIE-DROSTE SYNDROME	0.0036804999999999997	0.13785526881526466
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.0036804999999999997	0.13785526881526466
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.0036804999999999997	0.13785526881526466
DISTAL TRISOMY 5Q	0.0036804999999999997	0.13785526881526466
LAURENCE-MOON SYNDROME	0.0036804999999999997	0.13785526881526466
SILLENCE SYNDROME	0.0036804999999999997	0.13785526881526466
OROFACIODIGITAL SYNDROME IV; OFD4	0.0036804999999999997	0.13785526881526466
ABRUZZO-ERICKSON SYNDROME	0.0036804999999999997	0.13785526881526466
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.0036804999999999997	0.13785526881526466
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.0036804999999999997	0.13785526881526466
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.00359596	0.1346887739298843
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.00359596	0.1346887739298843
FEINGOLD SYNDROME 1; FGLDS1	0.00359596	0.1346887739298843
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.00359596	0.1346887739298843
FACIAL DYSMORPHISM-SHAWL SCROTUM-JOINT LAXITY SYNDROME	0.00359596	0.1346887739298843
CRI-DU-CHAT SYNDROME	0.00359596	0.1346887739298843
VAN MALDERGEM SYNDROME 2; VMLDS2	0.00359596	0.1346887739298843
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.00359596	0.1346887739298843
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.00359596	0.1346887739298843
MONOSOMY 5P	0.00359596	0.1346887739298843
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.00359596	0.1346887739298843
RING CHROMOSOME 13 SYNDROME	0.00359596	0.1346887739298843
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.00359596	0.1346887739298843
SHPRINTZEN OMPHALOCELE SYNDROME	0.00359596	0.1346887739298843
VAN MALDERGEM SYNDROME 1; VMLDS1	0.00359596	0.1346887739298843
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.00359596	0.1346887739298843
SCARF SYNDROME	0.00359596	0.1346887739298843
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00359596	0.1346887739298843
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.00359596	0.1346887739298843
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.00359596	0.1346887739298843
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.00359596	0.1346887739298843
JOUBERT SYNDROME 3; JBTS3	0.00359596	0.1346887739298843
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.00359596	0.1346887739298843
600736 VELOFACIOSKELETAL SYNDROME	0.00359596	0.1346887739298843
RING CHROMOSOME 6 SYNDROME	0.00359596	0.1346887739298843
OMODYSPLASIA 1; OMOD1	0.00359596	0.1346887739298843
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.00359596	0.1346887739298843
3Q13 MICRODELETION SYNDROME	0.00359596	0.1346887739298843
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.00359596	0.1346887739298843
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.0032703540000000005	0.12249301176228125
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.0032703540000000005	0.12249301176228125
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.0032703540000000005	0.12249301176228125
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.0032703540000000005	0.12249301176228125
3Q29 MICRODELETION SYNDROME	0.0032703540000000005	0.12249301176228125
17P13.3 MICRODUPLICATION SYNDROME	0.0032703540000000005	0.12249301176228125
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.0032703540000000005	0.12249301176228125
2Q32Q33 MICRODELETION SYNDROME	0.0032703540000000005	0.12249301176228125
CHAR SYNDROME	0.0032703540000000005	0.12249301176228125
EAR-PATELLA-SHORT STATURE SYNDROME	0.0032703540000000005	0.12249301176228125
SILVER-RUSSELL SYNDROME; SRS	0.0032703540000000005	0.12249301176228125
12Q14 MICRODELETION SYNDROME	0.0032703540000000005	0.12249301176228125
DISTAL TRISOMY 18Q	0.0032703540000000005	0.12249301176228125
OCULOFACIOCARDIODENTAL SYNDROME	0.0032703540000000005	0.12249301176228125
CHAR SYNDROME	0.0032703540000000005	0.12249301176228125
POPOV-CHANG SYNDROME; POPCHAS	0.0032703540000000005	0.12249301176228125
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.0032662190000000003	0.12233813293153784
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.0032662190000000003	0.12233813293153784
BOWEN-CONRADI SYNDROME	0.0032662190000000003	0.12233813293153784
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.0032662190000000003	0.12233813293153784
WARBURG MICRO SYNDROME 3; WARBM3	0.0032662190000000003	0.12233813293153784
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.0032662190000000003	0.12233813293153784
MICROPHTHALMIA, LENZ TYPE	0.0032662190000000003	0.12233813293153784
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.0032662190000000003	0.12233813293153784
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.0032662190000000003	0.12233813293153784
SECKEL SYNDROME 1; SCKL1	0.0032662190000000003	0.12233813293153784
BRANCHIOOCULOFACIAL SYNDROME	0.0032662190000000003	0.12233813293153784
PROTEUS SYNDROME	0.0032662190000000003	0.12233813293153784
CORNELIA DE LANGE SYNDROME 1	0.0032662190000000003	0.12233813293153784
SCHAAF-YANG SYNDROME; SHFYNG	0.003136153	0.11746643522912613
COWDEN SYNDROME	0.003136153	0.11746643522912613
TEMTAMY SYNDROME; TEMTYS	0.003136153	0.11746643522912613
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.003136153	0.11746643522912613
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.003136153	0.11746643522912613
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.003136153	0.11746643522912613
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.003136153	0.11746643522912613
MYHRE SYNDROME	0.003136153	0.11746643522912613
COFFIN-SIRIS SYNDROME 2; CSS2	0.003136153	0.11746643522912613
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.003136153	0.11746643522912613
ADAMS-OLIVER SYNDROME 1; AOS1	0.003136153	0.11746643522912613
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.003136153	0.11746643522912613
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.003051613	0.11429994034374574
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.003051613	0.11429994034374574
MENTAL RETARDATION, X-LINKED 104; MRX104	0.003051613	0.11429994034374574
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.003051613	0.11429994034374574
3Q29 MICRODUPLICATION SYNDROME	0.003051613	0.11429994034374574
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.003051613	0.11429994034374574
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.003051613	0.11429994034374574
BOHRING-OPITZ SYNDROME	0.003051613	0.11429994034374574
MICRO SYNDROME	0.003051613	0.11429994034374574
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.003051613	0.11429994034374574
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.003051613	0.11429994034374574
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.003051613	0.11429994034374574
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.003051613	0.11429994034374574
MOSAIC TRISOMY 14	0.003051613	0.11429994034374574
CHROMOSOME 1P35 DELETION SYNDROME	0.003051613	0.11429994034374574
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.003051613	0.11429994034374574
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.003051613	0.11429994034374574
TARP SYNDROME	0.003051613	0.11429994034374574
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.003051613	0.11429994034374574
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.003051613	0.11429994034374574
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.003051613	0.11429994034374574
KABUKI SYNDROME 1	0.003051613	0.11429994034374574
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.003051613	0.11429994034374574
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.003051613	0.11429994034374574
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.003051613	0.11429994034374574
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.003051613	0.11429994034374574
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.003051613	0.11429994034374574
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 4	0.0027248000000000003	0.10205896928890998
WT LIMB-BLOOD SYNDROME	0.0027248000000000003	0.10205896928890998
ACROFACIAL DYSOSTOSIS, WEYERS TYPE	0.0027248000000000003	0.10205896928890998
PTOSIS-UPPER OCULAR MOVEMENT LIMITATION-ABSENCE OF LACRIMAL PUNCTUM SYNDROME	0.0027248000000000003	0.10205896928890998
MICROCEPHALY 24, PRIMARY, AUTOSOMAL RECESSIVE; MCPH24	0.0027248000000000003	0.10205896928890998
GORDON SYNDROME	0.0027248000000000003	0.10205896928890998
TALONAVICULAR COALITION	0.0027248000000000003	0.10205896928890998
FIBROCHONDROGENESIS 1; FBCG1	0.0027248000000000003	0.10205896928890998
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.0027248000000000003	0.10205896928890998
PATENT DUCTUS ARTERIOSUS-BICUSPID AORTIC VALVE-HAND ANOMALIES SYNDROME	0.0027248000000000003	0.10205896928890998
MEIER-GORLIN SYNDROME 1; MGORS1	0.0027248000000000003	0.10205896928890998
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.0027248000000000003	0.10205896928890998
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.0027248000000000003	0.10205896928890998
JOHANSON-BLIZZARD SYNDROME; JBS	0.0027248000000000003	0.10205896928890998
HYPOSPADIAS-INTELLECTUAL DISABILITY, GOLDBLATT TYPE SYNDROME	0.0027248000000000003	0.10205896928890998
3MC SYNDROME 1	0.0027248000000000003	0.10205896928890998
MICROCEPHALY-CARDIOMYOPATHY	0.0027248000000000003	0.10205896928890998
DEAFNESS, CONDUCTIVE, WITH PTOSIS AND SKELETAL ANOMALIES	0.0027248000000000003	0.10205896928890998
MASA SYNDROME	0.0027248000000000003	0.10205896928890998
DENTAL ANKYLOSIS	0.0027248000000000003	0.10205896928890998
HAND-FOOT-GENITAL SYNDROME	0.0027248000000000003	0.10205896928890998
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.0027248000000000003	0.10205896928890998
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME	0.0027248000000000003	0.10205896928890998
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.0027248000000000003	0.10205896928890998
TRICHORHINOPHALANGEAL SYNDROME TYPE 1 AND 3	0.0027248000000000003	0.10205896928890998
19Q13.11 MICRODELETION SYNDROME	0.0027248000000000003	0.10205896928890998
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.0027248000000000003	0.10205896928890998
DIAPHRAGMATIC DEFECT-LIMB DEFICIENCY-SKULL DEFECT SYNDROME	0.0027248000000000003	0.10205896928890998
HALLUX VARUS-PREAXIAL POLYSYNDACTYLY SYNDROME	0.0027248000000000003	0.10205896928890998
BRACHYDACTYLY TYPE C	0.0027248000000000003	0.10205896928890998
BRACHYDACTYLY TYPE A1	0.0027248000000000003	0.10205896928890998
BRACHYDACTYLY TYPE A2	0.0027248000000000003	0.10205896928890998
BRACHYDACTYLY TYPE A7	0.0027248000000000003	0.10205896928890998
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.0027248000000000003	0.10205896928890998
HALLERMANN-STREIFF SYNDROME	0.0027248000000000003	0.10205896928890998
APLASIA CUTIS CONGENITA-INTESTINAL LYMPHANGIECTASIA SYNDROME	0.0027248000000000003	0.10205896928890998
BLOOM SYNDROME	0.0027248000000000003	0.10205896928890998
BOWEN-CONRADI SYNDROME	0.0027248000000000003	0.10205896928890998
TETRALOGY OF FALLOT	0.0027248000000000003	0.10205896928890998
ANONYCHIA-MICROCEPHALY SYNDROME	0.0027248000000000003	0.10205896928890998
SYNDACTYLY TYPE 5	0.0027248000000000003	0.10205896928890998
SYNDACTYLY TYPE 2	0.0027248000000000003	0.10205896928890998
MOSAIC TRISOMY 8	0.0027248000000000003	0.10205896928890998
NAIL-PATELLA SYNDROME	0.0027248000000000003	0.10205896928890998
CEREBROCOSTOMANDIBULAR SYNDROME	0.0027248000000000003	0.10205896928890998
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.0027248000000000003	0.10205896928890998
HUNTER-MACDONALD SYNDROME	0.0027248000000000003	0.10205896928890998
INTELLECTUAL DISABILITY-SHORT STATURE-HYPERTELORISM SYNDROME	0.0027248000000000003	0.10205896928890998
TOWNES-BROCKS SYNDROME	0.0027248000000000003	0.10205896928890998
ROBIN SEQUENCE-OLIGODACTYLY SYNDROME	0.0027248000000000003	0.10205896928890998
SYNDACTYLY, MESOAXIAL SYNOSTOTIC, WITH PHALANGEAL REDUCTION	0.0027248000000000003	0.10205896928890998
EYE DEFECTS-ARACHNODACTYLY-CARDIOPATHY SYNDROME	0.0027248000000000003	0.10205896928890998
SHORT STATURE-VALVULAR HEART DISEASE-CHARACTERISTIC FACIES SYNDROME	0.0027248000000000003	0.10205896928890998
SECKEL SYNDROME 5; SCKL5	0.0027248000000000003	0.10205896928890998
DIAPHRAGMATIC DEFECTS, LIMB DEFICIENCIES, AND OSSIFICATION DEFECTS OF SKULL	0.0027248000000000003	0.10205896928890998
BRACHYDACTYLY, TYPE A3	0.0027248000000000003	0.10205896928890998
INTELLECTUAL DISABILITY-SPASTICITY-ECTRODACTYLY SYNDROME	0.0027248000000000003	0.10205896928890998
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.0027248000000000003	0.10205896928890998
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP	0.0027248000000000003	0.10205896928890998
OSLAM SYNDROME	0.0027248000000000003	0.10205896928890998
MESOMELIC DYSPLASIA, KANTAPUTRA TYPE	0.0027248000000000003	0.10205896928890998
ALAGILLE SYNDROME	0.0027248000000000003	0.10205896928890998
PELVIS-SHOULDER DYSPLASIA	0.0027248000000000003	0.10205896928890998
EXTERNAL AUDITORY CANAL ATRESIA-VERTICAL TALUS-HYPERTELORISM SYNDROME	0.0027248000000000003	0.10205896928890998
DESBUQUOIS SYNDROME	0.0027248000000000003	0.10205896928890998
MOLAR I REINCLUSION	0.0027248000000000003	0.10205896928890998
CLEIDORHIZOMELIC SYNDROME	0.0027248000000000003	0.10205896928890998
THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME	0.0027248000000000003	0.10205896928890998
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.0027248000000000003	0.10205896928890998
BRACHYDACTYLY, TYPE A2; BDA2	0.0027248000000000003	0.10205896928890998
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.0027248000000000003	0.10205896928890998
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.0027248000000000003	0.10205896928890998
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.0027248000000000003	0.10205896928890998
LIMB-MAMMARY SYNDROME	0.0027248000000000003	0.10205896928890998
311895 PIERRE ROBIN SEQUENCE WITH FACIAL AND DIGITAL ANOMALIES	0.0027248000000000003	0.10205896928890998
MESOMELIC DYSPLASIA, NIEVERGELT TYPE	0.0027248000000000003	0.10205896928890998
EPIPHYSEAL DYSPLASIA, BAUMANN TYPE	0.0027248000000000003	0.10205896928890998
SYNPOLYDACTYLY 1	0.0027248000000000003	0.10205896928890998
ERMINE PHENOTYPE	0.0027248000000000003	0.10205896928890998
CLEIDORHIZOMELIC SYNDROME	0.0027248000000000003	0.10205896928890998
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.0027248000000000003	0.10205896928890998
SECKEL SYNDROME 2; SCKL2	0.0027248000000000003	0.10205896928890998
LACRIMOAURICULODENTODIGITAL SYNDROME; LADD	0.0027248000000000003	0.10205896928890998
3M SYNDROME	0.0027248000000000003	0.10205896928890998
X-LINKED INTELLECTUAL DISABILITY, STOLL TYPE	0.0027248000000000003	0.10205896928890998
METATROPIC DYSPLASIA	0.0027248000000000003	0.10205896928890998
CLEFT LIP/PALATE-INTESTINAL MALROTATION-CARDIOPATHY SYNDROME	0.0027248000000000003	0.10205896928890998
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.0027248000000000003	0.10205896928890998
SKELETAL DYSPLASIA WITH DELAYED EPIPHYSEAL AND CARPAL BONE OSSIFICATION	0.0027248000000000003	0.10205896928890998
MESOAXIAL SYNOSTOTIC SYNDACTYLY WITH PHALANGEAL REDUCTION	0.0027248000000000003	0.10205896928890998
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.0027248000000000003	0.10205896928890998
SPASTIC PARAPLEGIA-NEPHRITIS-DEAFNESS SYNDROME	0.0027248000000000003	0.10205896928890998
CATEL-MANZKE SYNDROME	0.0027248000000000003	0.10205896928890998
FETAL MINOXIDIL SYNDROME	0.0027248000000000003	0.10205896928890998
BRACHYDACTYLY, TYPE A1, D	0.0027248000000000003	0.10205896928890998
KERATOSIS PALMARIS ET PLANTARIS WITH CLINODACTYLY	0.0027248000000000003	0.10205896928890998
HYPOPLASTIC TIBIAE-POSTAXIAL POLYDACTYLY SYNDROME	0.0027248000000000003	0.10205896928890998
KERATOSIS PALMARIS ET PLANTARIS-CLINODACTYLY SYNDROME	0.0027248000000000003	0.10205896928890998
FLOATING-HARBOR SYNDROME	0.0027248000000000003	0.10205896928890998
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.002718293	0.10181524581813672
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.002718293	0.10181524581813672
MONOSOMY 18Q	0.002718293	0.10181524581813672
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.002718293	0.10181524581813672
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.002718293	0.10181524581813672
MENTAL RETARDATION, X-LINKED 91; MRX91	0.002718293	0.10181524581813672
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.002718293	0.10181524581813672
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.002718293	0.10181524581813672
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.002718293	0.10181524581813672
WEAVER SYNDROME	0.002718293	0.10181524581813672
LATHOSTEROLOSIS	0.002718293	0.10181524581813672
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.002718293	0.10181524581813672
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.002718293	0.10181524581813672
MONOSOMY 9P	0.002718293	0.10181524581813672
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.002718293	0.10181524581813672
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.002718293	0.10181524581813672
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.002718293	0.10181524581813672
XQ25 MICRODUPLICATION SYNDROME	0.002718293	0.10181524581813672
POTOCKI-SHAFFER SYNDROME	0.002718293	0.10181524581813672
CK SYNDROME	0.002718293	0.10181524581813672
TEMPLE-BARAITSER SYNDROME; TMBTS	0.002718293	0.10181524581813672
MONOSOMY 9Q22.3	0.002718293	0.10181524581813672
8P11.2 DELETION SYNDROME	0.002718293	0.10181524581813672
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.002718293	0.10181524581813672
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.002718293	0.10181524581813672
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.002718293	0.10181524581813672
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.002718293	0.10181524581813672
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.002718293	0.10181524581813672
DISTAL TRISOMY 17Q	0.002718293	0.10181524581813672
10Q22.3Q23.3 MICRODELETION SYNDROME	0.002718293	0.10181524581813672
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.002718293	0.10181524581813672
XQ25 DUPLICATION SYNDROME	0.002718293	0.10181524581813672
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.002718293	0.10181524581813672
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.002718293	0.10181524581813672
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.002718293	0.10181524581813672
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.002718293	0.10181524581813672
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.002718293	0.10181524581813672
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.002718293	0.10181524581813672
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.002718293	0.10181524581813672
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.002718293	0.10181524581813672
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.002718293	0.10181524581813672
PEHO SYNDROME; PEHO	0.002718293	0.10181524581813672
22Q11.2 MICRODUPLICATION SYNDROME	0.002718293	0.10181524581813672
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.0025947339999999996	0.09718727158649827
BARDET-BIEDL SYNDROME 1; BBS1	0.0025947339999999996	0.09718727158649827
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.0025947339999999996	0.09718727158649827
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.0025947339999999996	0.09718727158649827
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.0025947339999999996	0.09718727158649827
BARDET-BIEDL SYNDROME 17; BBS17	0.0025947339999999996	0.09718727158649827
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.0025947339999999996	0.09718727158649827
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.0025947339999999996	0.09718727158649827
GENITOPATELLAR SYNDROME; GTPTS	0.0025947339999999996	0.09718727158649827
20Q11.2 MICRODELETION SYNDROME	0.0025947339999999996	0.09718727158649827
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.0025947339999999996	0.09718727158649827
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.0025947339999999996	0.09718727158649827
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.0025947339999999996	0.09718727158649827
AL-RAQAD SYNDROME; ARS	0.0025947339999999996	0.09718727158649827
BARDET-BIEDL SYNDROME 3; BBS3	0.0025947339999999996	0.09718727158649827
CHOPS SYNDROME; CHOPS	0.0025947339999999996	0.09718727158649827
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.0025947339999999996	0.09718727158649827
MCKUSICK-KAUFMAN SYNDROME	0.0025947339999999996	0.09718727158649827
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.0025947339999999996	0.09718727158649827
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.002590599	0.09703239275575486
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.002590599	0.09703239275575486
PGM3-CDG	0.002590599	0.09703239275575486
CONO-SPONDYLAR DYSPLASIA	0.002590599	0.09703239275575486
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.002590599	0.09703239275575486
THANATOPHORIC DYSPLASIA TYPE 1	0.002590599	0.09703239275575486
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.002590599	0.09703239275575486
KLEEFSTRA SYNDROME	0.002590599	0.09703239275575486
21Q22.11Q22.12 MICRODELETION SYNDROME	0.002590599	0.09703239275575486
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.002590599	0.09703239275575486
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.002590599	0.09703239275575486
CRANIOSYNOSTOSIS 2	0.002590599	0.09703239275575486
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.002590599	0.09703239275575486
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.002590599	0.09703239275575486
ADAMS-OLIVER SYNDROME 5; AOS5	0.002590599	0.09703239275575486
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.002590599	0.09703239275575486
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.002590599	0.09703239275575486
THANATOPHORIC DYSPLASIA TYPE 2	0.002590599	0.09703239275575486
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.002590599	0.09703239275575486
SWEENEY-COX SYNDROME; SWCOS	0.0025101940000000003	0.09402077670111791
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.0025101940000000003	0.09402077670111791
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.0025101940000000003	0.09402077670111791
GOLDBERG-SHPRINTZEN SYNDROME	0.0025101940000000003	0.09402077670111791
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.0025101940000000003	0.09402077670111791
HURLER SYNDROME	0.0025101940000000003	0.09402077670111791
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.0025101940000000003	0.09402077670111791
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.0025101940000000003	0.09402077670111791
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.0025101940000000003	0.09402077670111791
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.0025101940000000003	0.09402077670111791
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.0025101940000000003	0.09402077670111791
8Q22.1 MICRODELETION SYNDROME	0.0025101940000000003	0.09402077670111791
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.0025101940000000003	0.09402077670111791
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.0025101940000000003	0.09402077670111791
TREACHER-COLLINS SYNDROME	0.0025101940000000003	0.09402077670111791
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.0025101940000000003	0.09402077670111791
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.0025101940000000003	0.09402077670111791
CHROMOSOME 18P DELETION SYNDROME	0.0025101940000000003	0.09402077670111791
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.0025101940000000003	0.09402077670111791
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.0025101940000000003	0.09402077670111791
GERMAN SYNDROME	0.0025101940000000003	0.09402077670111791
ALAZAMI SYNDROME; ALAZS	0.0025101940000000003	0.09402077670111791
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.0025101940000000003	0.09402077670111791
TARP SYNDROME; TARPS	0.0025101940000000003	0.09402077670111791
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.002506059	0.0938658978703745
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.002506059	0.0938658978703745
ACROCARDIOFACIAL SYNDROME	0.002506059	0.0938658978703745
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.002506059	0.0938658978703745
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.002506059	0.0938658978703745
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.002506059	0.0938658978703745
SPINOCEREBELLAR ATAXIA 47; SCA47	0.002506059	0.0938658978703745
17Q24.2 MICRODELETION SYNDROME	0.002506059	0.0938658978703745
PITT-HOPKINS SYNDROME	0.002506059	0.0938658978703745
FRYNS SYNDROME; FRNS	0.002506059	0.0938658978703745
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.002506059	0.0938658978703745
SIALIDOSIS TYPE 1	0.002506059	0.0938658978703745
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.002506059	0.0938658978703745
FAMILIAL BENIGN COPPER DEFICIENCY	0.002506059	0.0938658978703745
LISSENCEPHALY, X-LINKED, 2	0.002506059	0.0938658978703745
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.002506059	0.0938658978703745
ZLOTOGORA-OGUR SYNDROME	0.002506059	0.0938658978703745
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.002506059	0.0938658978703745
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.002506059	0.0938658978703745
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.002506059	0.0938658978703745
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.002506059	0.0938658978703745
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.002506059	0.0938658978703745
GLUTAMINE DEFICIENCY, CONGENITAL	0.002506059	0.0938658978703745
FILIPPI SYNDROME; FLPIS	0.002506059	0.0938658978703745
311450 PALLISTER W SYNDROME;;W SYNDROME	0.002506059	0.0938658978703745
ASPARTYLGLUCOSAMINURIA	0.002506059	0.0938658978703745
RING CHROMOSOME 10 SYNDROME	0.002506059	0.0938658978703745
COFS SYNDROME	0.002506059	0.0938658978703745
ZIMMERMANN-LABAND SYNDROME 1	0.002506059	0.0938658978703745
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.0021768739999999996	0.08153608217550887
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.0021768739999999996	0.08153608217550887
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.0021768739999999996	0.08153608217550887
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.0021768739999999996	0.08153608217550887
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.0021768739999999996	0.08153608217550887
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.0021768739999999996	0.08153608217550887
JOUBERT SYNDROME 14	0.0021768739999999996	0.08153608217550887
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.0021768739999999996	0.08153608217550887
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.0021768739999999996	0.08153608217550887
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.0021768739999999996	0.08153608217550887
HADZISELIMOVIC SYNDROME	0.0021768739999999996	0.08153608217550887
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.0021768739999999996	0.08153608217550887
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.0021768739999999996	0.08153608217550887
TOLUENE EMBRYOPATHY	0.0021768739999999996	0.08153608217550887
MONOSOMY 13Q34	0.0021768739999999996	0.08153608217550887
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.0021768739999999996	0.08153608217550887
WARSAW BREAKAGE SYNDROME; WABS	0.0021768739999999996	0.08153608217550887
FETAL HYDANTOIN SYNDROME	0.0021768739999999996	0.08153608217550887
FETAL ALCOHOL SYNDROME	0.0021768739999999996	0.08153608217550887
CHROMOSOME 17P13.1 DELETION SYNDROME	0.0021768739999999996	0.08153608217550887
48,XYYY SYNDROME	0.0021768739999999996	0.08153608217550887
HARTSFIELD SYNDROME; HRTFDS	0.0021768739999999996	0.08153608217550887
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.0021768739999999996	0.08153608217550887
ROTHMUND-THOMSON SYNDROME	0.0021768739999999996	0.08153608217550887
DESBUQUOIS DYSPLASIA 2; DBQD2	0.0021768739999999996	0.08153608217550887
NOONAN SYNDROME 3; NS3	0.0021768739999999996	0.08153608217550887
THAUVIN-ROBINET-FAIVRE SYNDROME	0.0021768739999999996	0.08153608217550887
LYMPHEDEMA, HEREDITARY, III	0.0021768739999999996	0.08153608217550887
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.0021768739999999996	0.08153608217550887
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.0021768739999999996	0.08153608217550887
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.0021768739999999996	0.08153608217550887
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.0021768739999999996	0.08153608217550887
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.0021768739999999996	0.08153608217550887
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.0021768739999999996	0.08153608217550887
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.0021768739999999996	0.08153608217550887
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.0021768739999999996	0.08153608217550887
FRONTOOCULAR SYNDROME	0.0021768739999999996	0.08153608217550887
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.0021768739999999996	0.08153608217550887
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.0021768739999999996	0.08153608217550887
16P11.2P12.2 MICRODELETION SYNDROME	0.0021768739999999996	0.08153608217550887
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.0021768739999999996	0.08153608217550887
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.0021768739999999996	0.08153608217550887
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.0021768739999999996	0.08153608217550887
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.0021768739999999996	0.08153608217550887
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.0021768739999999996	0.08153608217550887
ICF SYNDROME	0.0021768739999999996	0.08153608217550887
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.0021768739999999996	0.08153608217550887
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.0021768739999999996	0.08153608217550887
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.0021768739999999996	0.08153608217550887
LATERAL MENINGOCELE SYNDROME	0.0021768739999999996	0.08153608217550887
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.0021768739999999996	0.08153608217550887
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.002172739	0.08138120334476547
TETRASOMY 18P	0.002172739	0.08138120334476547
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.002172739	0.08138120334476547
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.002172739	0.08138120334476547
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.002172739	0.08138120334476547
MARDEN-WALKER SYNDROME	0.002172739	0.08138120334476547
KNOBLOCH SYNDROME	0.002172739	0.08138120334476547
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.002172739	0.08138120334476547
MOMO SYNDROME	0.002172739	0.08138120334476547
CHROMOSOME 18Q DELETION SYNDROME	0.002172739	0.08138120334476547
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.002172739	0.08138120334476547
MECKEL SYNDROME, TYPE 10; MKS10	0.002172739	0.08138120334476547
CHIME SYNDROME	0.002172739	0.08138120334476547
OCULODENTODIGITAL DYSPLASIA; ODDD	0.002172739	0.08138120334476547
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.002172739	0.08138120334476547
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.002172739	0.08138120334476547
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.002172739	0.08138120334476547
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.002172739	0.08138120334476547
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.002172739	0.08138120334476547
X-LINKED SKELETAL DYSPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.00204918	0.07675322911312703
SMITH-MAGENIS SYNDROME	0.00204918	0.07675322911312703
GREENBERG DYSPLASIA	0.00204918	0.07675322911312703
ECTRODACTYLY-POLYDACTYLY SYNDROME	0.00204918	0.07675322911312703
BRACHYDACTYLY-ARTERIAL HYPERTENSION SYNDROME	0.00204918	0.07675322911312703
BRACHYDACTYLY-MESOMELIA-INTELLECTUAL DISABILITY-HEART DEFECTS SYNDROME	0.00204918	0.07675322911312703
EMERY-NELSON SYNDROME	0.00204918	0.07675322911312703
HEART-HAND SYNDROME TYPE 2	0.00204918	0.07675322911312703
SYMPHALANGISM, DISTAL	0.00204918	0.07675322911312703
BRACHYTELEPHALANGY-DYSMORPHISM-KALLMANN SYNDROME	0.00204918	0.07675322911312703
191482 UNCOMBABLE HAIR, RETINAL PIGMENTARY DYSTROPHY, DENTAL ANOMALIES, ANDBRACHYDACTYLY;;BORK SYNDROME	0.00204918	0.07675322911312703
2Q37 MONOSOMY	0.00204918	0.07675322911312703
SYNDACTYLY, TYPE V	0.00204918	0.07675322911312703
PSEUDOACHONDROPLASIA	0.00204918	0.07675322911312703
TRIPHALANGEAL THUMBS WITH BRACHYECTRODACTYLY	0.00204918	0.07675322911312703
CARPENTER SYNDROME	0.00204918	0.07675322911312703
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.00204918	0.07675322911312703
HEART-HAND SYNDROME TYPE 3	0.00204918	0.07675322911312703
THANATOPHORIC DYSPLASIA, TYPE II	0.00204918	0.07675322911312703
CAMPTOBRACHYDACTYLY	0.00204918	0.07675322911312703
SYNOSTOSIS, CARPAL, WITH DYSPLASTIC ELBOW JOINTS AND BRACHYDACTYLY	0.00204918	0.07675322911312703
SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD	0.00204918	0.07675322911312703
CHROMOSOME 8Q22.1 DUPLICATION SYNDROME	0.00204918	0.07675322911312703
ARTHROGRYPOSIS, DISTAL, TYPE 2B2; DA2B2	0.00204918	0.07675322911312703
%112440 BRACHYDACTYLY, COMBINED B AND E TYPES;;PITT-WILLIAMS BRACHYDACTYLY;;BRACHYDACTYLY, BALLARD TYPE	0.00204918	0.07675322911312703
ACROMICRIC DYSPLASIA	0.00204918	0.07675322911312703
ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE	0.00204918	0.07675322911312703
DYSOSTOSIS WITH BRACHYDACTYLY	0.00204918	0.07675322911312703
BRACHYDACTYLY, TYPE E	0.00204918	0.07675322911312703
DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE	0.00204918	0.07675322911312703
BRACHYDACTYLY-ECTRODACTYLY WITH FIBULAR APLASIA OR HYPOPLASIA	0.00204918	0.07675322911312703
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.00204918	0.07675322911312703
METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE	0.00204918	0.07675322911312703
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.00204918	0.07675322911312703
DEAFNESS, CONGENITAL, AND ONYCHODYSTROPHY, AUTOSOMAL DOMINANT	0.00204918	0.07675322911312703
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00204918	0.07675322911312703
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE	0.00204918	0.07675322911312703
CAMPTOBRACHYDACTYLY	0.00204918	0.07675322911312703
HEART-HAND SYNDROME, SLOVENIAN TYPE	0.00204918	0.07675322911312703
CLEIDOCRANIAL DYSPLASIA; CCD	0.00204918	0.07675322911312703
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.00204918	0.07675322911312703
BRACHYDACTYLY, LONG-THUMB TYPE	0.00204918	0.07675322911312703
COOKS SYNDROME	0.00204918	0.07675322911312703
ENG-STROM SYNDROME	0.00204918	0.07675322911312703
SHORT RIB-POLYDACTYLY SYNDROME	0.00204918	0.07675322911312703
PYCNODYSOSTOSIS	0.00204918	0.07675322911312703
TRICHO-RETINO-DENTO-DIGITAL SYNDROME	0.00204918	0.07675322911312703
LOWRY-WOOD SYNDROME	0.00204918	0.07675322911312703
METATROPIC DYSPLASIA	0.00204918	0.07675322911312703
DYSOSTOSIS, STANESCU TYPE	0.00204918	0.07675322911312703
ATELOSTEOGENESIS TYPE I	0.00204918	0.07675322911312703
ACROMESOMELIC DYSPLASIA, GREBE TYPE	0.00204918	0.07675322911312703
SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1	0.00204918	0.07675322911312703
ACROFRONTOFACIONASAL DYSOSTOSIS	0.00204918	0.07675322911312703
JEUNE SYNDROME	0.00204918	0.07675322911312703
HYPOCHONDROPLASIA	0.00204918	0.07675322911312703
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.00204918	0.07675322911312703
AREDYLD SYNDROME	0.00204918	0.07675322911312703
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.00204918	0.07675322911312703
PREAXIAL DEFICIENCY, POSTAXIAL POLYDACTYLY, AND HYPOSPADIAS	0.00204918	0.07675322911312703
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.00204918	0.07675322911312703
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.00204918	0.07675322911312703
WEILL-MARCHESANI SYNDROME 2; WMS2	0.00204918	0.07675322911312703
SATOYOSHI SYNDROME	0.00204918	0.07675322911312703
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MICROMELIC	0.00204918	0.07675322911312703
SHORT-RIB THORACIC DYSPLASIA 17 WITH OR WITHOUT POLYDACTYLY; SRTD17	0.00204918	0.07675322911312703
SCHNECKENBECKEN DYSPLASIA	0.00204918	0.07675322911312703
OSTEOPOROSIS-MACROCEPHALY-BLINDNESS-JOINT HYPERLAXITY SYNDROME	0.00204918	0.07675322911312703
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.00204918	0.07675322911312703
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE; SEMDAG	0.00204918	0.07675322911312703
PYCNODYSOSTOSIS	0.00204918	0.07675322911312703
MULTIPLE SYNOSTOSES SYNDROME 4; SYNS4	0.00204918	0.07675322911312703
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.00204918	0.07675322911312703
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.00204918	0.07675322911312703
ANAUXETIC DYSPLASIA 2; ANXD2	0.00204918	0.07675322911312703
BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES; BCYM4	0.00204918	0.07675322911312703
SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATECALCIFICATIONS, AND DEAFNESS	0.00204918	0.07675322911312703
OSTEOGLOSPHONIC DYSPLASIA	0.00204918	0.07675322911312703
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.00204918	0.07675322911312703
ISOLATED BRACHYCEPHALY	0.00204918	0.07675322911312703
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.00204918	0.07675322911312703
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.00204918	0.07675322911312703
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00204918	0.07675322911312703
613005 SANTOS SYNDROME;;FIBULAR AGENESIS/HYPOPLASIA, OLIGODACTYLOUS CLUBFEET, AND ANONYCHIA/NAILHYPOPLASIA SYNDROME	0.00204918	0.07675322911312703
%609052 SPONDYLOMETAPHYSEAL DYSPLASIA, TYPE A4	0.00204918	0.07675322911312703
BARDET-BIEDL SYNDROME 18; BBS18	0.00204918	0.07675322911312703
LARON SYNDROME	0.00204918	0.07675322911312703
BARDET-BIEDL SYNDROME 5; BBS5	0.00204918	0.07675322911312703
RHIZOMELIC SYNDROME, URBACH TYPE	0.00204918	0.07675322911312703
300106 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED;;SEMD, X-LINKED; SEMDX	0.00204918	0.07675322911312703
WEILL-MARCHESANI SYNDROME	0.00204918	0.07675322911312703
PELVISCAPULAR DYSPLASIA	0.00204918	0.07675322911312703
ERYTHROKERATODERMIA VARIABILIS	0.00204918	0.07675322911312703
MULTIPLE SYNOSTOSES SYNDROME	0.00204918	0.07675322911312703
WEILL-MARCHESANI SYNDROME 1; WMS1	0.00204918	0.07675322911312703
ASPHYXIATING THORACIC DYSTROPHY 2; ATD2	0.00204918	0.07675322911312703
CARDIOSPONDYLOCARPOFACIAL SYNDROME	0.00204918	0.07675322911312703
BRACHYDACTYLY-SYNDACTYLY SYNDROME	0.00204918	0.07675322911312703
EIKEN SYNDROME	0.00204918	0.07675322911312703
SPONDYLOMETAPHYSEAL DYSPLASIA, EAST AFRICAN TYPE	0.00204918	0.07675322911312703
FGFR2-RELATED BENT BONE DYSPLASIA	0.00204918	0.07675322911312703
PARAPLEGIA-INTELLECTUAL DISABILITY-HYPERKERATOSIS SYNDROME	0.00204918	0.07675322911312703
DEAFNESS-SMALL BOWEL DIVERTICULOSIS-NEUROPATHY SYNDROME	0.00204918	0.07675322911312703
LETHAL KNIEST-LIKE DYSPLASIA	0.00204918	0.07675322911312703
OPSISMODYSPLASIA	0.00204918	0.07675322911312703
272150 SUGARMAN BRACHYDACTYLY;;BRACHYDACTYLY WITH MAJOR PROXIMAL PHALANGEAL SHORTENING	0.00204918	0.07675322911312703
ACROMESOMELIC DYSPLASIA, DEMIRHAN TYPE; AMDD	0.00204918	0.07675322911312703
SPONDYLOPERIPHERAL DYSPLASIA	0.00204918	0.07675322911312703
BARDET-BIEDL SYNDROME 4; BBS4	0.00204918	0.07675322911312703
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00204918	0.07675322911312703
FIBULAR APLASIA-COMPLEX BRACHYDACTYLY SYNDROME	0.00204918	0.07675322911312703
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.00204918	0.07675322911312703
MULTIPLE SYNOSTOSES SYNDROME 2	0.00204918	0.07675322911312703
ACRODYSPLASIA SCOLIOSIS	0.00204918	0.07675322911312703
RIN2 SYNDROME	0.00204918	0.07675322911312703
MAL DE MELEDA	0.00204918	0.07675322911312703
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.00204918	0.07675322911312703
RADIO-RENAL SYNDROME	0.00204918	0.07675322911312703
SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4	0.00204918	0.07675322911312703
FAMILIAL DIGITAL ARTHROPATHY-BRACHYDACTYLY	0.00204918	0.07675322911312703
BRACHYDACTYLOUS DWARFISM, MSELENI TYPE	0.00204918	0.07675322911312703
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.00204918	0.07675322911312703
HYPOCHONDROPLASIA	0.00204918	0.07675322911312703
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.00204918	0.07675322911312703
PSEUDOHYPOPARATHYROIDISM, TYPE IB	0.00204918	0.07675322911312703
POLYNEUROPATHY-INTELLECTUAL DISABILITY-ACROMICRIA-PREMATURE MENOPAUSE SYNDROME	0.00204918	0.07675322911312703
HIRSCHSPRUNG DISEASE-TYPE D BRACHYDACTYLY SYNDROME	0.00204918	0.07675322911312703
TIBIAL APLASIA-ECTRODACTYLY SYNDROME	0.00204918	0.07675322911312703
FEINGOLD SYNDROME 2; FGLDS2	0.00204918	0.07675322911312703
ULNAR/FIBULA RAY DEFECT-BRACHYDACTYLY SYNDROME	0.00204918	0.07675322911312703
SHORT STATURE-ADVANCED BONE AGE-EARLY-ONSET OSTEOARTHRITIS SYNDROME	0.00204918	0.07675322911312703
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.00204918	0.07675322911312703
CHITAYAT SYNDROME	0.00204918	0.07675322911312703
THIEMANN DISEASE, FAMILIAL FORM	0.00204918	0.07675322911312703
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.00204918	0.07675322911312703
CRANIOECTODERMAL DYSPLASIA 3	0.00204918	0.07675322911312703
MACS SYNDROME	0.00204918	0.07675322911312703
INFANTILE SYSTEMIC HYALINOSIS	0.00204918	0.07675322911312703
OSTEOCHONDRODYSPLASIA, BRACHYDACTYLY, AND OVERLAPPING MALFORMED DIGITS; OCBMD	0.00204918	0.07675322911312703
BENT BONE DYSPLASIA SYNDROME; BBDS	0.00204918	0.07675322911312703
SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET	0.00204918	0.07675322911312703
DESBUQUOIS DYSPLASIA 1	0.00204918	0.07675322911312703
601957 ODONTOTRICHOUNGUAL-DIGITAL-PALMAR SYNDROME;;OTUDP SYNDROME	0.00204918	0.07675322911312703
ADAMS-OLIVER SYNDROME 6; AOS6	0.00204918	0.07675322911312703
WEILL-MARCHESANI SYNDROME 4; WMS4	0.00204918	0.07675322911312703
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.00204918	0.07675322911312703
WEILL-MARCHESANI SYNDROME 3	0.00204918	0.07675322911312703
FOCAL DERMAL HYPOPLASIA; FDH	0.00204918	0.07675322911312703
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.00204918	0.07675322911312703
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.00204918	0.07675322911312703
RHYNS SYNDROME; RHYNS	0.00204918	0.07675322911312703
ACROCAPITOFEMORAL DYSPLASIA; ACFD	0.00204918	0.07675322911312703
BRACHYDACTYLY, TYPE E2; BDE2	0.00204918	0.07675322911312703
GRANGE SYNDROME; GRNG	0.00204918	0.07675322911312703
PROGRESSIVE OSSEOUS HETEROPLASIA	0.00204918	0.07675322911312703
CHST3-RELATED SKELETAL DYSPLASIA	0.00204918	0.07675322911312703
LERI PLEONOSTEOSIS	0.00204918	0.07675322911312703
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.00196464	0.07358673422774666
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.00196464	0.07358673422774666
OTOPALATODIGITAL SYNDROME TYPE 1	0.00196464	0.07358673422774666
FRONTOMETAPHYSEAL DYSPLASIA	0.00196464	0.07358673422774666
OROFACIODIGITAL SYNDROME XV; OFD15	0.00196464	0.07358673422774666
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.00196464	0.07358673422774666
DEAFNESS, X-LINKED 7; DFNX7	0.00196464	0.07358673422774666
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.00196464	0.07358673422774666
CYSTIC FIBROSIS-GASTRITIS-MEGALOBLASTIC ANEMIA SYNDROME	0.00196464	0.07358673422774666
SIMOSA CRANIOFACIAL SYNDROME	0.00196464	0.07358673422774666
WAARDENBURG SYNDROME	0.00196464	0.07358673422774666
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.00196464	0.07358673422774666
CRANIODIAPHYSEAL DYSPLASIA	0.00196464	0.07358673422774666
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.00196464	0.07358673422774666
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.00196464	0.07358673422774666
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00196464	0.07358673422774666
MARSHALL SYNDROME	0.00196464	0.07358673422774666
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR I RESISTANCE	0.00196464	0.07358673422774666
COG1-CDG	0.00196464	0.07358673422774666
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00196464	0.07358673422774666
WAARDENBURG SYNDROME TYPE 1	0.00196464	0.07358673422774666
WAARDENBURG-SHAH SYNDROME	0.00196464	0.07358673422774666
ISOLATED TRIGONOCEPHALY	0.00196464	0.07358673422774666
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.00196464	0.07358673422774666
ALAR CARTILAGES HYPOPLASIA-COLOBOMA-TELECANTHUS SYNDROME	0.00196464	0.07358673422774666
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.00196464	0.07358673422774666
MULIBREY NANISM	0.00196464	0.07358673422774666
BRANCHIO-OCULO-FACIAL SYNDROME	0.00196464	0.07358673422774666
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.00196464	0.07358673422774666
TRISOMY 18-LIKE SYNDROME	0.00196464	0.07358673422774666
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.00196464	0.07358673422774666
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.00196464	0.07358673422774666
AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	0.00196464	0.07358673422774666
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45	0.00196464	0.07358673422774666
DEAFNESS-CRANIOFACIAL SYNDROME	0.00196464	0.07358673422774666
FLAT FACE-MICROSTOMIA-EAR ANOMALY SYNDROME	0.00196464	0.07358673422774666
ADULT SYNDROME	0.00196464	0.07358673422774666
MICROPHTHALMIA, SYNDROMIC 12	0.00196464	0.07358673422774666
SCLEROSTEOSIS 1; SOST1	0.00196464	0.07358673422774666
INTELLECTUAL DISABILITY-CATARACTS-KYPHOSIS SYNDROME	0.00196464	0.07358673422774666
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.00196464	0.07358673422774666
JUNG SYNDROME	0.00196464	0.07358673422774666
DIAMOND-BLACKFAN ANEMIA 8	0.00196464	0.07358673422774666
NEONATAL MARFAN SYNDROME	0.00196464	0.07358673422774666
%265300 LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL;;LYMPHANGIOMATOSIS, PULMONARY;;PULMONARY CYSTIC LYMPHANGIECTASIS	0.00196464	0.07358673422774666
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00196464	0.07358673422774666
PILODENTAL DYSPLASIA WITH REFRACTIVE ERRORS	0.00196464	0.07358673422774666
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.00196464	0.07358673422774666
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00196464	0.07358673422774666
BOOMERANG DYSPLASIA	0.00196464	0.07358673422774666
DILATED CARDIOMYOPATHY-HYPERGONADOTROPIC HYPOGONADISM SYNDROME	0.00196464	0.07358673422774666
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	0.00196464	0.07358673422774666
RETINITIS PIGMENTOSA	0.00196464	0.07358673422774666
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.00196464	0.07358673422774666
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.00196464	0.07358673422774666
HYPERTELORISM-HYPOSPADIAS-POLYSYNDACTYLY SYNDROME	0.00196464	0.07358673422774666
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.00196464	0.07358673422774666
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.00196464	0.07358673422774666
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE; DDSH	0.00196464	0.07358673422774666
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.00196464	0.07358673422774666
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00196464	0.07358673422774666
FRONTONASAL DYSPLASIA 2; FND2	0.00196464	0.07358673422774666
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.00196464	0.07358673422774666
HISTIDINURIA-RENAL TUBULAR DEFECT SYNDROME	0.00196464	0.07358673422774666
STROMME SYNDROME; STROMS	0.00196464	0.07358673422774666
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.00196464	0.07358673422774666
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.00196464	0.07358673422774666
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.00196464	0.07358673422774666
CRANIOMETAPHYSEAL DYSPLASIA	0.00196464	0.07358673422774666
MULTICENTRIC CARPO-TARSAL OSTEOLYSIS WITH OR WITHOUT NEPHROPATHY	0.00196464	0.07358673422774666
MEGALENCEPHALY	0.00196464	0.07358673422774666
BEEMER-ERTBRUGGEN SYNDROME	0.00196464	0.07358673422774666
BARBER-SAY SYNDROME	0.00196464	0.07358673422774666
SHELDON-HALL SYNDROME	0.00196464	0.07358673422774666
MOSAIC TRISOMY 1	0.00196464	0.07358673422774666
CHOANAL ATRESIA-HEARING LOSS-CARDIAC DEFECTS-CRANIOFACIAL DYSMORPHISM SYNDROME	0.00196464	0.07358673422774666
ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE; ECTD13	0.00196464	0.07358673422774666
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.00196464	0.07358673422774666
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.00196464	0.07358673422774666
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.00196464	0.07358673422774666
FRASER SYNDROME	0.00196464	0.07358673422774666
CLOVERLEAF SKULL-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00196464	0.07358673422774666
TRISOMY 18P	0.00196464	0.07358673422774666
DEAFNESS-CRANIOFACIAL SYNDROME	0.00196464	0.07358673422774666
WAARDENBURG SYNDROME, TYPE 1; WS1	0.00196464	0.07358673422774666
EPICANTHUS	0.00163132	0.06110203970213763
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.00163132	0.06110203970213763
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.00163132	0.06110203970213763
PROGEROID SYNDROME, PETTY TYPE	0.00163132	0.06110203970213763
BRADDOCK SYNDROME	0.00163132	0.06110203970213763
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.00163132	0.06110203970213763
LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	0.00163132	0.06110203970213763
FETAL VALPROATE SYNDROME	0.00163132	0.06110203970213763
CHROMOSOME 13Q14 DELETION SYNDROME	0.00163132	0.06110203970213763
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00163132	0.06110203970213763
MYOTONIA PERMANENS	0.00163132	0.06110203970213763
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.00163132	0.06110203970213763
HYPOGLOSSIA-HYPODACTYLIA	0.00163132	0.06110203970213763
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.00163132	0.06110203970213763
DUANE-RADIAL RAY SYNDROME; DRRS	0.00163132	0.06110203970213763
LEGIUS SYNDROME	0.00163132	0.06110203970213763
COSTELLO SYNDROME	0.00163132	0.06110203970213763
133705 EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICALTALUS;;RASMUSSEN SYNDROME	0.00163132	0.06110203970213763
STICKLER SYNDROME	0.00163132	0.06110203970213763
SCARF SYNDROME	0.00163132	0.06110203970213763
8Q21.11 MICRODELETION SYNDROME	0.00163132	0.06110203970213763
NOONAN SYNDROME 8; NS8	0.00163132	0.06110203970213763
TRISOMY XQ28	0.00163132	0.06110203970213763
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00163132	0.06110203970213763
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.00163132	0.06110203970213763
EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2; EDSCL2	0.00163132	0.06110203970213763
45,X/46,XY MIXED GONADAL DYSGENESIS	0.00163132	0.06110203970213763
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.00163132	0.06110203970213763
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	0.00163132	0.06110203970213763
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.00163132	0.06110203970213763
DYSMORPHISM-CLEFT PALATE-LOOSE SKIN SYNDROME	0.00163132	0.06110203970213763
PFEIFFER-PALM-TELLER SYNDROME	0.00163132	0.06110203970213763
HYPOTONIA-CYSTINURIA SYNDROME	0.00163132	0.06110203970213763
PHAVER SYNDROME	0.00163132	0.06110203970213763
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.00163132	0.06110203970213763
EHLERS-DANLOS SYNDROME, TYPE I	0.00163132	0.06110203970213763
ACRO-RENAL-OCULAR SYNDROME	0.00163132	0.06110203970213763
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.00163132	0.06110203970213763
ACROOTOOCULAR SYNDROME	0.00163132	0.06110203970213763
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.00163132	0.06110203970213763
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00163132	0.06110203970213763
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.00163132	0.06110203970213763
BALLER-GEROLD SYNDROME	0.00163132	0.06110203970213763
SHORT RIB-POLYDACTYLY SYNDROME, VERMA-NAUMOFF TYPE	0.00163132	0.06110203970213763
BLEPHAROPHIMOSIS-EPICANTHUS INVERSUS-PTOSIS SYNDROME	0.00163132	0.06110203970213763
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.00163132	0.06110203970213763
ACHALASIA-MICROCEPHALY SYNDROME	0.00163132	0.06110203970213763
SCHOLTE SYNDROME; SHLTS	0.00163132	0.06110203970213763
SIFRIM-HITZ-WEISS SYNDROME	0.00163132	0.06110203970213763
DEAFNESS-HYPOGONADISM SYNDROME	0.00163132	0.06110203970213763
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00163132	0.06110203970213763
MICROCEPHALY-MICROCORNEA SYNDROME, SEEMANOVA TYPE	0.00163132	0.06110203970213763
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00163132	0.06110203970213763
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00163132	0.06110203970213763
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.00163132	0.06110203970213763
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.00163132	0.06110203970213763
CATARACT-ABERRANT ORAL FRENULA-GROWTH DELAY SYNDROME	0.00163132	0.06110203970213763
MARTSOLF SYNDROME	0.00163132	0.06110203970213763
HYPERTELORISM AND TETRALOGY OF FALLOT	0.00163132	0.06110203970213763
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.00163132	0.06110203970213763
BRITTLE CORNEA SYNDROME	0.00163132	0.06110203970213763
LICHTENSTEIN SYNDROME	0.00163132	0.06110203970213763
FOCAL FACIAL DERMAL DYSPLASIA 3, SETLEIS TYPE	0.00163132	0.06110203970213763
EHLERS-DANLOS SYNDROME, TYPE VI	0.00163132	0.06110203970213763
HYDROCEPHALY-LOW INSERTION UMBILICUS SYNDROME	0.00163132	0.06110203970213763
COFFIN-SIRIS SYNDROME 10; CSS10	0.00163132	0.06110203970213763
JUBERG-MARSIDI SYNDROME	0.00163132	0.06110203970213763
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.00163132	0.06110203970213763
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.00163132	0.06110203970213763
PFEIFFER-PALM-TELLER SYNDROME	0.00163132	0.06110203970213763
PRIMARY PULMONARY HYPOPLASIA	0.00163132	0.06110203970213763
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.00163132	0.06110203970213763
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.00163132	0.06110203970213763
MICROCORNEA-GLAUCOMA-ABSENT FRONTAL SINUSES SYNDROME	0.00163132	0.06110203970213763
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00163132	0.06110203970213763
14Q11.2 MICRODELETION SYNDROME	0.00163132	0.06110203970213763
MILROY DISEASE	0.00163132	0.06110203970213763
CLEFT PALATE-SHORT STATURE-VERTEBRAL ANOMALIES SYNDROME	0.00163132	0.06110203970213763
PTERYGIUM COLLI, ISOLATED	0.00163132	0.06110203970213763
AUTOSOMAL AGAMMAGLOBULINEMIA	0.00163132	0.06110203970213763
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00163132	0.06110203970213763
CEREBROFACIOTHORACIC DYSPLASIA	0.00163132	0.06110203970213763
SCALP-EAR-NIPPLE SYNDROME; SENS	0.00163132	0.06110203970213763
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00163132	0.06110203970213763
RING CHROMOSOME 8 SYNDROME	0.00163132	0.06110203970213763
MUCOLIPIDOSIS TYPE II	0.00163132	0.06110203970213763
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.001086973	0.040713206115999094
MEND SYNDROME	0.001086973	0.040713206115999094
JOUBERT SYNDROME WITH OCULAR DEFECT	0.001086973	0.040713206115999094
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.001086973	0.040713206115999094
ISOLATED GLYCEROL KINASE DEFICIENCY	0.001086973	0.040713206115999094
JOUBERT SYNDROME WITH RENAL DEFECT	0.001086973	0.040713206115999094
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.001086973	0.040713206115999094
NARP SYNDROME	0.001086973	0.040713206115999094
PRADER-WILLI-LIKE SYNDROME	0.001086973	0.040713206115999094
EAST SYNDROME	0.001086973	0.040713206115999094
PITT-HOPKINS SYNDROME	0.001086973	0.040713206115999094
ADULT-ONSET DYSTONIA-PARKINSONISM	0.001086973	0.040713206115999094
NEPHROGENIC DIABETES INSIPIDUS	0.001086973	0.040713206115999094
SRD5A3-CDG	0.001086973	0.040713206115999094
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.001086973	0.040713206115999094
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.001086973	0.040713206115999094
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.001086973	0.040713206115999094
15Q14 MICRODELETION SYNDROME	0.001086973	0.040713206115999094
GRISCELLI SYNDROME	0.001086973	0.040713206115999094
ALSTRÖM SYNDROME	0.001086973	0.040713206115999094
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.001086973	0.040713206115999094
WILSON-TURNER SYNDROME	0.001086973	0.040713206115999094
MEVALONIC ACIDURIA	0.001086973	0.040713206115999094
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.001086973	0.040713206115999094
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.001086973	0.040713206115999094
HARTNUP DISEASE	0.001086973	0.040713206115999094
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.001086973	0.040713206115999094
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.001086973	0.040713206115999094
DONNAI-BARROW SYNDROME	0.001086973	0.040713206115999094
LEBER CONGENITAL AMAUROSIS	0.001086973	0.040713206115999094
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.001086973	0.040713206115999094
DISTAL 16P11.2 MICRODELETION SYNDROME	0.001086973	0.040713206115999094
11P15.4 MICRODUPLICATION SYNDROME	0.001086973	0.040713206115999094
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.001086973	0.040713206115999094
PHACE SYNDROME	0.001086973	0.040713206115999094
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.001086973	0.040713206115999094
ISOVALERIC ACIDEMIA	0.001086973	0.040713206115999094
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.001086973	0.040713206115999094
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.001086973	0.040713206115999094
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.001086973	0.040713206115999094
HYDRANENCEPHALY	0.001086973	0.040713206115999094
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.001086973	0.040713206115999094
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.001086973	0.040713206115999094
NETHERTON SYNDROME	0.001086973	0.040713206115999094
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.001086973	0.040713206115999094
DYSTONIA-APHONIA SYNDROME	0.001086973	0.040713206115999094
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.001086973	0.040713206115999094
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.001086973	0.040713206115999094
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.001086973	0.040713206115999094
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.001086973	0.040713206115999094
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.001086973	0.040713206115999094
FOIX-CHAVANY-MARIE SYNDROME	0.001086973	0.040713206115999094
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.001086973	0.040713206115999094
CITRULLINEMIA TYPE II	0.001086973	0.040713206115999094
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.001086973	0.040713206115999094
WYBURN-MASON SYNDROME	0.001086973	0.040713206115999094
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.001086973	0.040713206115999094
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.001086973	0.040713206115999094
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.001086973	0.040713206115999094
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.001086973	0.040713206115999094
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.001086973	0.040713206115999094
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.001086973	0.040713206115999094
GALACTOSEMIA	0.001086973	0.040713206115999094
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.001086973	0.040713206115999094
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.001086973	0.040713206115999094
L1 SYNDROME	0.001086973	0.040713206115999094
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.001086973	0.040713206115999094
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.001086973	0.040713206115999094
CEDNIK SYNDROME	0.001086973	0.040713206115999094
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.001086973	0.040713206115999094
JOUBERT SYNDROME	0.001086973	0.040713206115999094
RFT1-CDG	0.001086973	0.040713206115999094
CENTRAL BILATERAL MACROGYRIA	0.001086973	0.040713206115999094
STT3A-CDG	0.001086973	0.040713206115999094
CRANIOPHARYNGIOMA	0.001086973	0.040713206115999094
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.001086973	0.040713206115999094
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.001086973	0.040713206115999094
KBG SYNDROME	0.001086973	0.040713206115999094
SSR4-CDG	0.001086973	0.040713206115999094
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.001086973	0.040713206115999094
STT3B-CDG	0.001086973	0.040713206115999094
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.001086973	0.040713206115999094
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.001086973	0.040713206115999094
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.001086973	0.040713206115999094
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.001086973	0.040713206115999094
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.001086973	0.040713206115999094
MAPLE SYRUP URINE DISEASE	0.001086973	0.040713206115999094
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.001086973	0.040713206115999094
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.001086973	0.040713206115999094
SEVERE CANAVAN DISEASE	0.001086973	0.040713206115999094
INCONTINENTIA PIGMENTI	0.001086973	0.040713206115999094
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.001086973	0.040713206115999094
ALG11-CDG	0.001086973	0.040713206115999094
XP21 MICRODELETION SYNDROME	0.001086973	0.040713206115999094
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.001086973	0.040713206115999094
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.001086973	0.040713206115999094
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.001086973	0.040713206115999094
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.001086973	0.040713206115999094
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.001086973	0.040713206115999094
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.001086973	0.040713206115999094
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.001086973	0.040713206115999094
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001086973	0.040713206115999094
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.001086973	0.040713206115999094
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.001086973	0.040713206115999094
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.001086973	0.040713206115999094
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.001086973	0.040713206115999094
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.001086973	0.040713206115999094
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.001086973	0.040713206115999094
SCHIZENCEPHALY	0.001086973	0.040713206115999094
SHUKLA-VERNON SYNDROME; SHUVER	0.001086973	0.040713206115999094
GLYCEROL KINASE DEFICIENCY; GKD	0.001086973	0.040713206115999094
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.001086973	0.040713206115999094
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.001086973	0.040713206115999094
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.001086973	0.040713206115999094
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.001086973	0.040713206115999094
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.001086973	0.040713206115999094
MENTAL RETARDATION, X-LINKED 103	0.001086973	0.040713206115999094
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001086973	0.040713206115999094
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.001086973	0.040713206115999094
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001086973	0.040713206115999094
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.001086973	0.040713206115999094
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.001086973	0.040713206115999094
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.001086973	0.040713206115999094
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.001086973	0.040713206115999094
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.001086973	0.040713206115999094
CODAS SYNDROME	0.001086973	0.040713206115999094
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.001086973	0.040713206115999094
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.001086973	0.040713206115999094
WALKER-WARBURG SYNDROME	0.001086973	0.040713206115999094
CHROMOSOME 5Q12 DELETION SYNDROME	0.001086973	0.040713206115999094
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001086973	0.040713206115999094
ARGININEMIA	0.001086973	0.040713206115999094
TIMOTHY SYNDROME; TS	0.001086973	0.040713206115999094
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.001086973	0.040713206115999094
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.001086973	0.040713206115999094
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.001086973	0.040713206115999094
CHROMOSOME 2Q37 DELETION SYNDROME	0.001086973	0.040713206115999094
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.001086973	0.040713206115999094
MENTAL RETARDATION, X-LINKED 9	0.001086973	0.040713206115999094
HEREDITARY FOLATE MALABSORPTION	0.001086973	0.040713206115999094
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.001086973	0.040713206115999094
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.001086973	0.040713206115999094
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.001086973	0.040713206115999094
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.001086973	0.040713206115999094
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001086973	0.040713206115999094
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.001086973	0.040713206115999094
PELIZAEUS-MERZBACHER DISEASE	0.001086973	0.040713206115999094
WAISMAN SYNDROME; WSMN	0.001086973	0.040713206115999094
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.001086973	0.040713206115999094
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.001086973	0.040713206115999094
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.001086973	0.040713206115999094
MEND SYNDROME; MEND	0.001086973	0.040713206115999094
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.001086973	0.040713206115999094
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.001086973	0.040713206115999094
COFFIN-SIRIS SYNDROME 5	0.001086973	0.040713206115999094
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001086973	0.040713206115999094
GM2-GANGLIOSIDOSIS, AB VARIANT	0.001086973	0.040713206115999094
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.001086973	0.040713206115999094
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.001086973	0.040713206115999094
SULFOCYSTEINURIA	0.001086973	0.040713206115999094
MIRAGE SYNDROME; MIRAGE	0.001086973	0.040713206115999094
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.001086973	0.040713206115999094
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.001086973	0.040713206115999094
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.001086973	0.040713206115999094
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.001086973	0.040713206115999094
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.001086973	0.040713206115999094
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.001086973	0.040713206115999094
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.001086973	0.040713206115999094
PYRUVATE CARBOXYLASE DEFICIENCY	0.001086973	0.040713206115999094
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.001086973	0.040713206115999094
SHASHI-PENA SYNDROME; SHAPNS	0.001086973	0.040713206115999094
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.001086973	0.040713206115999094
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.001086973	0.040713206115999094
ALG1-CDG	0.001086973	0.040713206115999094
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.001086973	0.040713206115999094
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.001086973	0.040713206115999094
IMMUNODEFICIENCY 49; IMD49	0.001086973	0.040713206115999094
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.001086973	0.040713206115999094
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.001086973	0.040713206115999094
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001086973	0.040713206115999094
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001086973	0.040713206115999094
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.001086973	0.040713206115999094
MENTAL RETARDATION, X-LINKED 101; MRX101	0.001086973	0.040713206115999094
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.001086973	0.040713206115999094
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.001086973	0.040713206115999094
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.001086973	0.040713206115999094
MENTAL RETARDATION, X-LINKED 88	0.001086973	0.040713206115999094
GRISCELLI SYNDROME TYPE 1	0.001086973	0.040713206115999094
MENTAL RETARDATION, X-LINKED 90	0.001086973	0.040713206115999094
PFEIFFER SYNDROME TYPE 2	0.001086973	0.040713206115999094
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.001086973	0.040713206115999094
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.001086973	0.040713206115999094
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.001086973	0.040713206115999094
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.001086973	0.040713206115999094
MENTAL RETARDATION, X-LINKED 72	0.001086973	0.040713206115999094
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.001086973	0.040713206115999094
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.001086973	0.040713206115999094
MEHMO SYNDROME; MEHMO	0.001086973	0.040713206115999094
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.001086973	0.040713206115999094
RAYNAUD-CLAES SYNDROME; MRXSRC	0.001086973	0.040713206115999094
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.001086973	0.040713206115999094
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.001086973	0.040713206115999094
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.001086973	0.040713206115999094
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.001086973	0.040713206115999094
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.001086973	0.040713206115999094
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001086973	0.040713206115999094
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.001086973	0.040713206115999094
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.001086973	0.040713206115999094
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001086973	0.040713206115999094
CHROMOSOME 19P13.13 DELETION SYNDROME	0.001086973	0.040713206115999094
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.001086973	0.040713206115999094
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.001086973	0.040713206115999094
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.001086973	0.040713206115999094
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.001086973	0.040713206115999094
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.001086973	0.040713206115999094
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.001086973	0.040713206115999094
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.001086973	0.040713206115999094
KEUTEL SYNDROME	0.001086973	0.040713206115999094
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.001086973	0.040713206115999094
LISSENCEPHALY 4	0.001086973	0.040713206115999094
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.001086973	0.040713206115999094
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.001086973	0.040713206115999094
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.001086973	0.040713206115999094
N-ACETYLASPARTATE DEFICIENCY; NACED	0.001086973	0.040713206115999094
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.001086973	0.040713206115999094
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.001086973	0.040713206115999094
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001086973	0.040713206115999094
GENITOPATELLAR SYNDROME	0.001086973	0.040713206115999094
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.001086973	0.040713206115999094
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.001086973	0.040713206115999094
EMANUEL SYNDROME	0.001086973	0.040713206115999094
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.001086973	0.040713206115999094
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.001086973	0.040713206115999094
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.001086973	0.040713206115999094
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.001086973	0.040713206115999094
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.001086973	0.040713206115999094
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001086973	0.040713206115999094
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.001086973	0.040713206115999094
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.001086973	0.040713206115999094
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.001086973	0.040713206115999094
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001086973	0.040713206115999094
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.001086973	0.040713206115999094
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.001086973	0.040713206115999094
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.001086973	0.040713206115999094
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.001086973	0.040713206115999094
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.001086973	0.040713206115999094
HOLOPROSENCEPHALY 7	0.001086973	0.040713206115999094
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001086973	0.040713206115999094
GLASS SYNDROME	0.001086973	0.040713206115999094
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001086973	0.040713206115999094
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.001086973	0.040713206115999094
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.001086973	0.040713206115999094
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.001086973	0.040713206115999094
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.001086973	0.040713206115999094
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.001086973	0.040713206115999094
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.001086973	0.040713206115999094
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.001086973	0.040713206115999094
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.001086973	0.040713206115999094
GABA-TRANSAMINASE DEFICIENCY	0.001086973	0.040713206115999094
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.001086973	0.040713206115999094
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.001086973	0.040713206115999094
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.001086973	0.040713206115999094
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.001086973	0.040713206115999094
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.001086973	0.040713206115999094
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.001086973	0.040713206115999094
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.001086973	0.040713206115999094
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.001086973	0.040713206115999094
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.001086973	0.040713206115999094
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.001086973	0.040713206115999094
PHACE ASSOCIATION	0.001086973	0.040713206115999094
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.001086973	0.040713206115999094
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.001086973	0.040713206115999094
PROPIONIC ACIDEMIA	0.001086973	0.040713206115999094
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001086973	0.040713206115999094
FREE SIALIC ACID STORAGE DISEASE	0.001086973	0.040713206115999094
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.001086973	0.040713206115999094
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.001086973	0.040713206115999094
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.001086973	0.040713206115999094
SALLA DISEASE	0.001086973	0.040713206115999094
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.001086973	0.040713206115999094
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.001086973	0.040713206115999094
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.001086973	0.040713206115999094
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001086973	0.040713206115999094
INFANTILE LIVER FAILURE SYNDROME 1	0.001086973	0.040713206115999094
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.001086973	0.040713206115999094
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.001086973	0.040713206115999094
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.001086973	0.040713206115999094
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001086973	0.040713206115999094
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.001086973	0.040713206115999094
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.001086973	0.040713206115999094
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.001086973	0.040713206115999094
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001086973	0.040713206115999094
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.001086973	0.040713206115999094
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.001086973	0.040713206115999094
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.001086973	0.040713206115999094
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.001086973	0.040713206115999094
ACROMELIC FRONTONASAL DYSPLASIA	0.001086973	0.040713206115999094
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001086973	0.040713206115999094
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.001086973	0.040713206115999094
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.001086973	0.040713206115999094
COFFIN-SIRIS SYNDROME 3; CSS3	0.001086973	0.040713206115999094
COFFIN-SIRIS SYNDROME 4; CSS4	0.001086973	0.040713206115999094
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.001086973	0.040713206115999094
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.001086973	0.040713206115999094
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.001086973	0.040713206115999094
PONTINE TEGMENTAL CAP DYSPLASIA	0.001086973	0.040713206115999094
NIEMANN-PICK DISEASE, TYPE C2	0.001086973	0.040713206115999094
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.001086973	0.040713206115999094
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.001086973	0.040713206115999094
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.001086973	0.040713206115999094
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.001086973	0.040713206115999094
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.001086973	0.040713206115999094
SIALIDOSIS TYPE 2	0.001086973	0.040713206115999094
LISSENCEPHALY 1; LIS1	0.001086973	0.040713206115999094
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.001086973	0.040713206115999094
LISSENCEPHALY 8; LIS8	0.001086973	0.040713206115999094
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.001086973	0.040713206115999094
HARTNUP DISORDER	0.001086973	0.040713206115999094
HOLOPROSENCEPHALY 2; HPE2	0.001086973	0.040713206115999094
DIGEORGE SYNDROME; DGS	0.001086973	0.040713206115999094
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.001086973	0.040713206115999094
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.001086973	0.040713206115999094
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.001086973	0.040713206115999094
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001086973	0.040713206115999094
VICI SYNDROME; VICIS	0.001086973	0.040713206115999094
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.001086973	0.040713206115999094
ARGININOSUCCINIC ACIDURIA	0.001086973	0.040713206115999094
JABERI-ELAHI SYNDROME; JABELS	0.001086973	0.040713206115999094
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.001086973	0.040713206115999094
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.001086973	0.040713206115999094
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.001086973	0.040713206115999094
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.001086973	0.040713206115999094
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.001086973	0.040713206115999094
HYPEREKPLEXIA 4; HKPX4	0.001086973	0.040713206115999094
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.001086973	0.040713206115999094
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.001086973	0.040713206115999094
INFANTILE REFSUM DISEASE	0.001086973	0.040713206115999094
KETOADIPICACIDURIA	0.001086973	0.040713206115999094
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.001086973	0.040713206115999094
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.001086973	0.040713206115999094
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.001086973	0.040713206115999094
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.001086973	0.040713206115999094
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.001086973	0.040713206115999094
MACDERMOT-WINTER SYNDROME	0.001086973	0.040713206115999094
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.001086973	0.040713206115999094
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.001086973	0.040713206115999094
CONGENITAL DISORDER OF GLYCOSYLATION	0.001086973	0.040713206115999094
LANDAU-KLEFFNER SYNDROME	0.001086973	0.040713206115999094
PITUITARY STALK INTERRUPTION SYNDROME	0.001086973	0.040713206115999094
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.001086973	0.040713206115999094
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.001086973	0.040713206115999094
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.001086973	0.040713206115999094
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.001086973	0.040713206115999094
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.001086973	0.040713206115999094
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.001086973	0.040713206115999094
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.001086973	0.040713206115999094
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.001086973	0.040713206115999094
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.001086973	0.040713206115999094
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.001086973	0.040713206115999094
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.001086973	0.040713206115999094
GAUCHER DISEASE, TYPE II	0.001086973	0.040713206115999094
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.001086973	0.040713206115999094
DISTAL MONOSOMY 19P13.3	0.001086973	0.040713206115999094
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.001086973	0.040713206115999094
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.001086973	0.040713206115999094
FOLATE MALABSORPTION, HEREDITARY	0.001086973	0.040713206115999094
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.001086973	0.040713206115999094
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.001086973	0.040713206115999094
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.001086973	0.040713206115999094
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.001086973	0.040713206115999094
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.001086973	0.040713206115999094
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.001086973	0.040713206115999094
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.001086973	0.040713206115999094
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.001086973	0.040713206115999094
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.001086973	0.040713206115999094
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.001086973	0.040713206115999094
COACH SYNDROME	0.001086973	0.040713206115999094
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.001086973	0.040713206115999094
CLASSIC PHENYLKETONURIA	0.001086973	0.040713206115999094
GRISCELLI SYNDROME, TYPE 1	0.001086973	0.040713206115999094
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.001086973	0.040713206115999094
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.001086973	0.040713206115999094
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.001086973	0.040713206115999094
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.001086973	0.040713206115999094
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.001086973	0.040713206115999094
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.001086973	0.040713206115999094
HOLOPROSENCEPHALY 1; HPE1	0.001086973	0.040713206115999094
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.001086973	0.040713206115999094
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001086973	0.040713206115999094
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.001086973	0.040713206115999094
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.001086973	0.040713206115999094
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.001086973	0.040713206115999094
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001086973	0.040713206115999094
CITRULLINEMIA, CLASSIC	0.001086973	0.040713206115999094
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.001086973	0.040713206115999094
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.001086973	0.040713206115999094
MELANOSIS, NEUROCUTANEOUS; NCMS	0.001086973	0.040713206115999094
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.001086973	0.040713206115999094
KBG SYNDROME	0.001086973	0.040713206115999094
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.001086973	0.040713206115999094
PALLISTER-HALL SYNDROME	0.001086973	0.040713206115999094
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.001086973	0.040713206115999094
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.001086973	0.040713206115999094
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.001086973	0.040713206115999094
MULTIPLE CARBOXYLASE DEFICIENCY	0.001086973	0.040713206115999094
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.001086973	0.040713206115999094
VICI SYNDROME	0.001086973	0.040713206115999094
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.001086973	0.040713206115999094
ALG3-CDG	0.001086973	0.040713206115999094
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.001086973	0.040713206115999094
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001086973	0.040713206115999094
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.001086973	0.040713206115999094
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.001086973	0.040713206115999094
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001086973	0.040713206115999094
2P21 MICRODELETION SYNDROME	0.001086973	0.040713206115999094
ELEJALDE DISEASE	0.001086973	0.040713206115999094
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.001086973	0.040713206115999094
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.001086973	0.040713206115999094
DISTAL MONOSOMY 15Q	0.001086973	0.040713206115999094
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.001086973	0.040713206115999094
COFFIN-SIRIS SYNDROME 1; CSS1	0.001086973	0.040713206115999094
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.001086973	0.040713206115999094
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.001086973	0.040713206115999094
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.001086973	0.040713206115999094
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.001086973	0.040713206115999094
LEIGH SYNDROME; LS	0.001086973	0.040713206115999094
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.001086973	0.040713206115999094
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.001086973	0.040713206115999094
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.001086973	0.040713206115999094
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.001086973	0.040713206115999094
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.001086973	0.040713206115999094
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.001086973	0.040713206115999094
17Q11.2 MICRODUPLICATION SYNDROME	0.001086973	0.040713206115999094
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.001086973	0.040713206115999094
METHYLMALONIC ACIDURIA, CBLA TYPE	0.001086973	0.040713206115999094
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.001086973	0.040713206115999094
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.001086973	0.040713206115999094
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.001086973	0.040713206115999094
ANGELMAN SYNDROME	0.001086973	0.040713206115999094
ADENYLOSUCCINASE DEFICIENCY	0.001086973	0.040713206115999094
XQ21 MICRODELETION SYNDROME	0.001086973	0.040713206115999094
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.001086973	0.040713206115999094
JOUBERT SYNDROME 30; JBTS30	0.001086973	0.040713206115999094
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.001086973	0.040713206115999094
XQ28 (MECP2) DUPLICATION	0.001086973	0.040713206115999094
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.001086973	0.040713206115999094
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.001086973	0.040713206115999094
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000545554	0.02043404247337125
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.000545554	0.02043404247337125
JOUBERT SYNDROME 6	0.000545554	0.02043404247337125
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000545554	0.02043404247337125
8P23.1 DUPLICATION SYNDROME	0.000545554	0.02043404247337125
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.000545554	0.02043404247337125
DUPLICATION OF THE PITUITARY GLAND	0.000545554	0.02043404247337125
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.000545554	0.02043404247337125
TOWNES-BROCKS SYNDROME 1; TBS1	0.000545554	0.02043404247337125
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.000545554	0.02043404247337125
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000545554	0.02043404247337125
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.000545554	0.02043404247337125
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.000545554	0.02043404247337125
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.02043404247337125
HURLER SYNDROME	0.000545554	0.02043404247337125
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.000545554	0.02043404247337125
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.000545554	0.02043404247337125
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.000545554	0.02043404247337125
SENIOR-LOKEN SYNDROME	0.000545554	0.02043404247337125
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.000545554	0.02043404247337125
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.000545554	0.02043404247337125
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.02043404247337125
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.000545554	0.02043404247337125
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.000545554	0.02043404247337125
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.000545554	0.02043404247337125
FRIED SYNDROME	0.000545554	0.02043404247337125
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000545554	0.02043404247337125
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.000545554	0.02043404247337125
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.000545554	0.02043404247337125
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.000545554	0.02043404247337125
THANATOPHORIC DYSPLASIA, TYPE I	0.000545554	0.02043404247337125
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000545554	0.02043404247337125
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000545554	0.02043404247337125
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.000545554	0.02043404247337125
SEPTOOPTIC DYSPLASIA	0.000545554	0.02043404247337125
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.000545554	0.02043404247337125
LIG4 SYNDROME	0.000545554	0.02043404247337125
FRIAS SYNDROME	0.000545554	0.02043404247337125
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.000545554	0.02043404247337125
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.000545554	0.02043404247337125
CURRARINO SYNDROME	0.000545554	0.02043404247337125
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.02043404247337125
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000545554	0.02043404247337125
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000545554	0.02043404247337125
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.000545554	0.02043404247337125
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.02043404247337125
HOLOPROSENCEPHALY 5; HPE5	0.000545554	0.02043404247337125
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.000545554	0.02043404247337125
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.02043404247337125
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.02043404247337125
ALSTROM SYNDROME; ALMS	0.000545554	0.02043404247337125
ABETAL34V AMYLOIDOSIS	0.000545554	0.02043404247337125
MEVALONIC ACIDURIA; MEVA	0.000545554	0.02043404247337125
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000545554	0.02043404247337125
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.000545554	0.02043404247337125
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.000545554	0.02043404247337125
JOUBERT SYNDROME 2	0.000545554	0.02043404247337125
LIGNEOUS CONJUNCTIVITIS	0.000545554	0.02043404247337125
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.000545554	0.02043404247337125
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000545554	0.02043404247337125
DUCHENNE MUSCULAR DYSTROPHY	0.000545554	0.02043404247337125
HOLOPROSENCEPHALY 3; HPE3	0.000545554	0.02043404247337125
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.000545554	0.02043404247337125
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000545554	0.02043404247337125
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.000545554	0.02043404247337125
RIGID SPINE SYNDROME	0.000545554	0.02043404247337125
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.000545554	0.02043404247337125
AUSTRALIA ANTIGEN	0.000545554	0.02043404247337125
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.000545554	0.02043404247337125
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000545554	0.02043404247337125
MICROPHTHALMIA, SYNDROMIC 3	0.000545554	0.02043404247337125
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.000545554	0.02043404247337125
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.000545554	0.02043404247337125
CREE MENTAL RETARDATION SYNDROME	0.000545554	0.02043404247337125
PELLAGRA-LIKE SYNDROME	0.000545554	0.02043404247337125
RITSCHER-SCHINZEL SYNDROME 1	0.000545554	0.02043404247337125
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.000545554	0.02043404247337125
WAARDENBURG-SHAH SYNDROME	0.000545554	0.02043404247337125
OBESITY DUE TO SIM1 DEFICIENCY	0.000545554	0.02043404247337125
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.000545554	0.02043404247337125
JOUBERT SYNDROME 7	0.000545554	0.02043404247337125
CEREBELLAR ATAXIA, CAYMAN TYPE	0.000545554	0.02043404247337125
300270 ADRENOMYODYSTROPHY	0.000545554	0.02043404247337125
JAWAD SYNDROME	0.000545554	0.02043404247337125
METHYLMALONIC ACIDURIA, CBLB TYPE	0.000545554	0.02043404247337125
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000545554	0.02043404247337125
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.000545554	0.02043404247337125
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000545554	0.02043404247337125
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.000545554	0.02043404247337125
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.000545554	0.02043404247337125
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.000545554	0.02043404247337125
HYPOTONIA-CYSTINURIA SYNDROME	0.000545554	0.02043404247337125
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.000545554	0.02043404247337125
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.000545554	0.02043404247337125
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000545554	0.02043404247337125
SPINOCEREBELLAR ATAXIA TYPE 7	0.000545554	0.02043404247337125
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.000545554	0.02043404247337125
MARINESCO-SJOGREN SYNDROME; MSS	0.000545554	0.02043404247337125
ABLEPHARON MACROSTOMIA SYNDROME	0.000545554	0.02043404247337125
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000545554	0.02043404247337125
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.000545554	0.02043404247337125
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02043404247337125
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000545554	0.02043404247337125
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.000545554	0.02043404247337125
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000545554	0.02043404247337125
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.000545554	0.02043404247337125
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000545554	0.02043404247337125
MUCOLIPIDOSIS IV; ML4	0.000545554	0.02043404247337125
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.000545554	0.02043404247337125
OROTIC ACIDURIA	0.000545554	0.02043404247337125
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.02043404247337125
OROFACIODIGITAL SYNDROME IX; OFD9	0.000545554	0.02043404247337125
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000545554	0.02043404247337125
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000545554	0.02043404247337125
NIEMANN-PICK DISEASE, TYPE A	0.000545554	0.02043404247337125
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.000545554	0.02043404247337125
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.02043404247337125
NAVAJO NEUROHEPATOPATHY	0.000545554	0.02043404247337125
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02043404247337125
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.02043404247337125
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.02043404247337125
PEROXISOME BIOGENESIS DISORDER 3B	0.000545554	0.02043404247337125
REVESZ SYNDROME	0.000545554	0.02043404247337125
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.000545554	0.02043404247337125
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000545554	0.02043404247337125
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.000545554	0.02043404247337125
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000545554	0.02043404247337125
NETHERTON SYNDROME; NETH	0.000545554	0.02043404247337125
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.000545554	0.02043404247337125
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.02043404247337125
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.000545554	0.02043404247337125
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.02043404247337125
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.000545554	0.02043404247337125
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.000545554	0.02043404247337125
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.02043404247337125
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.000545554	0.02043404247337125
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.02043404247337125
RIDDLE SYNDROME	0.000545554	0.02043404247337125
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.000545554	0.02043404247337125
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000545554	0.02043404247337125
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.000545554	0.02043404247337125
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.000545554	0.02043404247337125
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000545554	0.02043404247337125
CURRY-JONES SYNDROME	0.000545554	0.02043404247337125
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.000545554	0.02043404247337125
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.000545554	0.02043404247337125
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000545554	0.02043404247337125
CDAGS SYNDROME	0.000545554	0.02043404247337125
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.000545554	0.02043404247337125
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.000545554	0.02043404247337125
CONGENITAL HYPOTHYROIDISM	0.000545554	0.02043404247337125
FARBER DISEASE	0.000545554	0.02043404247337125
HOYERAAL-HREIDARSSON SYNDROME	0.000545554	0.02043404247337125
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000545554	0.02043404247337125
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.000545554	0.02043404247337125
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.000545554	0.02043404247337125
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.02043404247337125
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.000545554	0.02043404247337125
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.02043404247337125
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000545554	0.02043404247337125
NOONAN SYNDROME 2; NS2	0.000545554	0.02043404247337125
MACROCEPHALY/AUTISM SYNDROME	0.000545554	0.02043404247337125
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000545554	0.02043404247337125
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.000545554	0.02043404247337125
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.02043404247337125
ROSSELLI-GULIENETTI SYNDROME	0.000545554	0.02043404247337125
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.000545554	0.02043404247337125
HYPERTRYPTOPHANEMIA; HYPTRP	0.000545554	0.02043404247337125
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.000545554	0.02043404247337125
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.000545554	0.02043404247337125
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000545554	0.02043404247337125
RICHARDS-RUNDLE SYNDROME; RRNS	0.000545554	0.02043404247337125
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000545554	0.02043404247337125
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000545554	0.02043404247337125
THYROID ECTOPIA	0.000545554	0.02043404247337125
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.000545554	0.02043404247337125
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.000545554	0.02043404247337125
EPIDERMAL NEVUS SYNDROME	0.000545554	0.02043404247337125
ATHYREOSIS	0.000545554	0.02043404247337125
OROFACIODIGITAL SYNDROME TYPE 14	0.000545554	0.02043404247337125
OTOPALATODIGITAL SYNDROME TYPE 2	0.000545554	0.02043404247337125
ARIMA SYNDROME	0.000545554	0.02043404247337125
PROPIONIC ACIDEMIA	0.000545554	0.02043404247337125
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.000545554	0.02043404247337125
YUNIS-VARON SYNDROME	0.000545554	0.02043404247337125
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.000545554	0.02043404247337125
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000545554	0.02043404247337125
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02043404247337125
FAMILIAL THYROID DYSHORMONOGENESIS	0.000545554	0.02043404247337125
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.000545554	0.02043404247337125
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000545554	0.02043404247337125
THYROID HEMIAGENESIS	0.000545554	0.02043404247337125
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.000545554	0.02043404247337125
LOWRY-MACLEAN SYNDROME	0.000545554	0.02043404247337125
WEAVER SYNDROME	0.000545554	0.02043404247337125
THYROID HYPOPLASIA	0.000545554	0.02043404247337125
HYDROXYKYNURENINURIA	0.000545554	0.02043404247337125
HYDROCEPHALUS, NORMAL-PRESSURE	0.000545554	0.02043404247337125
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.000545554	0.02043404247337125
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.02043404247337125
7P22.1 MICRODUPLICATION SYNDROME	0.000545554	0.02043404247337125
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000545554	0.02043404247337125
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.000545554	0.02043404247337125
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.02043404247337125
PEROXISOME BIOGENESIS DISORDER 10B	0.000545554	0.02043404247337125
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000545554	0.02043404247337125
OPTIC ATROPHY 11; OPA11	0.000545554	0.02043404247337125
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.000545554	0.02043404247337125
DYSTONIA 28, CHILDHOOD-ONSET	0.000545554	0.02043404247337125
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000545554	0.02043404247337125
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.000545554	0.02043404247337125
ALAZAMI-YUAN SYNDROME	0.000545554	0.02043404247337125
JOUBERT SYNDROME 28	0.000545554	0.02043404247337125
JOUBERT SYNDROME 27	0.000545554	0.02043404247337125
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.000545554	0.02043404247337125
MEIER-GORLIN SYNDROME 7	0.000545554	0.02043404247337125
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.000545554	0.02043404247337125
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.02043404247337125
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000545554	0.02043404247337125
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02043404247337125
MARDEN-WALKER SYNDROME	0.000545554	0.02043404247337125
ALG6-CDG	0.000545554	0.02043404247337125
JOUBERT SYNDROME 31; JBTS31	0.000545554	0.02043404247337125
JOUBERT SYNDROME 32; JBTS32	0.000545554	0.02043404247337125
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000545554	0.02043404247337125
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.000545554	0.02043404247337125
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000545554	0.02043404247337125
INFANTILE DYSTONIA-PARKINSONISM	0.000545554	0.02043404247337125
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.000545554	0.02043404247337125
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.000545554	0.02043404247337125
MEDULLOBLASTOMA	0.000545554	0.02043404247337125
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000545554	0.02043404247337125
OROFACIODIGITAL SYNDROME XVI; OFD16	0.000545554	0.02043404247337125
MECKEL SYNDROME 13; MKS13	0.000545554	0.02043404247337125
GABRIELE-DE VRIES SYNDROME; GADEVS	0.000545554	0.02043404247337125
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.02043404247337125
RAHMAN SYNDROME	0.000545554	0.02043404247337125
YOU-HOOVER-FONG SYNDROME; YHFS	0.000545554	0.02043404247337125
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.02043404247337125
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.000545554	0.02043404247337125
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.000545554	0.02043404247337125
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.000545554	0.02043404247337125
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.000545554	0.02043404247337125
NOONAN SYNDROME 9; NS9	0.000545554	0.02043404247337125
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000545554	0.02043404247337125
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.000545554	0.02043404247337125
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000545554	0.02043404247337125
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000545554	0.02043404247337125
16P13.11 MICRODUPLICATION SYNDROME	0.000545554	0.02043404247337125
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.02043404247337125
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.000545554	0.02043404247337125
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000545554	0.02043404247337125
JOUBERT SYNDROME 23; JBTS23	0.000545554	0.02043404247337125
XQ27.3Q28 DUPLICATION SYNDROME	0.000545554	0.02043404247337125
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.000545554	0.02043404247337125
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000545554	0.02043404247337125
SENIOR-LOKEN SYNDROME 9	0.000545554	0.02043404247337125
JOUBERT SYNDROME 24	0.000545554	0.02043404247337125
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.02043404247337125
ISOLATED COMPLEX I DEFICIENCY	0.000545554	0.02043404247337125
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.000545554	0.02043404247337125
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000545554	0.02043404247337125
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.02043404247337125
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.000545554	0.02043404247337125
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.000545554	0.02043404247337125
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000545554	0.02043404247337125
JOUBERT SYNDROME 26	0.000545554	0.02043404247337125
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000545554	0.02043404247337125
SECKEL SYNDROME 9; SCKL9	0.000545554	0.02043404247337125
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000545554	0.02043404247337125
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000545554	0.02043404247337125
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000545554	0.02043404247337125
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000545554	0.02043404247337125
ATELOSTEOGENESIS TYPE III	0.000545554	0.02043404247337125
N SYNDROME	0.000545554	0.02043404247337125
JOUBERT SYNDROME 33; JBTS33	0.000545554	0.02043404247337125
USHER SYNDROME TYPE 1	0.000545554	0.02043404247337125
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000545554	0.02043404247337125
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.000545554	0.02043404247337125
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.000545554	0.02043404247337125
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.000545554	0.02043404247337125
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02043404247337125
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.000545554	0.02043404247337125
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02043404247337125
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.02043404247337125
TRANSALDOLASE DEFICIENCY	0.000545554	0.02043404247337125
GERODERMA OSTEODYSPLASTICA	0.000545554	0.02043404247337125
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.02043404247337125
SPINOCEREBELLAR ATAXIA TYPE 29	0.000545554	0.02043404247337125
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.000545554	0.02043404247337125
NOONAN SYNDROME 11; NS11	0.000545554	0.02043404247337125
BRAIN-LUNG-THYROID SYNDROME	0.000545554	0.02043404247337125
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.000545554	0.02043404247337125
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.000545554	0.02043404247337125
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.000545554	0.02043404247337125
COLE-CARPENTER SYNDROME	0.000545554	0.02043404247337125
RABSON-MENDENHALL SYNDROME	0.000545554	0.02043404247337125
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.000545554	0.02043404247337125
AURICULOCONDYLAR SYNDROME	0.000545554	0.02043404247337125
DYSKERATOSIS CONGENITA	0.000545554	0.02043404247337125
DISTAL TRISOMY 6P	0.000545554	0.02043404247337125
17P11.2 MICRODUPLICATION SYNDROME	0.000545554	0.02043404247337125
DEXTROCARDIA	0.000545554	0.02043404247337125
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.000545554	0.02043404247337125
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.000545554	0.02043404247337125
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.000545554	0.02043404247337125
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.02043404247337125
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.02043404247337125
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.02043404247337125
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.02043404247337125
RING CHROMOSOME 12 SYNDROME	0.000545554	0.02043404247337125
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.000545554	0.02043404247337125
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.000545554	0.02043404247337125
WOLMAN DISEASE	0.000545554	0.02043404247337125
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.02043404247337125
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000545554	0.02043404247337125
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.000545554	0.02043404247337125
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.000545554	0.02043404247337125
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02043404247337125
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000545554	0.02043404247337125
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000545554	0.02043404247337125
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.000545554	0.02043404247337125
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000545554	0.02043404247337125
PERMANENT CONGENITAL HYPOTHYROIDISM	0.000545554	0.02043404247337125
PRIMARY CONGENITAL HYPOTHYROIDISM	0.000545554	0.02043404247337125
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.000545554	0.02043404247337125
PERIPHERAL HYPOTHYROIDISM	0.000545554	0.02043404247337125
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.000545554	0.02043404247337125
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02043404247337125
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000545554	0.02043404247337125
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.000545554	0.02043404247337125
MICROVILLUS INCLUSION DISEASE	0.000545554	0.02043404247337125
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000545554	0.02043404247337125
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.02043404247337125
HYPERTRICHOSIS CUBITI	0.000545554	0.02043404247337125
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.000545554	0.02043404247337125
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.000545554	0.02043404247337125
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.02043404247337125
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.02043404247337125
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.000545554	0.02043404247337125
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.000545554	0.02043404247337125
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.02043404247337125
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000545554	0.02043404247337125
HYDROXYKYNURENINURIA	0.000545554	0.02043404247337125
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000545554	0.02043404247337125
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.02043404247337125
JOUBERT SYNDROME 35; JBTS35	0.000545554	0.02043404247337125
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.000545554	0.02043404247337125
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.000545554	0.02043404247337125
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.000545554	0.02043404247337125
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.000545554	0.02043404247337125
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.000545554	0.02043404247337125
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000545554	0.02043404247337125
JOUBERT SYNDROME 25	0.000545554	0.02043404247337125
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000545554	0.02043404247337125
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000545554	0.02043404247337125
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.000545554	0.02043404247337125
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.000545554	0.02043404247337125
PEROXISOME BIOGENESIS DISORDER 6B	0.000545554	0.02043404247337125
PEROXISOME BIOGENESIS DISORDER 5B	0.000545554	0.02043404247337125
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.000545554	0.02043404247337125
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.000545554	0.02043404247337125
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.000545554	0.02043404247337125
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.02043404247337125
ADAMS-OLIVER SYNDROME 3; AOS3	0.000545554	0.02043404247337125
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.000545554	0.02043404247337125
CONGENITAL VARICELLA SYNDROME	0.000545554	0.02043404247337125
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.02043404247337125
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02043404247337125
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.000545554	0.02043404247337125
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.000545554	0.02043404247337125
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.000545554	0.02043404247337125
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.000545554	0.02043404247337125
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000545554	0.02043404247337125
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000545554	0.02043404247337125
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.000545554	0.02043404247337125
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.000545554	0.02043404247337125
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.02043404247337125
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.000545554	0.02043404247337125
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000545554	0.02043404247337125
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.000545554	0.02043404247337125
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.02043404247337125
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000545554	0.02043404247337125
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000545554	0.02043404247337125
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.000545554	0.02043404247337125
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.000545554	0.02043404247337125
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.000545554	0.02043404247337125
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000545554	0.02043404247337125
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000545554	0.02043404247337125
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.000545554	0.02043404247337125
1P21.3 MICRODELETION SYNDROME	0.000545554	0.02043404247337125
JOUBERT SYNDROME 15	0.000545554	0.02043404247337125
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.000545554	0.02043404247337125
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.000545554	0.02043404247337125
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.000545554	0.02043404247337125
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.000545554	0.02043404247337125
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000545554	0.02043404247337125
AICARDI-GOUTIERES SYNDROME 5	0.000545554	0.02043404247337125
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.000545554	0.02043404247337125
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.02043404247337125
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.000545554	0.02043404247337125
JOUBERT SYNDROME 8	0.000545554	0.02043404247337125
OXOGLUTARIC ACIDURIA	0.000545554	0.02043404247337125
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.000545554	0.02043404247337125
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.000545554	0.02043404247337125
SAY-BARBER-MILLER SYNDROME	0.000545554	0.02043404247337125
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.000545554	0.02043404247337125
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.000545554	0.02043404247337125
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.000545554	0.02043404247337125
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.000545554	0.02043404247337125
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.000545554	0.02043404247337125
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.000545554	0.02043404247337125
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.02043404247337125
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.000545554	0.02043404247337125
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.000545554	0.02043404247337125
CHROMOSOME 15Q25 DELETION SYNDROME	0.000545554	0.02043404247337125
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000545554	0.02043404247337125
HOLOPROSENCEPHALY 11	0.000545554	0.02043404247337125
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000545554	0.02043404247337125
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.02043404247337125
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.000545554	0.02043404247337125
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.000545554	0.02043404247337125
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000545554	0.02043404247337125
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.000545554	0.02043404247337125
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000545554	0.02043404247337125
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000545554	0.02043404247337125
FORSYTHE-WAKELING SYNDROME; FWS	0.000545554	0.02043404247337125
NEPHRONOPHTHISIS 11; NPHP11	0.000545554	0.02043404247337125
OTOFACIOCERVICAL SYNDROME	0.000545554	0.02043404247337125
TRANSKETOLASE DEFICIENCY	0.000545554	0.02043404247337125
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.000545554	0.02043404247337125
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.02043404247337125
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.02043404247337125
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.000545554	0.02043404247337125
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000545554	0.02043404247337125
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000545554	0.02043404247337125
SECKEL SYNDROME 8; SCKL8	0.000545554	0.02043404247337125
LYSOSOMAL ACID LIPASE DEFICIENCY	0.000545554	0.02043404247337125
IMMUNODEFICIENCY 23; IMD23	0.000545554	0.02043404247337125
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.02043404247337125
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000545554	0.02043404247337125
XIA-GIBBS SYNDROME	0.000545554	0.02043404247337125
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.000545554	0.02043404247337125
CULLER-JONES SYNDROME; CJS	0.000545554	0.02043404247337125
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.02043404247337125
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000545554	0.02043404247337125
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.000545554	0.02043404247337125
OCULO-PALATO-CEREBRAL SYNDROME	0.000545554	0.02043404247337125
OROFACIODIGITAL SYNDROME XIV; OFD14	0.000545554	0.02043404247337125
BARDET-BIEDL SYNDROME 2	0.000545554	0.02043404247337125
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.000545554	0.02043404247337125
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.02043404247337125
SHWACHMAN-DIAMOND SYNDROME	0.000545554	0.02043404247337125
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.02043404247337125
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.02043404247337125
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000545554	0.02043404247337125
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000545554	0.02043404247337125
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.02043404247337125
JOUBERT SYNDROME 21	0.000545554	0.02043404247337125
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000545554	0.02043404247337125
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.000545554	0.02043404247337125
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.000545554	0.02043404247337125
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000545554	0.02043404247337125
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000545554	0.02043404247337125
CEREBELLOFACIODENTAL SYNDROME	0.000545554	0.02043404247337125
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.02043404247337125
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000545554	0.02043404247337125
LASSA FEVER	0.000541419	0.020279163642627843
INSULINOMA	0.000541419	0.020279163642627843
ACQUIRED PARTIAL LIPODYSTROPHY	0.000541419	0.020279163642627843
ONDINE SYNDROME	0.000541419	0.020279163642627843
JERVELL AND LANGE-NIELSEN SYNDROME	0.000541419	0.020279163642627843
NIPAH VIRUS DISEASE	0.000541419	0.020279163642627843
MIXED CONNECTIVE TISSUE DISEASE	0.000541419	0.020279163642627843
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.000541419	0.020279163642627843
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.000541419	0.020279163642627843
47,XYY SYNDROME	0.000541419	0.020279163642627843
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.000541419	0.020279163642627843
WHIM SYNDROME	0.000541419	0.020279163642627843
SECONDARY SYRINGOMYELIA	0.000541419	0.020279163642627843
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.000541419	0.020279163642627843
PFEIFFER SYNDROME TYPE 3	0.000541419	0.020279163642627843
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.000541419	0.020279163642627843
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.000541419	0.020279163642627843
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.000541419	0.020279163642627843
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.000541419	0.020279163642627843
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.000541419	0.020279163642627843
POSTENCEPHALITIC PARKINSONISM	0.000541419	0.020279163642627843
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.000541419	0.020279163642627843
SANDHOFF DISEASE	0.000541419	0.020279163642627843
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.000541419	0.020279163642627843
PORPHYRIA	0.000541419	0.020279163642627843
SCLERODERMA	0.000541419	0.020279163642627843
GRISCELLI SYNDROME TYPE 2	0.000541419	0.020279163642627843
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.000541419	0.020279163642627843
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.000541419	0.020279163642627843
NON-FUNCTIONING PITUITARY ADENOMA	0.000541419	0.020279163642627843
PRIMARY CUTIS VERTICIS GYRATA	0.000541419	0.020279163642627843
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.000541419	0.020279163642627843
IMMUNOGLOBULIN A VASCULITIS	0.000541419	0.020279163642627843
TSH-SECRETING PITUITARY ADENOMA	0.000541419	0.020279163642627843
RABIES	0.000541419	0.020279163642627843
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.000541419	0.020279163642627843
FETAL GAUCHER DISEASE	0.000541419	0.020279163642627843
DERMOTRICHIC SYNDROME	0.000541419	0.020279163642627843
ANGELMAN SYNDROME	0.000541419	0.020279163642627843
MEHMO SYNDROME	0.000541419	0.020279163642627843
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.000541419	0.020279163642627843
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.000541419	0.020279163642627843
FAMILIAL THROMBOCYTOSIS	0.000541419	0.020279163642627843
ADRENOMYODYSTROPHY	0.000541419	0.020279163642627843
MALIGNANT ATROPHIC PAPULOSIS	0.000541419	0.020279163642627843
FRAGILE X SYNDROME	0.000541419	0.020279163642627843
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.020279163642627843
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.000541419	0.020279163642627843
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.000541419	0.020279163642627843
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.000541419	0.020279163642627843
FAMILIAL MULTIPLE NEVI FLAMMEI	0.000541419	0.020279163642627843
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.000541419	0.020279163642627843
MYASTHENIA GRAVIS	0.000541419	0.020279163642627843
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.020279163642627843
ALG2-CDG	0.000541419	0.020279163642627843
ACUTE ADRENAL INSUFFICIENCY	0.000541419	0.020279163642627843
CONGENITAL MYASTHENIC SYNDROME	0.000541419	0.020279163642627843
MPDU1-CDG	0.000541419	0.020279163642627843
OCULOCEREBRORENAL SYNDROME OF LOWE	0.000541419	0.020279163642627843
L-2-HYDROXYGLUTARIC ACIDURIA	0.000541419	0.020279163642627843
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.000541419	0.020279163642627843
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.020279163642627843
DPM1-CDG	0.000541419	0.020279163642627843
SJÖGREN-LARSSON SYNDROME	0.000541419	0.020279163642627843
MUSCLE-EYE-BRAIN DISEASE	0.000541419	0.020279163642627843
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.000541419	0.020279163642627843
CAMOS SYNDROME	0.000541419	0.020279163642627843
SCRUB TYPHUS	0.000541419	0.020279163642627843
HEREDITARY METHEMOGLOBINEMIA	0.000541419	0.020279163642627843
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.000541419	0.020279163642627843
PARTINGTON SYNDROME	0.000541419	0.020279163642627843
CENTRONUCLEAR MYOPATHY	0.000541419	0.020279163642627843
RENIER-GABREELS-JASPER SYNDROME	0.000541419	0.020279163642627843
SMITH-FINEMAN-MYERS SYNDROME	0.000541419	0.020279163642627843
ISOLATED SPINA BIFIDA	0.000541419	0.020279163642627843
X-LINKED CENTRONUCLEAR MYOPATHY	0.000541419	0.020279163642627843
LYMPHANGIOLEIOMYOMATOSIS	0.000541419	0.020279163642627843
ENCEPHALITIS LETHARGICA	0.000541419	0.020279163642627843
3-HYDROXYISOBUTYRIC ACIDURIA	0.000541419	0.020279163642627843
SYSTEMIC SCLEROSIS	0.000541419	0.020279163642627843
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000541419	0.020279163642627843
LHERMITTE-DUCLOS DISEASE	0.000541419	0.020279163642627843
LEIGH SYNDROME	0.000541419	0.020279163642627843
DEND SYNDROME	0.000541419	0.020279163642627843
ACUTE BILIRUBIN ENCEPHALOPATHY	0.000541419	0.020279163642627843
EPISODIC ATAXIA TYPE 3	0.000541419	0.020279163642627843
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.000541419	0.020279163642627843
PORPHYRIA VARIEGATA	0.000541419	0.020279163642627843
NEVUS COMEDONICUS SYNDROME	0.000541419	0.020279163642627843
RECURRENT ACUTE PANCREATITIS	0.000541419	0.020279163642627843
CRIGLER-NAJJAR SYNDROME TYPE 1	0.000541419	0.020279163642627843
7Q11.23 MICRODUPLICATION SYNDROME	0.000541419	0.020279163642627843
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.000541419	0.020279163642627843
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.000541419	0.020279163642627843
NEUROFIBROMATOSIS TYPE 1	0.000541419	0.020279163642627843
LIPOID PROTEINOSIS	0.000541419	0.020279163642627843
ADDISON DISEASE	0.000541419	0.020279163642627843
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.000541419	0.020279163642627843
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020279163642627843
HEREDITARY COPROPORPHYRIA	0.000541419	0.020279163642627843
ECTODERMAL DYSPLASIA SYNDROME	0.000541419	0.020279163642627843
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.000541419	0.020279163642627843
GRANULOMATOSIS WITH POLYANGIITIS	0.000541419	0.020279163642627843
MOGS-CDG	0.000541419	0.020279163642627843
ACUTE INTERMITTENT PORPHYRIA	0.000541419	0.020279163642627843
ALG9-CDG	0.000541419	0.020279163642627843
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.000541419	0.020279163642627843
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.000541419	0.020279163642627843
WOLF-HIRSCHHORN SYNDROME	0.000541419	0.020279163642627843
KALLMANN SYNDROME	0.000541419	0.020279163642627843
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.000541419	0.020279163642627843
MUCOPOLYSACCHARIDOSIS, TYPE II	0.000541419	0.020279163642627843
CYCLIC VOMITING SYNDROME	0.000541419	0.020279163642627843
KEARNS-SAYRE SYNDROME; KSS	0.000541419	0.020279163642627843
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000541419	0.020279163642627843
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000541419	0.020279163642627843
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.000541419	0.020279163642627843
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000541419	0.020279163642627843
GURRIERI SYNDROME	0.000541419	0.020279163642627843
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000541419	0.020279163642627843
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000541419	0.020279163642627843
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000541419	0.020279163642627843
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.000541419	0.020279163642627843
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.000541419	0.020279163642627843
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.020279163642627843
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.000541419	0.020279163642627843
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000541419	0.020279163642627843
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000541419	0.020279163642627843
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.020279163642627843
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.000541419	0.020279163642627843
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.020279163642627843
GLYCINE ENCEPHALOPATHY; GCE	0.000541419	0.020279163642627843
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000541419	0.020279163642627843
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000541419	0.020279163642627843
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.000541419	0.020279163642627843
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.000541419	0.020279163642627843
GRISCELLI SYNDROME, TYPE 2; GS2	0.000541419	0.020279163642627843
ALZHEIMER DISEASE 3; AD	0.000541419	0.020279163642627843
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.000541419	0.020279163642627843
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000541419	0.020279163642627843
MICROPHTHALMIA, SYNDROMIC 1	0.000541419	0.020279163642627843
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000541419	0.020279163642627843
ADRENOLEUKODYSTROPHY	0.000541419	0.020279163642627843
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000541419	0.020279163642627843
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.000541419	0.020279163642627843
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.000541419	0.020279163642627843
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.020279163642627843
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000541419	0.020279163642627843
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000541419	0.020279163642627843
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000541419	0.020279163642627843
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.000541419	0.020279163642627843
MENTAL RETARDATION, X-LINKED 82	0.000541419	0.020279163642627843
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.020279163642627843
FRAGILE X MENTAL RETARDATION SYNDROME	0.000541419	0.020279163642627843
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000541419	0.020279163642627843
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.020279163642627843
MENTAL RETARDATION, X-LINKED 100	0.000541419	0.020279163642627843
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.000541419	0.020279163642627843
MENTAL RETARDATION, X-LINKED 102	0.000541419	0.020279163642627843
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.000541419	0.020279163642627843
IMMUNODEFICIENCY 47	0.000541419	0.020279163642627843
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.000541419	0.020279163642627843
COFFIN-LOWRY SYNDROME; CLS	0.000541419	0.020279163642627843
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.000541419	0.020279163642627843
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.000541419	0.020279163642627843
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.020279163642627843
ICHTHYOSIS AND MALE HYPOGONADISM	0.000541419	0.020279163642627843
INCONTINENTIA PIGMENTI; IP	0.000541419	0.020279163642627843
LOWE OCULOCEREBRORENAL SYNDROME	0.000541419	0.020279163642627843
MENKES DISEASE	0.000541419	0.020279163642627843
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000541419	0.020279163642627843
MENTAL RETARDATION, X-LINKED 1	0.000541419	0.020279163642627843
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.000541419	0.020279163642627843
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000541419	0.020279163642627843
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.000541419	0.020279163642627843
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.000541419	0.020279163642627843
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.000541419	0.020279163642627843
PERRAULT SYNDROME 3	0.000541419	0.020279163642627843
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000541419	0.020279163642627843
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000541419	0.020279163642627843
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.000541419	0.020279163642627843
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.020279163642627843
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.000541419	0.020279163642627843
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000541419	0.020279163642627843
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.000541419	0.020279163642627843
BARAITSER-WINTER SYNDROME 2; BRWS2	0.000541419	0.020279163642627843
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000541419	0.020279163642627843
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.000541419	0.020279163642627843
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.000541419	0.020279163642627843
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.000541419	0.020279163642627843
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.000541419	0.020279163642627843
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.000541419	0.020279163642627843
AUTISM, SUSCEPTIBILITY TO, 18	0.000541419	0.020279163642627843
COWDEN SYNDROME 5; CWS5	0.000541419	0.020279163642627843
COWDEN SYNDROME 6; CWS6	0.000541419	0.020279163642627843
LISSENCEPHALY 5; LIS5	0.000541419	0.020279163642627843
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.000541419	0.020279163642627843
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000541419	0.020279163642627843
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000541419	0.020279163642627843
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.000541419	0.020279163642627843
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000541419	0.020279163642627843
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000541419	0.020279163642627843
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000541419	0.020279163642627843
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.000541419	0.020279163642627843
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000541419	0.020279163642627843
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.000541419	0.020279163642627843
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.000541419	0.020279163642627843
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.000541419	0.020279163642627843
RETINITIS PIGMENTOSA 59; RP59	0.000541419	0.020279163642627843
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.000541419	0.020279163642627843
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.000541419	0.020279163642627843
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.000541419	0.020279163642627843
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.000541419	0.020279163642627843
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.000541419	0.020279163642627843
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000541419	0.020279163642627843
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000541419	0.020279163642627843
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.000541419	0.020279163642627843
PACHYGYRIA, FRONTOTEMPORAL	0.000541419	0.020279163642627843
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.000541419	0.020279163642627843
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000541419	0.020279163642627843
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000541419	0.020279163642627843
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000541419	0.020279163642627843
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000541419	0.020279163642627843
LISSENCEPHALY 3; LIS3	0.000541419	0.020279163642627843
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000541419	0.020279163642627843
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.000541419	0.020279163642627843
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.020279163642627843
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.000541419	0.020279163642627843
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.000541419	0.020279163642627843
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.000541419	0.020279163642627843
EPISODIC ATAXIA, TYPE 6	0.000541419	0.020279163642627843
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000541419	0.020279163642627843
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000541419	0.020279163642627843
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.000541419	0.020279163642627843
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.000541419	0.020279163642627843
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.000541419	0.020279163642627843
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.000541419	0.020279163642627843
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.000541419	0.020279163642627843
MENTAL RETARDATION, X-LINKED 21	0.000541419	0.020279163642627843
LISSENCEPHALY, X-LINKED, 1; LISX1	0.000541419	0.020279163642627843
HEREDITARY FRUCTOSE INTOLERANCE	0.000541419	0.020279163642627843
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.000541419	0.020279163642627843
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.020279163642627843
STURGE-WEBER SYNDROME	0.000541419	0.020279163642627843
SUPRABULBAR PARESIS, CONGENITAL	0.000541419	0.020279163642627843
PREECLAMPSIA/ECLAMPSIA 1	0.000541419	0.020279163642627843
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.000541419	0.020279163642627843
ACTH DEFICIENCY, ISOLATED; IAD	0.000541419	0.020279163642627843
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.000541419	0.020279163642627843
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000541419	0.020279163642627843
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000541419	0.020279163642627843
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.000541419	0.020279163642627843
AUTISM	0.000541419	0.020279163642627843
BANGSTAD SYNDROME	0.000541419	0.020279163642627843
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000541419	0.020279163642627843
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.000541419	0.020279163642627843
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.020279163642627843
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.000541419	0.020279163642627843
CEREBELLOPARENCHYMAL DISORDER II	0.000541419	0.020279163642627843
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.000541419	0.020279163642627843
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.000541419	0.020279163642627843
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.000541419	0.020279163642627843
COCKAYNE SYNDROME A; CSA	0.000541419	0.020279163642627843
COHEN SYNDROME	0.000541419	0.020279163642627843
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000541419	0.020279163642627843
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.000541419	0.020279163642627843
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000541419	0.020279163642627843
CROME SYNDROME	0.000541419	0.020279163642627843
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.000541419	0.020279163642627843
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.000541419	0.020279163642627843
DIAMINOPENTANURIA	0.000541419	0.020279163642627843
SNEDDON SYNDROME	0.000541419	0.020279163642627843
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000541419	0.020279163642627843
MENTAL RETARDATION, X-LINKED 14	0.000541419	0.020279163642627843
PARIETAL FORAMINA	0.000541419	0.020279163642627843
1P36 MICRODELETION SYNDROME	0.000541419	0.020279163642627843
ANGELMAN SYNDROME (TYPE 1)	0.000541419	0.020279163642627843
2Q33.1 DELETION SYNDROME	0.000541419	0.020279163642627843
ANGELMAN SYNDROME (TYPE 2)	0.000541419	0.020279163642627843
NEUROFIBROMATOSIS, TYPE II	0.000541419	0.020279163642627843
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.020279163642627843
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.000541419	0.020279163642627843
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000541419	0.020279163642627843
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000541419	0.020279163642627843
PAPILLORENAL SYNDROME	0.000541419	0.020279163642627843
CROUZON SYNDROME	0.000541419	0.020279163642627843
DARIER-WHITE DISEASE; DAR	0.000541419	0.020279163642627843
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000541419	0.020279163642627843
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.000541419	0.020279163642627843
EPILEPSY, BENIGN OCCIPITAL	0.000541419	0.020279163642627843
EPILEPSY, READING	0.000541419	0.020279163642627843
FLYNN-AIRD SYNDROME	0.000541419	0.020279163642627843
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.020279163642627843
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.000541419	0.020279163642627843
HUNTINGTON DISEASE; HD	0.000541419	0.020279163642627843
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.020279163642627843
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000541419	0.020279163642627843
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000541419	0.020279163642627843
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.000541419	0.020279163642627843
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.020279163642627843
NEUROFIBROMATOSIS, TYPE I	0.000541419	0.020279163642627843
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000541419	0.020279163642627843
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000541419	0.020279163642627843
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.020279163642627843
224250 DYSMYELINATION WITH JAUNDICE	0.000541419	0.020279163642627843
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.000541419	0.020279163642627843
EPILEPSY-TELANGIECTASIA	0.000541419	0.020279163642627843
VISCERAL STEATOSIS, CONGENITAL	0.000541419	0.020279163642627843
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.000541419	0.020279163642627843
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.000541419	0.020279163642627843
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.000541419	0.020279163642627843
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.000541419	0.020279163642627843
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000541419	0.020279163642627843
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.000541419	0.020279163642627843
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.000541419	0.020279163642627843
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.000541419	0.020279163642627843
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000541419	0.020279163642627843
NEURAMINIDASE DEFICIENCY	0.000541419	0.020279163642627843
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.000541419	0.020279163642627843
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.020279163642627843
PHENYLKETONURIA	0.000541419	0.020279163642627843
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000541419	0.020279163642627843
GITELMAN SYNDROME	0.000541419	0.020279163642627843
GLUTATHIONE SYNTHETASE DEFICIENCY	0.000541419	0.020279163642627843
RAMON SYNDROME	0.000541419	0.020279163642627843
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.020279163642627843
KNOBLOCH SYNDROME 1; KNO1	0.000541419	0.020279163642627843
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.000541419	0.020279163642627843
SJOGREN-LARSSON SYNDROME; SLS	0.000541419	0.020279163642627843
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.000541419	0.020279163642627843
TAY-SACHS DISEASE; TSD	0.000541419	0.020279163642627843
THREONINEMIA	0.000541419	0.020279163642627843
THYROCEREBRORETINAL SYNDROME	0.000541419	0.020279163642627843
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.000541419	0.020279163642627843
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.000541419	0.020279163642627843
XYLOSIDASE DEFICIENCY	0.000541419	0.020279163642627843
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.000541419	0.020279163642627843
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.000541419	0.020279163642627843
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.000541419	0.020279163642627843
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000541419	0.020279163642627843
HYPOADRENOCORTICISM, FAMILIAL	0.000541419	0.020279163642627843
FOUNTAIN SYNDROME	0.000541419	0.020279163642627843
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.020279163642627843
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.020279163642627843
GAPO SYNDROME; GAPOS	0.000541419	0.020279163642627843
GAUCHER DISEASE, TYPE IIIC	0.000541419	0.020279163642627843
BERNARD-SOULIER SYNDROME	0.000541419	0.020279163642627843
GLUTARIC ACIDEMIA I; GA1	0.000541419	0.020279163642627843
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000541419	0.020279163642627843
HYPER-BETA-ALANINEMIA	0.000541419	0.020279163642627843
HYPERLEUCINE-ISOLEUCINEMIA	0.000541419	0.020279163642627843
HYPERLYSINEMIA, TYPE I	0.000541419	0.020279163642627843
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.020279163642627843
HYPERPROLINEMIA, TYPE II	0.000541419	0.020279163642627843
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.020279163642627843
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000541419	0.020279163642627843
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.000541419	0.020279163642627843
HYPOPHOSPHATASIA, INFANTILE	0.000541419	0.020279163642627843
HYPOPHOSPHATASIA, CHILDHOOD	0.000541419	0.020279163642627843
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.020279163642627843
KAPUR-TORIELLO SYNDROME	0.000541419	0.020279163642627843
KEUTEL SYNDROME; KTLS	0.000541419	0.020279163642627843
KIFAFA SEIZURE DISORDER	0.000541419	0.020279163642627843
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.020279163642627843
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.000541419	0.020279163642627843
MAPLE SYRUP URINE DISEASE; MSUD	0.000541419	0.020279163642627843
MEGALENCEPHALY WITH DYSMYELINATION	0.000541419	0.020279163642627843
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.020279163642627843
METACHROMATIC LEUKODYSTROPHY	0.000541419	0.020279163642627843
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.000541419	0.020279163642627843
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.000541419	0.020279163642627843
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.000541419	0.020279163642627843
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.000541419	0.020279163642627843
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.000541419	0.020279163642627843
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.000541419	0.020279163642627843
EPENDYMOMA	0.000541419	0.020279163642627843
SUBEPENDYMOMA	0.000541419	0.020279163642627843
PINEOBLASTOMA	0.000541419	0.020279163642627843
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.000541419	0.020279163642627843
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.000541419	0.020279163642627843
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.000541419	0.020279163642627843
MICROSPORIDIOSIS	0.000541419	0.020279163642627843
MOYAMOYA DISEASE	0.000541419	0.020279163642627843
MOYNAHAN SYNDROME	0.000541419	0.020279163642627843
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.020279163642627843
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.020279163642627843
LINEAR VERRUCOUS NEVUS SYNDROME	0.000541419	0.020279163642627843
17Q12 MICRODUPLICATION SYNDROME	0.000541419	0.020279163642627843
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.000541419	0.020279163642627843
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.000541419	0.020279163642627843
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.000541419	0.020279163642627843
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.000541419	0.020279163642627843
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.000541419	0.020279163642627843
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.000541419	0.020279163642627843
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.000541419	0.020279163642627843
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.000541419	0.020279163642627843
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020279163642627843
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.020279163642627843
INHERITED CREUTZFELDT-JAKOB DISEASE	0.000541419	0.020279163642627843
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.000541419	0.020279163642627843
TYROSINEMIA TYPE 2	0.000541419	0.020279163642627843
PHAKOMATOSIS PIGMENTOVASCULARIS	0.000541419	0.020279163642627843
1Q41Q42 MICRODELETION SYNDROME	0.000541419	0.020279163642627843
JUVENILE HUNTINGTON DISEASE	0.000541419	0.020279163642627843
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.000541419	0.020279163642627843
NEUROCUTANEOUS MELANOCYTOSIS	0.000541419	0.020279163642627843
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.000541419	0.020279163642627843
EPISODIC ATAXIA TYPE 6	0.000541419	0.020279163642627843
HARROD SYNDROME	0.000541419	0.020279163642627843
CYSTATHIONINURIA	0.000541419	0.020279163642627843
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.000541419	0.020279163642627843
NODULAR NEURONAL HETEROTOPIA	0.000541419	0.020279163642627843
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.020279163642627843
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.000541419	0.020279163642627843
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.000541419	0.020279163642627843
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.000541419	0.020279163642627843
CONGENITAL HYDROCEPHALUS	0.000541419	0.020279163642627843
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.000541419	0.020279163642627843
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.020279163642627843
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.000541419	0.020279163642627843
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.000541419	0.020279163642627843
5Q14.3 MICRODELETION SYNDROME	0.000541419	0.020279163642627843
5Q35 MICRODUPLICATION SYNDROME	0.000541419	0.020279163642627843
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.000541419	0.020279163642627843
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.000541419	0.020279163642627843
KABUKI SYNDROME	0.000541419	0.020279163642627843
SANJAD-SAKATI SYNDROME	0.000541419	0.020279163642627843
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.000541419	0.020279163642627843
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.000541419	0.020279163642627843
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020279163642627843
4Q21 MICRODELETION SYNDROME	0.000541419	0.020279163642627843
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.000541419	0.020279163642627843
LOWRY-MACLEAN SYNDROME	0.000541419	0.020279163642627843
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.000541419	0.020279163642627843
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.000541419	0.020279163642627843
CONGENITAL RUBELLA SYNDROME	0.000541419	0.020279163642627843
CRONKHITE-CANADA SYNDROME	0.000541419	0.020279163642627843
PORENCEPHALY	0.000541419	0.020279163642627843
PROLACTINOMA	0.000541419	0.020279163642627843
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.000541419	0.020279163642627843
WORSTER-DROUGHT SYNDROME	0.000541419	0.020279163642627843
ZIMMERMANN-LABAND SYNDROME	0.000541419	0.020279163642627843
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.020279163642627843
GALACTOSIALIDOSIS	0.000541419	0.020279163642627843
GM1 GANGLIOSIDOSIS	0.000541419	0.020279163642627843
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.000541419	0.020279163642627843
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.020279163642627843
GLIOBLASTOMA	0.000541419	0.020279163642627843
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.000541419	0.020279163642627843
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.000541419	0.020279163642627843
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.000541419	0.020279163642627843
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.000541419	0.020279163642627843
ATYPICAL JUVENILE PARKINSONISM	0.000541419	0.020279163642627843
CLASSIC HOMOCYSTINURIA	0.000541419	0.020279163642627843
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.000541419	0.020279163642627843
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.000541419	0.020279163642627843
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.000541419	0.020279163642627843
GYRATE ATROPHY OF CHOROID AND RETINA	0.000541419	0.020279163642627843
HYPERPROLINEMIA TYPE 1	0.000541419	0.020279163642627843
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.000541419	0.020279163642627843
HYPOPHOSPHATASIA	0.000541419	0.020279163642627843
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.000541419	0.020279163642627843
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.020279163642627843
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.000541419	0.020279163642627843
ADENYLOSUCCINATE LYASE DEFICIENCY	0.000541419	0.020279163642627843
PAROXYSMAL EXTREME PAIN DISORDER	0.000541419	0.020279163642627843
ACQUIRED METHEMOGLOBINEMIA	0.000541419	0.020279163642627843
SLC39A8-CDG	0.000541419	0.020279163642627843
FAMILIAL MEDITERRANEAN FEVER	0.000541419	0.020279163642627843
VIRAL HEMORRHAGIC FEVER	0.000541419	0.020279163642627843
TRISOMY 13	0.000541419	0.020279163642627843
LUJO HEMORRHAGIC FEVER	0.000541419	0.020279163642627843
LEUKOCYTE ADHESION DEFICIENCY	0.000541419	0.020279163642627843
SPONTANEOUS PERIODIC HYPOTHERMIA	0.000541419	0.020279163642627843
DDOST-CDG	0.000541419	0.020279163642627843
RAMON SYNDROME	0.000541419	0.020279163642627843
ISOLATED BILIARY ATRESIA	0.000541419	0.020279163642627843
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.000541419	0.020279163642627843
BENIGN FAMILIAL INFANTILE EPILEPSY	0.000541419	0.020279163642627843
FADD-RELATED IMMUNODEFICIENCY	0.000541419	0.020279163642627843
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.000541419	0.020279163642627843
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.000541419	0.020279163642627843
NOCARDIOSIS	0.000541419	0.020279163642627843
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.000541419	0.020279163642627843
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.000541419	0.020279163642627843
EBOLA HEMORRHAGIC FEVER	0.000541419	0.020279163642627843
THYROCEREBRORENAL SYNDROME	0.000541419	0.020279163642627843
RIFT VALLEY FEVER	0.000541419	0.020279163642627843
HEREDITARY HYPEREKPLEXIA	0.000541419	0.020279163642627843
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.000541419	0.020279163642627843
STURGE-WEBER SYNDROME	0.000541419	0.020279163642627843
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.000541419	0.020279163642627843
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.000541419	0.020279163642627843
EARLY-ONSET LAFORA BODY DISEASE	0.000541419	0.020279163642627843
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.000541419	0.020279163642627843
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.000541419	0.020279163642627843
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.000541419	0.020279163642627843
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.000541419	0.020279163642627843
TAKAYASU ARTERITIS	0.000541419	0.020279163642627843
MERCURY POISONING	0.000541419	0.020279163642627843
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.020279163642627843
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.020279163642627843
CRIGLER-NAJJAR SYNDROME	0.000541419	0.020279163642627843
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.000541419	0.020279163642627843
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.000541419	0.020279163642627843
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000541419	0.020279163642627843
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.000541419	0.020279163642627843
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.000541419	0.020279163642627843
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000541419	0.020279163642627843
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000541419	0.020279163642627843
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.000541419	0.020279163642627843
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000541419	0.020279163642627843
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.000541419	0.020279163642627843
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.000541419	0.020279163642627843
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.000541419	0.020279163642627843
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.020279163642627843
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000541419	0.020279163642627843
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.000541419	0.020279163642627843
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000541419	0.020279163642627843
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000541419	0.020279163642627843
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.000541419	0.020279163642627843
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.000541419	0.020279163642627843
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000541419	0.020279163642627843
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.020279163642627843
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000541419	0.020279163642627843
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.000541419	0.020279163642627843
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.000541419	0.020279163642627843
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.000541419	0.020279163642627843
COFFIN-SIRIS SYNDROME 8; CSS8	0.000541419	0.020279163642627843
ATAXIA-TELANGIECTASIA	0.000541419	0.020279163642627843
ABETA AMYLOIDOSIS, DUTCH TYPE	0.000541419	0.020279163642627843
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020279163642627843
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.000541419	0.020279163642627843
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.000541419	0.020279163642627843
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000541419	0.020279163642627843
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.000541419	0.020279163642627843
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.000541419	0.020279163642627843
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.020279163642627843
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.020279163642627843
PERRAULT SYNDROME 5; PRLTS5	0.000541419	0.020279163642627843
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000541419	0.020279163642627843
TENORIO SYNDROME; TNORS	0.000541419	0.020279163642627843
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000541419	0.020279163642627843
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.000541419	0.020279163642627843
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000541419	0.020279163642627843
INFANTILE LIVER FAILURE SYNDROME 2	0.000541419	0.020279163642627843
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000541419	0.020279163642627843
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.000541419	0.020279163642627843
SMITH-KINGSMORE SYNDROME; SKS	0.000541419	0.020279163642627843
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.000541419	0.020279163642627843
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.000541419	0.020279163642627843
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.000541419	0.020279163642627843
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.000541419	0.020279163642627843
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.000541419	0.020279163642627843
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.000541419	0.020279163642627843
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.020279163642627843
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.020279163642627843
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.000541419	0.020279163642627843
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.000541419	0.020279163642627843
SUDDEN CARDIAC FAILURE, INFANTILE	0.000541419	0.020279163642627843
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.000541419	0.020279163642627843
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.000541419	0.020279163642627843
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.000541419	0.020279163642627843
PSEUDO-TORCH SYNDROME 2	0.000541419	0.020279163642627843
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.000541419	0.020279163642627843
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.000541419	0.020279163642627843
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.000541419	0.020279163642627843
PULMONARY ARTERIOVENOUS MALFORMATION	0.000541419	0.020279163642627843
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.000541419	0.020279163642627843
CRYPTOCOCCOSIS	0.000541419	0.020279163642627843
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.000541419	0.020279163642627843
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.000541419	0.020279163642627843
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.000541419	0.020279163642627843
HUNTINGTON DISEASE-LIKE 1	0.000541419	0.020279163642627843
HUNTINGTON DISEASE-LIKE 3	0.000541419	0.020279163642627843
ROSAÏ-DORFMAN DISEASE	0.000541419	0.020279163642627843
2Q24 MICRODELETION SYNDROME	0.000541419	0.020279163642627843
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.020279163642627843
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.000541419	0.020279163642627843
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020279163642627843
DISTAL TRISOMY 15Q	0.000541419	0.020279163642627843
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.000541419	0.020279163642627843
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.000541419	0.020279163642627843
FAMILIAL DYSAUTONOMIA	0.000541419	0.020279163642627843
DYSEQUILIBRIUM SYNDROME	0.000541419	0.020279163642627843
CENTRAL DIABETES INSIPIDUS	0.000541419	0.020279163642627843
EDINBURGH MALFORMATION SYNDROME	0.000541419	0.020279163642627843
COCKAYNE SYNDROME	0.000541419	0.020279163642627843
FRONTAL ENCEPHALOCELE	0.000541419	0.020279163642627843
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.000541419	0.020279163642627843
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.020279163642627843
EPILEPSY-TELANGIECTASIA SYNDROME	0.000541419	0.020279163642627843
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.000541419	0.020279163642627843
FAMILIAL MULTIPLE LIPOMATOSIS	0.000541419	0.020279163642627843
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.000541419	0.020279163642627843
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.000541419	0.020279163642627843
ENDOCARDIAL FIBROELASTOSIS	0.000541419	0.020279163642627843
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.000541419	0.020279163642627843
CRISPONI SYNDROME	0.000541419	0.020279163642627843
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.000541419	0.020279163642627843
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.000541419	0.020279163642627843
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.000541419	0.020279163642627843
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.020279163642627843
ROMANO-WARD SYNDROME	0.000541419	0.020279163642627843
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.000541419	0.020279163642627843
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.000541419	0.020279163642627843
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.000541419	0.020279163642627843
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.020279163642627843
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.000541419	0.020279163642627843
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.000541419	0.020279163642627843
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.000541419	0.020279163642627843
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.000541419	0.020279163642627843
BETA-MANNOSIDOSIS	0.000541419	0.020279163642627843
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.000541419	0.020279163642627843
PROGRESSIVE HEMIFACIAL ATROPHY	0.000541419	0.020279163642627843
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.000541419	0.020279163642627843
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.000541419	0.020279163642627843
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.000541419	0.020279163642627843
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.000541419	0.020279163642627843
SYMMETRICAL THALAMIC CALCIFICATIONS	0.000541419	0.020279163642627843
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.000541419	0.020279163642627843
BETA-KETOTHIOLASE DEFICIENCY	0.000541419	0.020279163642627843
HISTIOCYTOID CARDIOMYOPATHY	0.000541419	0.020279163642627843
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.000541419	0.020279163642627843
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.000541419	0.020279163642627843
ISOLATED CEREBELLAR AGENESIS	0.000541419	0.020279163642627843
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.000541419	0.020279163642627843
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.020279163642627843
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.000541419	0.020279163642627843
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.000541419	0.020279163642627843
ATYPICAL TERATOID RHABDOID TUMOR	0.000541419	0.020279163642627843
